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I. Introduction
Cell adhesion is critical for the genesis and mainte-
nance of both three-dimensional structure and normal
function in tissues. The biochemical entities mediating
cell adhesion are multiprotein complexes comprising
three broad classes of macromolecules: the adhesion re-
ceptors, the extracellular matrix molecules, and the ad-
hesion plaque proteins (Gumbiner, 1996). Cell adhesion
receptors are typically transmembrane glycoproteins
that mediate binding to extracellular matrix (ECM)
b
molecules or to counter-receptors on other cells; these
molecules determine the specificity of cell-cell or cell-
ECM interaction. The ECM proteins are usually fibrillar
in nature and provide a complex structural and func-
tional network that can interact simultaneously with
multiple cell surface receptors. The intracellular plaque
proteins (or peripheral membrane proteins) provide
structural and functional linkages between adhesion re-
ceptors and the actin microfilaments, microtubules, and
intermediate filaments of the cytoskeleton. An exciting
concept that has emerged from recent cell biological
research is that cell adhesion complexes are not simply
static architectural entities. Rather, they are dynamic
units that are capable of capturing and integrating sig-
nals from the extracellular environment (Rosales et al.,
1995). Moreover, the functions of cell adhesion com-
plexes are regulated precisely by biochemical events
within the cell. Thus cell adhesion receptors are at a
nexus of two-way signaling between the cell and its
external environment. This review will examine current
knowledge concerning signal transduction events initi-
ated or modulated by cell adhesion receptors. The em-
phasis will be on the integrin family of receptors because
their signaling functions have been studied more exten-
sively than those of other adhesion receptor families.
However, we also will examine signaling events involv-
ing the cadherin, immunoglobulin-cell adhesion mole-
cule (Ig-CAM), and selectin families of adhesion recep-
tors. Adhesion-mediated signaling influences several
critical cellular processes including gene expression, cell
cycle, and programmed cell death; these aspects will be
explored. However, the major emphasis of this review
will be on mechanisms of adhesion receptor signaling.
II. Families of Cell Adhesion Receptors
A. Overview
This section will review some of the key features of the
integrin, cadherin, Ig-CAM, and selectin families of cell
adhesion receptors. Because there are thousands of pub-
lications on these topics (Edelman, 1993), only a few
research articles and reviews will be used here to intro-
duce some key ideas about these molecules. A diagram of
the structures of several types of adhesion receptors,
their counter-receptors, and some of their associated
cytoskeletal components is presented in fig. 1.
B. Integrins
The integrins are a family of cell-surface glycoproteins
that act as receptors for ECM proteins, or for membrane-
bound counter-receptors on other cells. Integrin-medi-
ated cell-ECM adhesion sites are complex specialized
structures termed focal contacts or focal adhesions
(Jockush et al., 1995) and are discussed in more detail in
Section III. Each integrin is a heterodimer that contains
an a and a b subunit with each subunit having a large
extracellular domain, a single membrane-spanning re-
gion, and in most cases (other than b4), a short cytoplas-
mic domain (Hynes, 1992; Rosales et al., 1992; Ruos-
lahti, 1991). The integrin receptor family of vertebrates
includes at least 16 distinct a subunits and 8 or more b
subunits which can associate to form more than 20 dis-
b Abbreviations: AA, arachidonic acid; APC, adenomatous polyp-
osis coli; CAKb, cell adhesion kinase b; CAS, Crk-associated sub-
strate; CDI, cyclin-dependent kinase inhibitor protein; CEF, chicken
embryo fibroblast; CHD, CAM-homology domain; CHO, Chinese
hamster ovary; CIB, calcium- and integrin-binding protein; CSK,
C-terminal Src kinase; ECM, extracellular matrix; EGF, epidermal
growth factor; ERM, ezrin/radixin/moesin; FAK, focal adhesion ki-
nase; FAT, focal adhesion targeting; FGF, fibroblast growth factor;
FRNK, FAK-related nonkinase; GAP, GTPase-activating protein
family; GDP, guanosine 59-diphosphate; GNEF, guanine nucleotide
exchange factor; GRAF, GTPase regulator associated with FAK;
GRB2, growth factor receptor-binding protein 2; GSK3, glycogen
synthase kinase 3; GTPase, guanosine 59-triphosphatase; IAP, inte-
grin-associated protein; IBP, integrin-binding protein; ICAM, inter-
cellular adhesion molecule; ICAP, integrin cytoplasmic domain-as-
sociated protein; Ig-CAM, immunoglobulin-cell adhesion molecule;
IL, interleukin; ILK, integrin-linked kinase; IP3, inositol triphos-
phate; IRS-1, insulin receptor substrate 1; JNK, Jun N-terminal
kinase; LIM, Lin-II, Islet I and Mec 3; LPA, lysophosphatidic acid;
MAPK, mitogen-activated protein kinase; MEK, MAPK-ERK kinase;
MEKK-1, MEK Kinase-1; MHC, major histocompatibility complex;
MLC, myosin light chain; MLCK, myosin light chain kinase; MLCP,
myosin light chain phosphatase; NCAM, neural cell adhesion mole-
cule; NGF, nerve growth factor; PA, phosphatidic acid; PAF, platelet-
activating factor; PDGF, platelet-derived growth factor; PECAM-1,
platelet endothelial cell adhesion molecule-1; PH, plekstrin homol-
ogy; pHi, intracellular pH; PI-3K, phosphatidylinositol-3-kinase;
PIP2, PI(4,5)P2, phosphatidylinositol 4,5-bisphosphate; PKC, protein
kinase C; PLA2, phospholipase A2; PLC, phospholipase C; PLD,
phospholipase D; PMN, polymorphonuclear leukocyte; PSGL-1, P-
selectin glycoprotein ligand-1; PTP, phosphotyrosine phosphatase;
PYK2, proline-rich tyrosine kinase 2; Rb, retinoblastoma; REF, rat
embryo fibroblast; RPTP, receptor tyrosine kinase phosphatase;
RTK, receptor tyrosine kinase; SAPK, stress-activated protein ki-
nase; SH2, Src homology region 2; SH3, Src homology region 3; SRE,
serum response element; SRF, serum response factor; SYK, spleen
tyrosine kinase; TCF, ternary complex factor; TCR, T-cell receptor;
TNF, tumor necrosis factor; uPAR, urokinase-type plasminogen ac-
tivator receptor; WASP, Wiskott-Aldrich Syndrome protein.
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a/b pairings specify the ligand-binding abilities of the
integrin heterodimers. Although the ligands for inte-
grins are often large ECM proteins such as collagen,
laminin, vitronectin, or fibronectin, some integrins rec-
ognize rather short peptide sequences within the larger
protein, for example, the RGD (Arg-Gly-Asp) sequence
found in fibronectin and vitronectin. Because of this,
there has been considerable interest in the pharmaceu-
tical industry in developing short peptides or peptidomi-
FIG. 1. Families of cell adhesion receptors. This diagram presents basic information about the integrin, cadherin, Ig-CAM, and selectin families of
cell adhesion receptors. It illustrates their approximate structures, their ligands or counter-receptors, and some of their associated cytoskeletal
proteins when they are known. A more detailed description is given in the text. The molecules illustrated here are not drawn to scale.
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of disease processes including coagulation disorders, in-
flammation, and cancer (Arap and Pasqualini, 1998;
Ruoslahti, 1996). In other cases, however, integrin-li-
gand recognition depends on the overall conformation of
the ligand protein (Kuhn and Eble, 1994). For example,
some integrins interact with members of other adhesion
receptor families, including Ig-CAMs and cadherins, in a
manner that does not involve RGD motifs (Felding-
Habermann et al., 1997; Higgins et al., 1998; Piali et al.,
1995). Some integrins, such as a5b1, the “classic” fi-
bronectin receptor, bind to a single ECM protein. More
generally, an individual integrin will recognize several
distinct proteins (Hynes, 1992; Rosales and Juliano,
1995); for example, the avb3 integrin has been reported
to bind collagen VI, laminin, fibronectin, vitronectin,
thrombospondin, Von Willebrand factor, and fibrinogen
(Kuhn and Eble, 1994). Cells often display multiple in-
tegrins capable of interacting with a particular ECM
protein, thus integrin expression is often apparently
redundant, at least in terms of simple cell adhesion.
Some integrin subunits undergo alternative splicing of
their cytoplasmic domain regions in a tissue-type spe-
cific and developmentally regulated manner; this sug-
gests that there are discrete intracellular functions for
individual integrins, as we will discuss in much more
detail below.
The relationships between integrin structure and the
various functions of integrins are being actively investi-
gated. In terms of ligand binding, it seems clear that
both a and b subunit extracellular domains contribute to
the formation of the binding site. The ligand binding
regions of integrins have been explored with chemical
cross-linking of ligands, monoclonal antibodies, muta-
tion, and most recently, molecular modeling and X-ray
crystallography (Loftus et al., 1994; Qu and Leahy, 1995;
Springer, 1997). Three regions apparently are particu-
larly important: (a) a series of seven repeats of approx-
imately 60 amino acids in the N-terminal portion of the
a chain, each containing a putative Ca
21 binding site;
(b) an inserted domain (I-domain) of approximately 200
amino acids found in several a chains and containing a
nucleotide binding fold and a divalent cation coordina-
tion site; (c) an I-domain like region of approximately
250 amino acids found in the N-terminal region of the b
subunit (Loftus and Liddington, 1997). The seven-repeat
sequences of the a chain have been predicted by molec-
ular modeling to form a b-propeller structure with the
upper face of the propeller being the ligand binding
region and the Ca
21 coordination motifs lying on the
lower face (but probably essential to maintain the struc-
ture) (Loftus and Liddington, 1997; Springer, 1997). Pro-
peller structures of this type have been found in a vari-
ety of other proteins, including the b subunit of trimeric
G-proteins (Sondek et al., 1996), and usually are in-
volved in protein-protein interactions. The structure of
the I-domain region has been determined by X-ray crys-
tallography (Lee et al., 1995; Qu and Leahy, 1995); the
divalent ion binding motif has been designated the “met-
al ion-dependent adhesion site” and seems to play a
critical role in ligand coordination for integrins with
I-domains. Less information is available about the
I-domain-like region in the b subunit; however, molecu-
lar modeling and mutagenesis studies support its ligand
binding role (Loftus and Liddington, 1997). Integrins
likely undergo dynamic structural changes as part of the
ligand binding process including relative movements of
subunits and of domains, and conformational changes
within domains (Loftus and Liddington, 1997). As we
will discuss in more detail below, integrins can exist in
various affinity states for their ligands; structural
changes that occur in moving from low- to high-affinity
states (or vice versa) can be detected by certain mono-
clonal antibodies (Hughes et al., 1997).
Integrin cytoplasmic domains are a key nexus of in-
teraction between the extracellular environment and
intracellular structures and signaling cascades. Both
the a and b subunit cytoplasmic domains make impor-
tant contributions to various aspects of overall integrin
function including cytoskeletal organization, cell motil-
ity, signal transduction, and modulation of integrin af-
finity for ligands (“activation”). Several cytoplasmic pro-
teins including talin, a-actinin, and possibly focal
adhesion kinase (FAK) bind directly to the b1 cytoplas-
mic domain and contribute to integrin-cytoskeletal in-
teractions (Burridge and Chrzanowska-Wodnicka, 1996;
Yamada and Geiger, 1997). Studies using truncation,
mutation, or “domain swaps” of cytoplasmic domains
have delineated several important structure-function re-
lationships for this region of integrins. The b cytoplas-
mic domain is critical for recruitment of integrins to
focal contacts because its truncation/mutation impairs
this process; in fact, the b cytoplasmic domain alone,
expressed as a fusion chimera with another membrane
protein, seems sufficient for focal contact localization
(LaFlamme et al., 1992; Reszka et al., 1992; Rosales et
al., 1992). A widely accepted current model is that the a
subunit cytoplasmic domain inhibits certain functions of
the b cytoplasmic domain (e.g., focal contact recruit-
ment) but that binding of a ligand to the integrin re-
lieves this inhibition, possibly by allowing the subunits
to swing apart like a hinge (Burridge and Chrzanowska-
Wodnicka, 1996; Hughes et al., 1996). The b cytoplasmic
domain is also important in signal transduction, partic-
ularly integrin activation of FAK (discussed in detail
below), whereas truncation/mutation of the a cytoplas-
mic domain has little effect on this process (Akiyama et
al., 1994; Bauer et al., 1993; Tahiliani et al., 1997). b
cytoplasmic domains have played a critical role in a
variety of cellular processes including endocytosis (Van
Nhieu et al., 1996), “cross-talk” between different inte-
grins (Blystone et al., 1995), assembly of fibronectin
fibrils (Wu et al., 1995), and cell motility (Pasqualini and
Hemler, 1994), whereas a cytoplasmic domains also can
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et al., 1992).
Like other receptors, integrins can exist in different
affinity states with respect to their ligands. Integrins
can enter a high-affinity (“activated”) state in response
to certain agents that bind the extracellular domain and
influence its conformation (divalent cations, antibodies);
they also can respond to signals generated within the
cell that presumably have an impact on the cytoplasmic
domain (“inside-out signaling”) (Humphries, 1996; Keely
et al., 1998; O’Toole et al., 1994). The activation status of
a particular integrin is cell-type dependent and usually
critically depends on cellular energy metabolism. The
roles of the cytoplasmic domains in integrin activation
have been studied extensively, and the findings are
quite complex. For example, partial truncation of a4, a2,
or b2 cytoplasmic domains prevents integrin activation,
whereas truncation of the aIIb subunit activates the
fibrinogen-binding integrin aIIbb3 (O’Toole et al., 1994).
Recently, a coherent model of how cytoplasmic domain
structure relates to integrin activation has been pre-
sented (Hughes et al., 1996). The membrane proximal
regions of all a and b subunits are highly conserved,
whereas the remainder of the subunits are quite diver-
gent. The conserved a sequence is GFFKR, whereas the
conserved b sequence is LLv-iHDR. Deletion of either of
these conserved sequences activates the integrin, essen-
tially “locking” it in a high-affinity conformation inde-
pendent of cellular energy metabolism, whereas muta-
tion at sites C-terminal to these conserved sequences
can affect energy-dependent activation (Hughes et al.,
1996; O’Toole et al., 1994). The conserved membrane
proximal sequences may interact through salt bridges
between the subunits, normally keeping the integrin in
a low-affinity state. Cytoplasmic events, that is “inside-
out signaling,” can disrupt the a/b association allowing
the “hinge” to swing and opening up the extracellular
ligand binding site (see fig. 2).
Recently, some of the biochemical pathways underly-
ing “inside-out signaling” have begun to come to light. As
first elucidated in platelets with regard to the aIIbb3
integrin (Smyth et al., 1993), several agonists (usually
acting through heterotrimeric G-protein–coupled recep-
tors) can activate integrins in various cell types. It also
seems clear that signaling pathways coupled to Ras-
related guanosine 59-triphosphatases (GTPases) im-
pinge on integrin activation and function. For example,
chemokines such as formyl peptide or interleukin (IL)-8
which enhance b1 and b2 integrin-mediated adhesion in
lymphoid cells seem to act via the Rho GTPase (Lau-
danna et al., 1996); in this case, it is not entirely clear
whether this represents is a change in integrin affinity
(interaction of a single ligand with its receptor) or in
avidity (concerted interaction of several receptors with a
polyvalent ligand). Transfection of myeloid cells with a
constitutively activated form of the R-Ras GTPase
clearly causes an increase in the affinity of several inte-
grins, including avb3, a4b1, and a5b1, whereas coex-
pressed aIIbb3 can be activated by R-Ras in Chinese
hamster ovary (CHO) cells (Zhang et al., 1996). By con-
trast, transfection of activated H-Ras, or of its down-
stream kinase Raf-1, inhibited the activation of coex-
pressed aIIbb3 (Hughes et al., 1997). Thus, different
Ras-related small GTPases and their downstream effec-
tors can either positively or negatively modulate the
ligand binding affinity of integrins. Presumably integrin
activation through inside-out signaling ultimately in-
volves intracellular proteins that directly interact with
integrin cytoplasmic domains; a discussion of proteins
that interact directly with integrins is presented further
on in this review (see Section III.).
In summary, integrins are a particularly complex
family of cell adhesion receptors. These heterodimeric
cell membrane glycoproteins can bind to a variety of
ECM ligands or cellular counter-receptors. They engage
with elements of the cytoskeleton and can thus influence
cell shape, intracellular architecture, and cell motility.
Integrins exist in either high- or low-affinity states with
respect to their ligands, and they can engage in both
“inside-out” and “outside-in” signal transduction via
pathways that just now are being elucidated.
C. Cadherins
The cadherins comprise a family of transmembrane
proteins that share an extracellular domain consisting
of multiple repeats of a cadherin-specific motif (Suzuki,
1996) (see fig. 1). Members of the “classic” cadherin
subfamily are calcium-dependent homotypic cell-cell ad-
hesion molecules. This subfamily includes the N-, P-, R-,
B-, and E-cadherins as well approximately 10 other
members (Takeichi, 1995). These molecules localize in
specialized sites of cell-to-cell adhesion that are termed
adherence junctions; at these sites cadherins can estab-
lish linkages with the actin-containing cytoskeleton. The
FIG. 2. Activation of integrins. Both high-affinity and low-affinity
binding states exist for integrins. This may be because of conformational
changes that occur when regulatory proteins bind to integrin cytoplasmic
tails. The conformational changes are depicted here as integrin subunits
swinging on a “hinge” and exposing ligand binding sites (aI, bI and
propeller “prop”). The activating process is regulated by G-protein-cou-
pled receptors and by small GTPases, where R-Ras activates and H-Ras
inhibits high-affinity binding. Integrin ligands bind to the a and b sub-
units with the aI domain and bI-like domain being particularly impor-
tant. Adapted from Loftus and Liddington (1997).
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cesses. For example, “knockout” of the gene for E-cad-
herin (which mediates epithelial interactions) results in
an embryonic lethal that arrests before blastocyst for-
mation (Takeichi, 1995). Another important subfamily
of cadherins involved in adhesion is represented by the
desmogleins and desmocollins, a group of desmosome-
associated cadherins that form intracellular linkages to
intermediate filaments rather than actin filaments
(Cowin and Burke, 1996).
The structure of a typical classic cadherin consists of
an amino-terminal external domain having five tandem
repeats, a single transmembrane segment, and a cyto-
plasmic carboxy-terminal domain of approximately 150
amino acids (fig. 1). The binding functions of the cad-
herin are localized in the amino-terminal tandem re-
peat, whereas the other repeats are bridged by calcium
binding sites that impart rigidity to the molecule (Aberle
et al., 1996). A recent model based on the X-ray structure
of N-cadherin (Shapiro et al., 1995) suggests that cell-
cell adhesion mediated by cadherins involves a “zipper”
type of organization. Cadherins on one cell surface form
a series of rigid dimers that presents the first (N-termi-
nal) cadherin repeat to equivalent dimers on the oppos-
ing cells (Aberle et al., 1996; Gumbiner, 1996). Lateral
motion of these complexes allows the cell junction site to
“zip up.”
The cytoplasmic domains of cadherins interact
strongly with a group of intracellular proteins known as
catenins; these proteins are essential for cadherin func-
tion, because truncation of the cadherin cytoplasmic do-
main to delete catenin binding sites leads to a loss of
cadherin-mediated adhesion (Gumbiner, 1996; Takeichi,
1995). Because there is considerable homology among
their cytoplasmic domains, different classic cadherins
can compete for the same pool of catenins (Kinter, 1992).
The catenins were described initially as a set of three
proteins, a-, b-, and g-catenin (also termed plakoglobin).
b-Catenin binds directly to the cadherin cytoplasmic
domain; subsequently, a-catenin binds to b-catenin and
links the complex to the actin cytoskeleton by direct
interaction with actin and by binding a-actinin, an ac-
tin-bundling protein (Cowin and Burke, 1996). The
structure of a-catenin shows substantial homology to the
protein vinculin, which binds a-actinin and talin and is
critical for cytoskeletal assembly at integrin-mediated
focal adhesion sites (see Section III. below) (Aberle et al.,
1996). In some cases plakoglobin replaces b-catenin in
mediating cadherin-cytoskeletal complexes.
The cadherins play a critical role in the development
of tissue organization during ontogeny and in mainte-
nance of normal tissue structures in adult organisms
(Huber et al., 1996). For example, a variety of cadherins
have been implicated in generating the complex archi-
tecture of the brain (Redies and Takeichi, 1996). In adult
organisms, loss of cadherin expression or function can
lead to serious pathophysiological consequences. Thus
progression toward an invasive, malignant phenotype in
epithelial tumors is associated with loss or mutation of
E-cadherin, or with the disruption of cadherin-catenin
complexes. Phosphorylation of b-catenin by v-Src or
other tyrosine kinases can lead to a breakdown of cad-
herin-cytoskeleton associations and loss of the adher-
ence junctions that maintain normal epithelial organi-
zation (Behrens and Birchmeier, 1994; Birchmeier,
1995).
Recent evidence has indicated that cadherins and
catenins also play an important role in signal transduc-
tion. As discussed in more detail below (Section VIII.),
b-catenin not only interacts with cadherins but also with
components of the wingless/Wnt signaling pathway
(Peifer, 1996). Thus the cell-cell adherence junction,
maintained by cadherins and their associated catenins,
is a key element in both tissue organization and in
regulation of signaling cascades.
D. Immunoglobulin-Cell Adhesion Molecule
Superfamily
A diverse array of cell adhesion receptors are included
in the immunoglobulin superfamily of cell adhesion mol-
ecules (Ig-CAMs). Proteins of this family are defined by
the presence of one or more copies of the Ig fold, a
compact structure with two cysteine residues separated
by 55 to 75 amino acids arranged as two antiparallel b
sheets (Vaughn and Bjorkman, 1996). In many (but not
all) cases, CAMs in the Ig superfamily also contain one
or more copies of a fibronectin type III repeat domain. Ig
family adhesion receptors typically have a large amino-
terminal extracellular domain, a single transmembrane
helical segment, and a cytoplasmic tail (fig. 1). Members
of the Ig-CAM family function in a wide variety of cell
types and are involved in many different biological pro-
cesses.
One of the most important contexts for Ig-CAMs is the
developing nervous system, where many different mem-
bers of this superfamily are involved in axon guidance
and in the establishment and maintenance of neural
connections (Baldwin et al., 1996; Tessier-Lavigne and
Goodman, 1996). The “classic” example of an Ig super-
family adhesion receptor is NCAM, which contains five
Ig folds in its extracellular portion; there are three forms
of NCAM, two with transmembrane domains and one
having a glycosylphosphatidylinositol (GPI) link to the
membrane (Edelman and Crossin, 1991). NCAM func-
tions as a homotypic calcium-independent adhesion re-
ceptor and seems to be almost universally present in the
nervous system. Adhesive interactions mediated by
NCAMs are known to be regulated by both the abun-
dance of receptor and its degree of polysialyation (Edel-
man and Crossin, 1991; Tessier-Lavigne and Goodman,
1996). Several other homotypic neural cell adhesion mol-
ecules belong to the Ig superfamily, including L1, TAG1,
contactin, and Drosophila fasiculin II (Baldwin et al.,
1996; Tessier-Lavigne and Goodman, 1996). Another
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the netrin receptors. Netrins are ECM matrix proteins,
distantly related to laminins, that provide guidance cues
to migrating axons (Tessier-Lavigne and Goodman,
1996). Vertebrate netrin receptors belong to the Ig fam-
ily and include DCC, a protein originally identified as
the product of a key tumor suppressor gene for colon
cancer (Keino-Masu et al., 1996). Yet another group of
key adhesion receptors involved in neural development
is the dozen or so members of the Eph subfamily of
transmembrane tyrosine kinases; these proteins contain
an Ig fold in their extracellular domains and are thus
Ig-CAMs (Tessier-Lavigne and Goodman, 1996). The
Eph kinases and their cell-bound ligands seem to be
involved primarily in axon-target cell interactions. Thus
neural Ig-CAMs can be involved in either homotypic
(NCAM) or heterotypic (DCC, Eph kinases) adhesive
interactions. There is relatively little known about the
interactions of neural Ig-CAMs with cytoskeletal pro-
teins. One report has suggested an association between
the 180 kDa form of NCAM and spectrin (which can link
to the actin cytoskeleton) (Pollerberg et al., 1997). How-
ever, it seems likely that other interactions exist and
contribute to the functions of neural Ig-CAMs. Presum-
ably many of the interactions between neural adhesion
molecules result in signal generation, as well as in es-
tablishment of adhesive contacts between cells; how-
ever, with a few exceptions (see Section VIII.), the mech-
anistic details of the signaling pathways are poorly
understood at present.
Another important biological context for Ig-CAMs lies
in the immune system. In fact, integrins, selectins, and
Ig-CAMs are all critically involved in multiple aspects of
immune function (Dustin and Springer, 1991; Rosales
and Juliano, 1995; Springer, 1995). T lymphocytes ex-
press several Ig superfamily receptors including CD2,
CD4, or CD8, ICAMs 1 and 2, and the T-cell receptor
(TCR) itself. These receptors play important roles in
antigen recognition, cytotoxic T-cell functions, and lym-
phocyte recirculation. In contrast to many of the neural
Ig-CAMs, which are often homotypic receptors, Ig family
proteins involved in the immune system primarily en-
gage in heterotypic interactions. For example, CD2 on T
cells interacts with LFA-3 (another Ig-CAM) expressed
on target cells, the TCR interacts with major histocom-
patibility complex (MHC) class II proteins on antigen
presenting cells (both Ig superfamily), whereas ICAMs
on endothelial cells are recognized by b2 integrins on
leukocytes. Other Ig-CAM family adhesion receptors are
found on vascular endothelial cells and play an impor-
tant role in leukocyte trafficking to inflamed tissue sites.
For example, vascular cell adhesion molecule-1
(VCAM-1) is an endothelial cell counter-receptor for the
integrin a4b1 found on leukocytes. Platelet endothelial
cell adhesion molecule-1 (PECAM-1) is an Ig-family cell-
cell adhesion molecule that can engage in both homo-
typic and heterotypic interactions; one of its roles seems
to be maintaining tight contacts between adjacent vas-
cular endothelial cells (DeLisser et al., 1994).
Recently, X-ray crystal structure was obtained for the
extracellular domains of several Ig-CAMs important in
immune function including intercellular adhesion mole-
cule (ICAM)-2, vascular cell adhesion molecule-1 and
CD2 (Casanovas et al., 1997). This has allowed a more
detailed understanding of how these molecules recog-
nize their ligands and support cell-cell contact. As with
the cadherins, the intracellular domains of Ig-CAMs
may also be important in regulating the adhesive func-
tions of these receptors (DeLisser et al., 1994; Doherty et
al., 1992).
Immune system Ig-CAMs are critically involved in the
key signal transduction processes leading to activation
of T cells and B cells by antigens (Weiss and Littman,
1994). A detailed account of these complex events is
beyond the scope of this review. In essence, however,
Ig-CAM and integrin-mediated contacts are established
between the antigen-presenting cell and the T cell such
that the TCR recognizes antigen bound to an MHC pro-
tein on the presenting cell. This triggers the activation of
intracellular tyrosine kinases associated with the TCR
and with accessory receptors (Crabtree and Clipstone,
1994). In B cells, the B-cell receptor (also an Ig-CAM)
can recognize either soluble or particulate antigen, and
it also can activate intracellular tyrosine kinases upon
ligation. Both the Src family and the spleen tyrosine
kinase (SYK)/ZAP-70 family of tyrosine kinases have
been implicated in antigen-induced T- and B-lymphocyte
signaling (Weiss and Littman, 1994). Further on in this
review, we will return to the theme of adhesion receptors
activating intracellular tyrosine kinases in great detail
as we consider adhesion receptor signaling in fibro-
blasts, epithelial cells, and tumor cells.
Another important group of signaling proteins that
overlaps the Ig-CAM superfamily are the receptor pro-
tein tyrosine phosphatases (RPTPs) (Neel and Tonks,
1997). Many of these transmembrane enzymes have ex-
tracellular domains that include Ig folds (and often fi-
bronectin type III repeats as well). The RPTPs typically
have a large external domain, a single transmembrane
helix, and a cytoplasmic domain containing two signa-
ture tyrosine phosphatase domains flanked by a variety
of noncatalytic sequences. RPTPs seem to function con-
versely to receptor tyrosine kinases (RTKs); that is, li-
gand binding results in dimerization of RPTPs but in-
hibits enzyme activity (rather than activating it as with
RTKs). It has become clear recently that several RPTPs
can engage in homotypic or heterotypic cell adhesion
through their extracellular domains. For example, Dro-
sophila LAR, a Drosophila Ig-CAM-RPTP, plays an im-
portant role in axon migration and innervation of muscle
targets (Neel and Tonks, 1997).
Thus Ig-CAMs play multiple roles in the developing
embryo and in the adult organism. In addition to medi-
ating adhesive contacts that are important in tissue
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system, many Ig-CAMs function in key signal transduc-
tion processes as well.
E. Selectins
The selectins are a small family of lectin-like adhesion
receptors composed of three members, L-, E-, and P-
selectin (Lasky, 1995; Rosen and Bertozzi, 1994; Tedder
et al., 1995). The structure of a selectin includes an
amino-terminal domain that is homologous to calcium-
dependent animal lectins, followed by an epidermal
growth factor (EGF)-type domain, two to nine comple-
ment regulatory protein repeats, a transmembrane he-
lical segment, and a short cytoplasmic tail (fig. 1). Se-
lectins mediate heterotypic cell-cell interactions through
calcium-dependent recognition of sialyated glycans. The
best defined physiological role for selectins concerns leu-
kocyte adherence to endothelial cells and platelets dur-
ing inflammatory processes (Rosales and Juliano, 1995;
Springer, 1995). The expression and function of selectins
is tightly regulated so as to come into play only when
leukocytes need to stick to the vessel wall as part of
normal immune system cellular trafficking or during
inflammation. Thus P-selectin is present in latent form
in endothelial cells and platelets and it is rapidly trans-
located from secretory granules to the cell surface upon
cell activation by thrombin or other agonists. E-selectin
is synthesized and expressed on endothelial cells in re-
sponse to inflammatory cytokines such as tumor necro-
sis factor (TNF) or IL-1. L-selectin is expressed consti-
tutively on leukocytes, but its presentation at the cell
surface may be regulated.
The precise identities of the ligands for the three
currently known selectins are being pursued actively
and are a matter of some controversy (Varki, 1997). For
all three selectins, a key component of the binding ligand
is tetrasaccharide residues of the sialyl-Lewis
X type
(previously defined as a blood group antigen); such mo-
tifs appear on glycolipids as well as on glycoproteins.
However, the binding affinities of selectins for isolated
sialyl-Lewis
X saccharides are very poor, although selec-
tins clearly are responsible for high-affinity cell-cell
binding. Thus physiological high-affinity ligands for se-
lectins likely must include sialyl-Lewis
X saccharides in
the context of a macromolecular scaffold. The best doc-
umented high-affinity counter-receptor for a selectin is
P-selectin glycoprotein ligand-1 (PSGL-1), an O-glycosy-
lated mucin-like transmembrane glycoprotein found on
leukocytes and lymphoid cells (Norman et al., 1995).
Glycoproteins of this type likely have a rigid, rod-like
structure and may be able to present multiple copies of
sialyl-Lewis
X to endothelial cell selectins. Two potential
counter-receptors for L-selectin have been identified;
GlyCAM-1 which is a small, secreted mucin-like glycop-
rotein, and CD34 a transmembrane mucin-like protein
found on endothelial cells. A putative counter-receptor
for E-selectin has been termed ESL-1 and is a glycopro-
tein bearing N-linked carbohydrate residues. However,
the physiological importance of GlyCAM-1, CD34, and
ESL-1 in leukocyte to endothelial adherence and leuko-
cyte trafficking is still unclear (Varki, 1997).
There is much less known about selectin-mediated
signal transduction than is the case for integrins, cad-
herins, and Ig-CAMs. However, it is rapidly becoming
clear that selectins play an important role in signaling
processes that regulate leukocyte-endothelial cell inter-
actions (Zimmerman et al., 1996b).
III. The Components of Adhesive Junctions
Signal transduction by cell adhesion receptors primar-
ily occurs in the context of highly organized supramo-
lecular complexes that are assembled at sites of cell-to-
cell or cell-to-ECM adhesion. There are several distinct
types of adhesive junctions. However, our present un-
derstanding of the role of adhesive junctions in signaling
extends primarily to one type of junction, the integrin-
containing focal contact (also termed focal adhesion) and
thus we will discuss these structures in some detail.
Another growing body of information concerns cadherin-
containing adherence junctions, whereas less is known
about the signaling properties of other types of adhesive
junctions.
A. Integrin Containing Focal Contacts
Focal contacts are specialized sites where cells attach
to the ECM (Burridge and Chrzanowska-Wodnicka,
1996; Jockush et al., 1995). At focal adhesions, clusters
of integrins bind externally to ECM proteins and inter-
nally to several specialized cytoplasmic proteins that in
turn bind to actin filaments. It is becoming clear that
focal adhesions are dynamic structures that change in
size (and likely in composition) as the cell adhesion
process progresses. Initially, rather small punctate
structures are formed at sites of cell-to-substratum con-
tact. As the focal contact matures, the actin filaments
extend and bundle to form prominent structures termed
stress fibers. Integrins can interact with numerous pro-
teins at focal contacts and at other sites in the cell. In
addition, there is a complex network of interactions
among the specialized cytoplasmic focal contact pro-
teins. In this section of the review we will introduce
some of the key components of focal contacts. We also
will discuss transmembrane proteins that directly inter-
act with integrins. Finally, we will introduce several
newly discovered cytoplasmic proteins that bind directly
to integrin a or b subunit cytoplasmic tails and which
may play important roles in integrin signaling. The
known interactions of most of the proteins to be dis-
cussed below are depicted in fig. 3.
1. Cytoskeletal proteins The cytoplasmic structural
proteins of the focal contact that directly bind to inte-
grins include talin and a-actinin, which in turn bind to
other structural proteins including vinculin, paxillin,
and tensin, ultimately leading to the recruitment of ac-
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eral cytoskeletal proteins seems to have a role in the
organization of stress fibers at focal adhesions. It has
been shown that several kinases, including FAK, play a
role in the organization of cytoskeleton (see Section IV.
below). The structure and function of several of the key
structural proteins of the focal contact is described below
(fig. 3A).
a. TALIN. Talin is a cytoskeletal protein that typically
is localized in focal adhesions (Burridge and Connel,
1983). It is a homodimer of two 270 kDa polypeptides
(Rees et al., 1990) arranged in an antiparallel orienta-
tion. The N-terminal region interacts with phospholip-
ids and membranes, whereas the C-terminal portion
interacts with sites on the b1o rb3 integrin cytoplasmic
domain (Horwitz et al., 1986; Jockush et al., 1995; Niggli
et al., 1994). Talin has a role in connecting the actin
cytoskeleton to focal adhesions and it is crucial in the
initial formation of new focal adhesions (Nuckolls et al.,
1992; Pavalko et al., 1991). In addition to binding inte-
grins and actin, talin also binds to vinculin and to FAK
(Burridge and Chrzanowska-Wodnicka, 1996; Chen et
al., 1995).
b. a-ACTININ. a-Actinin is an actin-bundling protein
that comprises two identical polypeptides, each of which
is approximately 104 kDa in size. The protein can be
divided into three regions: the N-terminal actin binding
site, a central region with four a-helical motifs, and a
carboxy-terminal region (Jockush et al., 1995; Noegel et
al., 1987). a-Actinin has been shown to interact with the
cytoplasmic domains of the integrin b1, b2, and b3 sub-
units (Burridge and Chrzanowska-Wodnicka, 1996;
Otey and Burridge, 1990; Pavalko and LaRoche, 1993).
The same region of a-actinin that binds to b1 integrin,
also binds to vinculin (Jockush et al., 1995). a-Actinin
also has a binding domain for zyxin within the actin
binding region, and zyxin colocalizes with a-actinin at
focal adhesions, at the ends of stress fibers, and in cell-
cell junctions (Crawford et al., 1992). Zyxin has Lin-II,
Islet I, and Mec 3 (LIM) domains which are thought to
play a role in signal transduction. a-Actinin has been
shown to be necessary for the association of actin mole-
cules to focal adhesions (Pavalko and Burridge, 1991).
c. TENSIN. This protein was so named because of its
proposed role in connecting actin to focal adhesions and
maintaining mechanical tension (Lo et al., 1994; Wilkins
and Lin, 1986). Tensin consists of two 200 kDa polypep-
tide chains and has three actin binding sites per chain.
In addition, tensin has been reported to bind to vinculin,
paxillin, Src, FAK, phosphatidylinositol-3-kinase (PI-
3K), and CrK-associated substrate (CAS) p130
CAS (see
below). Tensin has sequence homologies to several other
structural proteins including spectrin, dystrophin, a-ac-
tinin, plasmin/fimbrin, phosphatase related to tensin
(PTEN), and a-catenin (Lo et al., 1994). The site with
homology to a-catenin is predicted to be the vinculin
binding site of tensin because both a-catenin and tensin
bind vinculin (Nagafuchi et al., 1991). In addition, tensin
also has a Src homology type 2 (SH2) domain which
binds to Src, paxillin, and other tyrosine-phosphorylated
proteins in vitro (Davis et al., 1991). Recently, it was
shown that tensin forms complexes with PI-3K in a
platelet-derived growth factor (PDGF)-dependent man-
ner, suggesting that tensin might help localize the PI-3K
to focal adhesions (Auger et al., 1996). A tyrosine-phos-
phorylated 130 kDa protein (p130
CAS) associates with
tensin via the tensin SH2 domain (Lo et al., 1994).
As with certain integrins (Keely et al., 1998), vinculin
(Rodriguez-Fernandez et al., 1992), and a-actinin (Gluck
et al., 1993), overexpression of tensin has been impli-
cated in retarding tumor formation (Lo et al., 1994).
Recently, a novel tumor suppressor gene PTEN or
FIG. 3. Proteins associated with integrin-containing focal contacts. (A)
Focal contact proteins and their interactions. This diagram illustrates the
patterns of binding interactions of key structural proteins of the focal
contact including talin (Tal), vinculin (Vinc), a-actinin (a-act), tensin
(Tens), and paxillin (Pax). See text for additional details. (B) Proteins
interacting directly with integrins. This diagram recapitulates current
information concerning proteins that bind directly to integrins. In many
cases it is clear that the interaction occurs with a particular a or b
subunit or with an individual integrin heterodimer, whereas in other
cases the interaction may involve binding to many different integrins.
Clearly only some of these interactions will take place in any given type
of cell, with the pattern of interaction determined by the expression of the
various binding proteins, of various integrins, and by the physiological
status of the cell.
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fied; this gene codes for a protein tyrosine phosphatase
and also has strong homologies to the tensin gene. It is
interesting to note that tensin also has a signature se-
quence for protein tyrosine phosphatases, although no
phosphatase activity has been reported yet (Haynie and
Ponting, 1996). Because PTEN has tensin homology re-
gions, and has been proven to be a tumor suppressor, it
is tempting to speculate that tensin might also function
as a tumor suppressor.
d. VINCULIN. Vinculin is a 116 kDa polypeptide en-
riched in focal contacts. Vinculin binds to actin, a-acti-
nin, talin, and paxillin (reviewed in Jockush et al., 1995).
Electron micrographs showed that vinculin has a glob-
ular head and a rod-like tail region (Molony and Burr-
idge, 1985). The first 120 amino acids in the head region
are essential for binding of talin (Burridge and Mageat,
1984; Gilmore et al., 1992) and a-actinin (Kroemker et
al., 1994), whereas paxillin and actin bind to the rod-like
tail region (Johnson and Craig, 1994, 1995). In addition,
vinculin binds to acidic phospholipids (Isenebrg, 1991;
Niggli et al., 1986) including phosphatidylinositol 4,5-
bisphosphate (PIP2) (Fukami et al., 1994). The head-tail
association of vinculin masks its ability to bind other
proteins. When PIP2 binds to a region in the hinge
between head and tail segments (Fukami et al., 1994),
the head-tail association of vinculin is disrupted allow-
ing other interactions to occur (Gilmore and Burridge,
1996b). Thus PIP2 regulation of vinculin may be an
important way in which inositol lipids influence focal
contact formation and stability.
e. PAXILLIN. The name paxillin is derived from Latin,
meaning stake or peg because the 68 kDa protein seems
tethered to the membrane at focal adhesions (Glenney
and Zokas, 1989; Turner, 1994). The amino-terminal
region of paxillin has a putative Src homology region 3
(SH3) domain and multiple putative SH2 binding sites,
and the carboxy terminus has four LIM domains that
are involved in protein-protein interactions (Turner and
Miller, 1994). Paxillin binds to a region of 140 amino
acid residues in the carboxy terminus of FAK, and it has
been hypothesized that this interaction might coordi-
nate the signals from focal adhesions to the cytoplasm or
cytoskeleton (Hildebrand et al., 1995). The paxillin bind-
ing domain of FAK overlaps with the focal adhesion
targeting (FAT) domain (see Section IV. below) (Hanks
and Polte, 1997). In addition to FAK, paxillin also asso-
ciates with vinculin (Turner et al., 1990), p47
gag-crk
(Birge et al., 1993), C-terminal Src Kinase (CSK) (Sabe
et al., 1994), and pp60
src (Weng et al., 1993), which
indicates that paxillin functions as an adapter protein
involved in forming multiprotein complexes. There is
evidence that integrin cytoplasmic peptides directly bind
to FAK and paxillin in vitro (Schaller et al., 1995;
Tanaka et al., 1996), but the biological significance of
this is unclear.
f. FILAMIN. Filamin is an actin-binding protein that is
involved in the formation of actin networks (Gorlin et al.,
1990; Stossel, 1993). Filamin exists as a homodimer with
the two polypeptides associating only at the carboxy-
terminal region, whereas the amino-terminal ends link
with actin. This molecule has been referred to as “leaf
spring,” because of its flexible nature (Gorlin et al.,
1990). Recently filamin has been shown to associate
with the b2 integrin cytoplasmic domain and it has been
suggested that the association of filamin with integrins
might be important in spreading and extension of lamel-
lopodia during cell movement and in phagocytosis
(Sharma et al., 1995).
In summary, the specialized focal contact proteins
form an elaborate multiprotein complex. This complex
serves as a structural and functional link between inte-
grins and the actin-containing cytoskeleton.
2. Transmembrane proteins: tetraspanners, integrin-
associated protein 50, caveolin As discussed above, inte-
grins interact via their cytoplasmic tails with an assem-
blage of cytoplasmic proteins. However, the external and
transmembrane domains of integrins also can partici-
pate in protein-protein interactions; in some cases these
interactions may occur at sites away from focal contacts
(fig. 3B).
Recently, it has been shown that certain proteins hav-
ing four transmembrane a-helical regions, and thus
known as tetraspan or TM4 proteins, can interact with
integrins (Shaw et al., 1995). These interactions seem to
occur on the external surface of the cell and do not
involve the integrin cytoplasmic domains. In general,
integrin-TM4 complexes reside outside of focal adhesion
sites. The precise function of TM4 proteins is unknown;
however, they have been suggested to be involved in cell
motility (Dong et al., 1995), signaling (Shaw et al., 1995;
Wright and Tomlinson, 1994), and in functioning as ion
channels (Wright and Tomlinson, 1994). Several groups
have indicated that b1 and b3 integrins may interact
with TM4 proteins such as CD9 and CD63 (Nakamura et
al., 1995; Slupsky et al., 1989). Further evidence for
CD9, CD63, and CD81 association with b1 integrins has
come from a study by Berditchevski et al. (1996). In this
study, an interaction of integrins with CD81 was ob-
served, and TM4 proteins also were found to interact
with a3b1 and a6b1, but not with a2b1, a5b1, or a6b4.
This pattern of association also was detected in keratin-
ocytes (Jones et al., 1996). However, previous reports
indicated that CD9 interacts with a3b1 (Nakamura et
al., 1995), a4b1, a5b1 (Rubinstein et al., 1994), and
aIIbb3 (Slupsky et al., 1989) in B lymphocytes; the as-
sociation between CD9 and a5b1 thus was suggested to
be cell type specific. An association of CD9 with a3 and
a6 integrins also was shown in Schwann cells (Hadjiar-
gyrou et al., 1996). Recently, an interaction was demon-
strated between phosphatidylinositol-4-kinase and
a3b1-CD63 complexes, suggesting a possible role of in-
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ditchevski et al., 1997).
A novel protein of 50 kDa and having five transmem-
brane domains was shown to be associated with b3 in-
tegrins (Lindberg et al., 1993). The protein was named
integrin-associated protein (IAP 50) and has been impli-
cated in integrin-mediated phagocytosis in leukocytes.
IAP 50 also is involved in the increase in calcium levels
observed upon cell adhesion to fibronectin- or vitronec-
tin-coated surfaces (Schwartz et al., 1993). IAP 50 has a
wide range of tissue expression (Campbell et al., 1992;
Reinhald et al., 1995), whereas avb3 has only limited
tissue expression, suggesting that IAP 50 has functions
in addition to cooperation with integrins.
Recently, evidence has been developed that certain
integrins can interact with caveolin, a transmembrane
protein found at specialized membrane sites rich in gly-
cosphingolipids termed caveolae. Integrin-caveolin in-
teractions may be quite important in signaling (Wary et
al., 1996), as discussed in more detail in Section V.
below.
3. Cytoplasmic integrin-binding proteins The cytoplas-
mic domains of integrins have been implicated in the
bi-directional transfer of information across the plasma
membrane. Integrin cytoplasmic tails interact with sev-
eral proteins that may participate in integrin-mediated
functions including signal transduction. Novel proteins
have been identified that interact with either the a or b
cytoplasmic domains of integrins (fig. 3B).
a. b SUBUNIT-ASSOCIATED PROTEINS.
i. b3 endonexin. A novel 111 amino acid protein, b3
endonexin, was cloned by using the integrin b3 cytoplas-
mic tail as bait in the yeast two-hybrid system (Shattil et
al., 1995). This interaction is very specific to b3, because
a mutation of serine to proline at position 752 in the b3
cytoplasmic tail reduced the binding by 64%; this muta-
tion is critical for aIIbb3 integrin-mediated function
(Chen et al., 1994b). Because this b3 mutation abolishes
binding to fibrinogen (Chen et al., 1992b) and cell
spreading (Chen et al., 1994b), it suggests that b3 en-
donexin is involved in the selective modulation of b3
integrin function. In addition, it has been proposed that
b3 endonexin has a function independent of integrins
because endonexin is expressed in a wide variety of
tissues. An NITY motif at positions 756 to 759 of b3i s
critical for the interaction with endonexin (Eigenthaler
et al., 1997); this motif is highly conserved in b3 inte-
grins of different species. Another study from the same
group (Kashiwagi et al., 1997) demonstrated that b3
endonexin bound to aIIbb3 in mammalian cells and was
able to modulate the affinity state of aIIbb3, leading to
fibrinogen-dependent aggregation. Only a weak staining
of b3 endonexin was observed in focal adhesions, sug-
gesting that b3 endonexin interacts with integrins tran-
siently, so that other interactions with the integrin tails
can follow after endonexin dissociation (Kashiwagi et al.,
1997). A role of b3 endonexin in outside-in signaling
events has yet to be demonstrated.
ii. Integrin-linked kinase. A yeast two-hybrid ap-
proach also was used to identify another b subunit-
binding protein termed integrin-linked kinase (ILK)
(Hannigan et al., 1996). ILK is a 59 kDa serine-threo-
nine kinase that can associate with b1, b2, and b3 cyto-
plasmic domains and has been shown to phosphorylate a
b1 integrin cytoplasmic domain peptide in vitro (Dedhar
and Hannigan, 1996). Cell attachment to fibronectin
reduced ILK kinase activity, whereas overexpression of
ILK induced anchorage-independent growth and re-
duced cell adhesion to laminin, fibronectin, and vitro-
nectin (Hannigan et al., 1996). ILK and b1 integrins
colocalize in focal adhesions, suggesting a possible role
in cytoskeletal assembly. Recently, it has been shown
that ILK overexpression induces anchorage-indepen-
dent cell cycle progression (Radeva et al., 1997). As dis-
cussed in detail in Section X. below, upon integrin-me-
diated cell adhesion, levels of cyclins D1 and A are
up-regulated and cyclin-dependent kinase (CDK) inhib-
itor levels are down-regulated. Normal cells placed in
suspension have down-regulated expression of cyclin D1
and cyclin A and hypophosphorylated retinoblastoma
(Rb), whereas suspension cells overexpressing ILK have
higher expression of cyclin D1 and cyclin A and hyper-
phosphorylated Rb (Radeva et al., 1997). Thus ILK may
be a key link between integrins and downstream signal-
ing events that influence the cell cycle. In addition, very
recent evidence suggests that ILK is involved in epithe-
lial cell differentiation and gene expression (see Section
XI.).
iii. Cytohesin 1. Using the b2 cytoplasmic domain as
bait in the yeast two-hybrid system, Kolanus et al.
(1996) identified a protein they termed cytohesin-1. In
lymphoid cells cytohesin-1 binds to b2; further, there
seems to be a significant role for cytohesin-1 in the
regulation of integrin activation, as measured by aLb2
adhesion to ICAM1. Cytohesin-1 has a plekstrin homol-
ogy (PH) domain and a domain that resembles the yeast
SEC7 protein. The SEC7 domain alone induces aLb2
binding to ICAM1, whereas the PH domain inhibits the
process, seemingly acting in a dominant negative role. It
has been postulated that PH domains function like SH2
and SH3 domains, mediating protein-protein associa-
tions in signal transduction pathways and/or localizing
proteins to the plasma membrane (Pawson, 1995). Cy-
tohesin-1 recently has been shown to function as a gua-
nine nucleotide exchange factor (GNEF) probably via its
SEC7 domain (Meacci et al., 1997). Moreover, cytohe-
sin-1 also binds via its PH domain to phosphoinositol
3,4,5-triphosphate, suggesting a link with PI-3K path-
ways (Klarlund et al., 1997). Thus cytohesin-1 may play
several important roles in integrin activation and in
intracellular signaling.
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tein 1. Recently, another novel b1 integrin cytoplasmic
domain-associated protein (ICAP1) was isolated using a
yeast two-hybrid approach. Two isoforms of ICAP1 that
are derived from alternatively spliced mRNA have been
reported; the longer isoform has 200 amino acids
(ICAP1a) and the shorter isoform has 150 amino acids
(ICAP1b). The interaction of ICAP1a with b1 integrins
has been shown in vitro and in vivo. ICAP is a phospho-
protein, and its phosphorylation is regulated during cell-
matrix interactions. Cell attachment to fibronectin re-
sulted in enhancement of ICAP1a phosphorylation,
whereas expression of Rho A that disrupts cell-matrix
interactions resulted in dephosphorylation of ICAP1a.
These data indicate that ICAP1a has a role in integrin-
mediated cell adhesion and spreading (Chang et al.,
1997).
b. a SUBUNIT INTERACTING PROTEINS.
i. Calreticulin. A conserved stretch of seven amino
acids (KXGFFKR) exists in all integrins and subunits.
To understand the role of such a highly conserved re-
gion, investigators tried to identify proteins that inter-
act with this region. Rojiani et al. (1991) reported a 60
kDa protein that specifically binds to the KXGFFKR
sequence. This protein had significant homologies to
rabbit calreticulin (Fliegel et al., 1989) and the Ro/SS-A
antigen, its human equivalent (McCauliffe et al., 1990).
An in vivo interaction of calreticulin with the active form
of the a2b1 integrin has been demonstrated (Coppolino
et al., 1995). Further, inhibition of expression of calreti-
culin by antisense oligonucleotides resulted in inhibition
of cell adhesion and less cell spreading, indicating a role
for calreticulin in cell-ECM interactions (Leung-Hages-
teijn et al., 1994). Recently, a double knockout of calre-
ticulin in embryonic stem cells suggested that calreticu-
lin is essential for the function of integrins including
“outside-in” signaling (Coppolino et al., 1997).
ii. Calcium- and integrin-binding protein. A
novel calcium- and integrin-binding protein (CIB) of 25
kDa that interacts with aIIb was identified using the
yeast two-hybrid system. This protein specifically binds
to aIIb and has similarities to the calcium-binding pro-
teins calmodulin and calcineurin. CIB interacts with
aIIbb3 in vitro and is expressed in platelets, which sug-
gests that it may function as a regulatory molecule for
aIIbb3 (Naik et al., 1997).
iii. Integrin-binding protein 1. Using a yeast two-
hybrid approach, we identified a novel protein that in-
teracts with the a5 subunit cytoplasmic tail (Alahari and
Juliano, unpublished results). This protein does not
have significant homologies to known proteins, and
henceforth was tentatively named integrin-binding pro-
tein 1 (IBP1). IBP1 binds to human a5b1 in vitro, but its
physiological role is currently unknown.
4. Interactions with Integrin Heterodimers. There
have been several reports of proteins that associate with
integrin heterodimers. In most cases it has not been
established clearly whether the interactions are direct
or are mediated through other, as yet unidentified, pro-
teins.
a. INSULIN RECEPTOR SUBSTRATE 1 AND 190 KDA. Two
cytoplasmic proteins have been shown to associate with
avb3 integrin in response to growth factor stimulation.
A 190 kDa tyrosine-phosphorylated protein associates
with avb3 in PDGF-stimulated fibroblasts (Bartfeld et
al., 1993). This protein is likely to be the PDGF receptor
itself (Schneller et al., 1997). Tyrosine-phosphorylated
insulin receptor substrate-1 (IRS-1) associates with
avb3 upon insulin stimulation; IRS-1 mediates insulin
signaling by binding to other signaling molecules includ-
ing GRB2 and PI-3K (Vuori and Ruoslahti, 1994). The
involvement of IRS-1 and 190 kDa with integrins is
suggestive of a role in signal transduction, but the mech-
anistic details remain undetermined at this time (see
Section IX.).
b. PROTEASES. Some recent observations have indi-
cated the existence of interactions between integrins
and proteases or protease receptors that may be very
important in the regulation of inflammation and of tu-
mor cell invasion and metastasis. Thus the avb3 inte-
grin has been shown to associate with both the matrix
metallo protease (MMP2) (Brooks et al., 1996) as well as
with the urokinase-type plasminogen activator receptor
(uPAR) (Wei et al., 1996). In the first case, association of
MMP2 and the integrin facilitated matrix protein deg-
radation suggesting a role in invasion. In the second
case, complex formation between uPAR and the integrin
blocked the adhesive function of the integrin. These
observations suggest a complex interplay between cer-
tain integrins and extracellular proteolytic cascades
which may be of great biological importance.
B. Other Adhesive Junctions
In addition to integrin-containing focal adhesions,
there are several other types of structures that link cells
to each other or to the extracellular matrix. These in-
clude: cadherin-based cell-cell adherence junctions, and
cell adhesion junctions containing certain proteoglycans
and ezrin/radixin/moesin (ERM) proteins, both of which
associate with the actin cytoskeleton; desmosomes and
hemidemosomes that interdigitate with intermediate fil-
aments; tight junctions that serve a barrier function in
epithelial sheets; gap junctions that play a role in cell-
cell ionic communication; transient cell-cell junctions
that occur in immune recognition; and specialized junc-
tions such as nerve synapses (Staehlin and Hull, 1978).
In most cases little is known about the role of junctional
proteins in signal transduction. Thus we will mention
only briefly two types of actin-based junctions where
some understanding of signaling processes is beginning
to emerge.
1. Cadherin-mediated adherence junctions As dis-
cussed in Section II. above, the classic cadherins bind to
a group of proteins termed catenins which in turn can
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ture termed an adherence junction. Structures of this
type are particularly important to the biology of epithe-
lial cells, where “belts” of adherence junctions in neigh-
boring cells are joined by dense bundles of actin fila-
ments thus stabilizing the epithelial sheet. A more
detailed picture of the structure of cadherin-based ad-
herence junctions can be found elsewhere (Cowin and
Burke, 1996; Geiger et al., 1995); whereas the role of
cadherin-based junctions in signaling will be described
in detail in Section VIII.
2. Junctions containing ezrin/radixin/moesin pro-
teins The ERM family of linker proteins seems to play a
vital role in some aspects of cytoskeletal assembly (Tsu-
kita et al., 1997). These proteins share a highly homol-
ogous COOH-terminal actin binding domain and an
equally well conserved N-terminal membrane binding
domain. The membrane molecules that are the binding
partners of ERM proteins have not been fully worked
out; the polymorphic transmembrane glycoprotein/pro-
teoglycan CD44 is clearly one of them, but the Na/K
ATPase and the Ig-superfamily member ICAM-1 may
also interact with ERM proteins. The ability of ERM
proteins to link membrane molecules to actin seems to
be closely regulated by the small GTPase Rho. However,
evidence has been developed recently that moesin may
in turn play a role in regulating the activity of Rho
family GTPases (Takahashi et al., 1997). In this manner,
ERM proteins might affect the assembly of a variety of
cytoskeletal structures thought to be regulated by Rho
family proteins (see Section VI. for more detail). Thus,
the precise biological role of ERM proteins has yet to be
defined, but it seems likely that assembly/disassembly of
adhesive junctions will be one aspect of their function.
IV. Direct Signal Transduction by Integrins:
Activation of Tyrosine Kinases
A. Introduction
The concept that integrins function not merely as
receptors for cell adhesion, but also elicit signal trans-
duction events, emerged from several types of observa-
tions. For example, when a3b1 integrins were clustered
on the surface of human carcinoma cells, the tyrosine
phosphorylation level of a 115 to 130 kDa subset of
proteins was enhanced (Kornberg et al., 1991). Essen-
tially the same subset of proteins was tyrosine phos-
phorylated in NIH3T3 and rat embryo fibroblasts
(REFs) spreading on fibronectin-coated surfaces (Burr-
idge et al., 1992; Guan et al., 1991). These effects were
deemed to be integrin-specific through the use of anti-
bodies to non-integrin cell surface molecules or by means
of nonspecific attachment to polylysine-coated surfaces
(Burridge et al., 1992; Guan et al., 1991; Kornberg et al.,
1991). Simultaneously, a similar pattern of tyrosine
phosphorylation was observed in v-Src-transformed
chicken embryo fibroblasts (CEFs) (Kanner et al., 1990)
and upon treatment of quiescent Swiss 3T3 fibroblasts
with the G-protein-coupled receptor agonists bombesin,
vasopressin, and endothelin (Zachary et al., 1991). These
data helped to consolidate the idea that integrins have
the ability to convey signals directly from the ECM to
the inside of the cell. In this section and the next, we will
review the identified key components, mechanistic mod-
els, and significance of these direct integrin-mediated
effects on signaling, concentrating here on tyrosine
phosphorylation events.
B. Focal Adhesion Kinase-Mediated Events
1. Linkage to integrin signaling Of the tyrosine phos-
phorylation events described above, the most prominent
effect is observed in proteins in the molecular weight
range of 110 to 130 kDa. It is now clear that the cyto-
plasmic tyrosine kinase, FAK accounts for a large pro-
portion of the tyrosine phosphorylation in this region.
Furthermore, tyrosine phosphorylation of FAK is re-
garded not only as an important event in integrin-medi-
ated signaling, but as a common theme in multiple sig-
nal transduction pathways (see table 1) (Zachary et al.,
1992). FAK was cloned independently by the use of
monoclonal antibodies raised to tyrosine-phosphory-
lated proteins in v-Src transformed CEFs (Schaller et
al., 1992) and by using a homology-based strategy to
identify novel protein tyrosine kinases in a mouse cDNA
library (Hanks et al., 1992). FAK is a unique protein
tyrosine kinase of approximately 125 kDa; it contains a
central consensus kinase domain, a C-terminal domain
having two proline-rich sequence, and a region required
for focal adhesion targeting termed the “FAT” sequence.
FAK has no transmembrane, SH2, or SH3 domains (fig.
4) (Hanks et al., 1992; Hildebrand et al., 1993; Schaller
et al., 1992). FAK now also has been cloned from humans
(Andre and Becker, 1993) and Xenopus (Zhang et al.,
1995b) and exhibits a high degree of conservation be-
tween species.
An overabundance of evidence lends its weight to a
critical role for FAK in integrin-mediated signaling.
First, immunofluorescent staining shows that FAK co-
localizes with proteins such as talin and tensin in focal
adhesion sites of fibroblasts (Hanks et al., 1992; Korn-
berg et al., 1992; Schaller et al., 1992). Immunoprecipi-
tation studies demonstrate that FAK undergoes en-
hanced tyrosine phosphorylation upon adhesion to
fibronectin or antibody-mediated integrin clustering
(Burridge et al., 1992; Guan and Shalloway, 1992; Korn-
berg et al., 1992). Moreover, the tyrosine kinase activity
of FAK in NIH 3T3 fibroblasts is increased two- to three-
fold upon adhesion to fibronectin and activity is en-
hanced further in v-Src-transformed cells (Guan and
Shalloway, 1992). FAK activity directly correlates with
its phosphotyrosine content in several normal and tu-
mor cell lines (Withers et al., 1996). In platelets the FAK
response is specific to a particular integrin, aIIbb3, the
molecule that is required both for platelet aggregation
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lium (Kieffer and Phillips, 1990; Phillips et al., 1991;
Weiss et al., 1986, 1989). Platelet aIIbb3 undergoes a
conformational change upon activation by thrombin or
collagen enabling it to bind to fibrinogen (Siess, 1989).
FAK shows increased tyrosine phosphorylation levels in
platelets that have been stimulated with agonist and
allowed to aggregate. In contrast, in platelets derived
from patients with Glanzmann’s thrombasthenia, which
are deficient in aIIbb3, FAK is not phosphorylated un-
der the same experimental conditions (Lipfert et al.,
1992). FAK tyrosine phosphorylation in response to cel-
lular adhesion to extracellular matrix proteins now has
been shown in a range of cell types, which indicates that
this pathway is used by a variety of integrins. In these
cases, phosphorylation levels usually plateau 20 to 30
min after initiation of adhesion and remain persistently
high for several hours (Burridge et al., 1992; Hanks et
al., 1992; Lin et al., 1997a). A central piece in the puzzle
was provided by the development of FAK-deficient mice.
These animals die early in development and the em-
bryos show gastrulation abnormalities similar to those
found in fibronectin-deficient animals, indicating that
the same pathway is impacted in both models (George et
al., 1993; Ilic et al., 1995).
More direct, albeit less physiological, evidence for an
integrin-FAK connection is the finding that, under in
vitro conditions, synthetic peptides based on b subunit
cytoplasmic domains can bind to the N-terminal region
of FAK (Schaller et al., 1995); it should be noted that this
putative integrin binding region is distinct from the
focal adhesion targeting sequence. Additionally, fibro-
blasts expressing chimeric receptors containing the cy-
toplasmic domain of various integrins linked to the ex-
tracellular domain of the IL-2 receptor show increased
phosphorylation of FAK (Akiyama et al., 1994). In this
scenario, chimeras containing the b1, b3, and b5 cyto-
plasmic domains, but not the a5 or alternatively spliced
b3B cytoplasmic tail, enhance FAK tyrosine phosphory-
lation, indicating the participation only of specific inte-
grin subunits in the process (Akiyama et al., 1994).
However, it is still controversial as to whether FAK
interacts directly or indirectly with integrin cytoplasmic
tails.
Besides integrin-mediated events, FAK tyrosine phos-
phorylation is increased through a variety of non-inte-
grin cell surface receptors including growth factor recep-
tor tyrosine kinases and G-protein-coupled receptors
(see table 1). Many of these studies have been carried
out using adherent quiescent Swiss 3T3 cells which, in
contrast to NIH3T3 fibroblasts under similar conditions,
exhibit low levels of focal adhesions and actin stress
fibers. In this paradigm, effects on FAK are usually
evident within seconds of treatment and are of a tran-
sient nature. The actions of G-protein-coupled receptor
agonists, such as bombesin, sphingolipid metabolites,
and lysophosphatidic acid (LPA), are likely to be medi-
ated through the small GTP-binding protein Rho (Ridley
and Hall, 1994; Wang et al., 1997).
2. Mechanism of activation In growing fibroblasts,
FAK is phosphorylated on both tyrosine and serine res-
idues (Calalb et al., 1995; Schlaepfer and Hunter, 1996).
TABLE 1
Non-integrin-mediated tyrosine phosphorylation of focal adhesion kinase
Stimulus Cell type Observations References
Anti-NCAM antibodies and
soluble NCAM
NCAM-transfected COS-7 cells Coprecipitates with NCAM140 (Beggs et al., 1997)
PDGF Quiescent Swiss 3T3 vascular
smooth muscle cells
Bell-shaped dose response BB-
homodimer only
(Abedi et al., 1995; Rankin
and Rozengurt, 1994)
Vascular endothelial growth
factor
Human umbilical vein
endothelial cells
Rapid, partially PKC-dependent
response
(Abedi and Zachary, 1997)
Hepatocyte growth factor/scatter
factor acting via the c-Met
RTK
Human squamous carcinoma
cells
Transient response, loss of
phosphorylation corresponds with
motile phenotype
(Matsumoto et al., 1994)
Macrophage colony-stimulating
factor via the M-CSF RTK
Human monocytes Results in GRB2 binding to FAK (Kharbanda et al., 1995)
Bombesin, bradykinin,
vasopressin, and endothelin
acting via G-protein-coupled
receptors
Quiescent Swiss 3T3 Rapid response (seconds) (Leeb-Lundberg et al., 1994;
Zachary et al., 1992)
Angiotensin II acting via G-
protein-coupled receptor
Quiescent vascular smooth
muscle cells
Rapid response (Polte et al., 1994; Turner et
al., 1995)
Prolactin acting via a cytokine
family receptor
Human breast carcinoma cells Also results in paxillin
phosphorylation
(Canbay et al., 1997)
Intracellular acting bacterial
toxin
Quiescent Swiss 3T3 Response dissociated from PKC
activation
(Lacerda et al., 1996)
Bioactive lipids, e.g. sphingolipid
metabolites and
lysophosphatidic acid
Quiescent Swiss 3T3 Rapid, response, independent of
PKC activation and Ca
21
mobilization
(Seufferlein and Rozengurt,
1994a, b)
Aggregation of the Fc«RI Rat basophilic leukemia cells Phosphorylation requires adherence (Hamawy et al., 1993)
Amyloid peptide Differentiated neuroblastoma
cultures
Effects with aggregated but not
soluble peptide
(Zhang et al., 1994)
Hyaluronan mediated by the HA
receptor RHAMM
C-H-ras transformed 10T1/2
fibroblast cells
Rapid and transient response (Hall et al., 1994)
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upon cell detachment, whereas phosphorylation at
serine residues is largely unaffected (Calalb et al., 1995).
Presumably a protein tyrosine phosphatase is activated
upon cell detachment, but the identity of this enzyme(s)
remains elusive. Although it is worth remembering that
serine phosphorylation can control protein function and
protein-protein interactions (Muslin et al., 1996), rela-
tively little is known about the sites and function of FAK
serine phosphorylation, and therefore this review will
focus on the importance of tyrosine-phosphorylated res-
idues. As observed for many receptor tyrosine kinases, it
is the autophosphorylation of FAK that is the trigger for
the regulation its downstream functional activities. FAK
autophosphorylation within the sequence Y
397AEI oc-
curs in vitro in a bacterial-fusion protein and in immune
complex kinase reactions of FAK expressed in fibro-
blasts (Calalb et al., 1995; Schaller et al., 1994). In some
cell types, autophosphorylation of FAK in trans may also
occur, as exogenously expressed kinase-dead FAK can be
tyrosine phosphorylated (Cary et al., 1996; Eide et al.,
1995; Schlaepfer and Hunter, 1996). FAK additionally is
phosphorylated at Tyr407, Tyr576, Tyr577, Tyr861, and
Tyr925 in growing fibroblasts (Calalb et al., 1995, 1996;
Schlaepfer et al., 1994; Schlaepfer and Hunter, 1996).
Phosphorylation at Tyr576 and Tyr577 in the catalytic
domain of FAK is important for maximal kinase activity
(Calalb et al., 1995). Tyr925 is within a consensus site,
YENV, for binding the SH2 domain of the adapter pro-
tein, growth factor receptor-binding protein-2 (GRB2)
(Schlaepfer et al., 1994; Songyang et al., 1993). The roles
of P-Tyr407 and P-Tyr861 as yet remain elusive.
3. The role of Src in focal adhesion kinase signaling
Evidence of Src playing a pivotal role in FAK signaling
events is manifest by augmented tyrosine phosphoryla-
tion of FAK in v-Src-transformed fibroblasts (Calalb et
al., 1995; Guan and Shalloway, 1992). The FAK auto-
phosphorylation motif (YAEI) resembles the YEEI con-
sensus site for Src-SH2 binding (Songyang et al., 1993)
and indeed Src binds FAK at this site after integrin-
mediated FAK autophosphorylation in fibroblasts and in
v-Src-transformed 3T3 fibroblasts (Schaller et al., 1994;
Schlaepfer et al., 1994). This association is transient in
adhering fibroblasts and is absent upon serum-starva-
tion despite unaffected phosphorylation of FAK at
Tyr397. However, in v-Src-transformed cells the associ-
ation is stable and independent of serum and adhesion
(Cobb et al., 1994a; Schaller et al., 1994; Schlaepfer et
al., 1994; Schlaepfer and Hunter, 1996). Thus, addi-
tional factors regulate the ability of Src to bind FAK,
even when FAK is in a “primed” state. The FAK residues
Tyr407, Tyr576, Tyr577, Tyr861, and Tyr925 all show
enhanced phosphorylation upon v-Src transformation
and can be phosphorylated directly by Src in vitro (Ca-
FIG. 4. The structural domains of integrin-responsive tyrosine kinases. The domain structure of FAK, c-Src, c-Abl, and Syk are shown. The position
of the kinase domain and Src homology 2 (SH2) and 3 (SH3) domains, which mediate protein-protein interactions, are indicated. In FAK, the
C-terminal proline-rich (PR) and focal adhesion targeting (FAT) domains are shown. Similarly, in c-Abl the position of the DNA and F-actin binding
domains are illustrated.
212 APLIN ET AL.lalb et al., 1995, 1996; Schlaepfer and Hunter, 1996). Src
interaction with Tyr397 and subsequent phosphoryla-
tion of FAK results in GRB2 binding to Tyr925; GRB2
binding to FAK is a putative link between FAK tyrosine
phosphorylation and the integrin-mediated activation of
mitogen-activated protein kinase (MAPK) (see Section
V.) (Schlaepfer and Hunter, 1996, 1997). FAK-Src inter-
action also enhances the association of the adapter pro-
tein, p130
CAS with FAK signaling complexes in cells
adhering to fibronectin (Schlaepfer and Hunter, 1997).
In conclusion, these data point toward a model
whereby the autophosphorylation of FAK leads to bind-
ing of the SH2 domain of Src and the resultant phos-
phorylation of FAK by Src on multiple residues. Phos-
phorylation of these residues directly initiates FAK-
mediated signal transduction events (see fig. 5). It is
noteworthy that FAK is capable of binding other Src-
family kinases, including Fyn and Yes (Cobb et al.,
1994a; Polte and Hanks, 1995; Schlaepfer et al., 1997),
and hence, the relevant Src-family kinase may depend
on cell-specific expression and/or regulation mecha-
nisms.
4. Other focal adhesion kinase-binding proteins For-
mation of complexes through SH2 and SH3 domain-
mediated protein-protein interactions is often essential
for the instigation of a signaling cascade. FAK interacts
with a variety of SH2/SH3 domain containing proteins
within the focal adhesion. Some of these interactions are
constitutive, whereas some depend on the tyrosine phos-
phorylation state of FAK. Src-family kinases are not the
only possible occupants of the Tyr397 binding site. The
p85a subunit of PI-3K interacts with Tyr397 upon cell
adhesion or PDGF treatment of NIH3T3 cells, despite
the fact that YAEI is not an optimal binding site for the
p85 SH2 domain (Chen et al., 1994a, 1996a; Songyang et
al., 1993). In thrombin-activated platelets, p85 binds
FAK, but interactions are directed by the SH3 domain of
p85 and the second proline-rich region of FAK (Guine-
bault et al., 1995). Addition of the relevant FAK-derived
peptides to p85 immunoprecipitates activates PI-3K ac-
tivity in each case (Chen et al., 1996a; Guinebault et al.,
1995).
Extensive studies show that the focal adhesion pro-
teins p130
CAS, paxillin, tensin, and cortactin, in addition
to FAK, show increased tyrosine phosphorylation levels
upon integrin-mediated adhesion in fibroblasts (Bock-
holt and Burridge, 1993; Burridge et al., 1992; Nojima et
al., 1995; Petch et al., 1995; Vuori and Ruoslahti, 1995).
These proteins account for some of the additional phos-
photyrosine bands initially identified in extracts from
cells adhering to the ECM and in v-Src-transformed
fibroblasts. Two of these proteins, namely p130
CAS and
paxillin, are able to interact with FAK; p130
CAS via SH3
domain interactions with the FAK proline-rich se-
FIG. 5. Mechanism of integrin-mediated activation of FAK and signaling complex formation. Cytoplasmic FAK (1) is associated constitutively with
paxillin and talin. Upon integrin engagement (2), FAK localizes to focal adhesions, possibly through an interaction with the integrin b subunit,
resulting in autophosphorylation at Tyr397. This creates a binding site for the SH2 domain of c-Src, which on binding phosphorylates at the sites
Tyr407, Tyr576, Tyr577, Tyr861, and Tyr925. Src phosphorylation of FAK enhances binding of p130
CAS and GRB2, the latter through binding to
Tyr925 (3). Thus, a multimeric signaling complex may be formed (4), which can control downstream events and which contains a negative feedback
mechanism through the binding of GRAF. The interaction of PI-3K with FAK has not been illustrated here.
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acids 904 to 1054 (Bellis et al., 1995; Harte et al., 1996;
Hildebrand et al., 1995; Polte and Hanks, 1995, 1997;
Schaller et al., 1993). p130
CAS originally was identified
as a highly tyrosine-phosphorylated protein in v-Src-
and v-Crk-transformed fibroblasts (Birge et al., 1992;
Kanner et al., 1990, 1991; Matsuda et al., 1990). Struc-
turally, p130
CAS resembles a “docking protein” because
it contains a SH3 domain followed by multiple SH2
binding motifs (Sakai et al., 1994). The SH3 domain of
p130
CAS is essential for focal adhesion targeting, a func-
tion that is independent of FAK binding (Nakamoto et
al., 1997). A pool of p130
CAS is associated constitutively
with FAK, but upon adhesion, Src kinase activity may be
responsible for stabilizing the FAK- p130
CAS complex
(Nakamoto et al., 1996, 1997; Polte and Hanks, 1997).
Recently, p130
CAS was identified as an important medi-
ator of FAK-promoted cell motility (Cary et al., 1998).
Another integrin-regulated protein is the 68 kDa
adapter molecule, paxillin (discussed in Section III.
above). Paxillin includes a proline-rich sequence, four
LIM domains and multiple putative SH2 binding sites
(Salgia et al., 1995; Sanchez-Garcia and Rabbitts, 1994;
Turner and Miller, 1994). The paxillin binding site in
FAK overlaps the C-terminal FAT sequence. Some
groups report FAK localization to integrin clusters/focal
adhesions in the absence of paxillin binding (Hildebrand
et al., 1995; Miyamoto et al., 1995b), whereas others
indicate that paxillin binding recruits FAK to focal ad-
hesions (Tachibana et al., 1995). Association between
FAK and another focal adhesion protein, talin, also was
observed by co-immunoprecipitation experiments, and
the binding site was localized by in vitro experiments to
amino acids 965 to 1012 in FAK (Chen et al., 1995). The
second proline-rich region in the C-terminus of FAK is
capable of binding the SH3 domain of GRAF (GTPase
regulator associated with FAK), a member of the GT-
Pase-activating protein family (GAP) (Hildebrand et al.,
1996). This interaction may serve to turn off RhoA and
Cdc42 activities after the formation of focal adhesions
and actin stress fibers. Under in vitro conditions, phos-
phorylated FAK also can bind the SH2 domains of NCK,
phospholipase C, and CSK (Sabe et al., 1994; Schlaepfer
et al., 1994). As evident from the above data, FAK is
capable of forming multiple associations with a variety
of proteins and these interactions are likely to serve as
connections to the actin cytoskeleton and to recruit other
proteins to form complex signaling units (fig. 5). The
relative importance of FAK kinase activity versus the
ability of FAK to serve as a scaffolding molecule is under
close scrutiny, and there is growing evidence that the
scaffolding function is important (Cary et al., 1996;
Hamawy et al., 1997).
5. Inhibition of focal adhesion kinase activity The ad-
hesion-induced phosphorylation of FAK can be inhibited
by agents that disrupt the cytoskeleton or delay cell
spreading. Tyrosine phosphorylation of FAK can be po-
tently blocked by treatment with either the actin depo-
lymerizing agent, cytochalasin, or the tyrosine kinase
inhibitor, herbimycin (Burridge et al., 1992; Sinnett-
Smith et al., 1993). Extracellular stimulation by insulin
causes transient dephosphorylation of FAK and paxillin
in rat 1 fibroblasts and in CHO cell lines overexpressing
the insulin receptor (Knight et al., 1995; Konstantpolu-
los and Clark, 1996; Ouwens et al., 1996; Pillay et al.,
1995). This may be caused by insulin-mediated effects
on the cytoskeleton or through phosphotyrosine phos-
phatase (PTP) 1D activity (Knight et al., 1995; Ouwens
et al., 1996). FAK is dephosphorylated rapidly upon cell
detachment (Calalb et al., 1995), indicating a PTP is
activated under these conditions. Recently the leukocyte
common antigen related (LAR) PTP was found to local-
ize partially to focal adhesions in human breast adeno-
carcinoma cells, although its specificity for proteins,
such as FAK and paxillin, and therefore its role in focal
adhesion disassembly, are presently unclear (Serra-
Pages et al., 1995). Additionally, a proteolytic mecha-
nism may be used in activated platelets. FAK, activated
on aIIbb3 engagement and platelet aggregation, can be
proteolyzed by the protease calpain to produce frag-
ments that exhibit reduced autokinase activity and dis-
sociate from the cytoskeleton, an action that may be
involved in cytoskeletal changes associated with blood
clot retraction (Cooray et al., 1996).
A regulatory mechanism that is likely to operate in
some cell types is the autonomous expression of the
C-terminus of FAK, referred to as FAK-related nonki-
nase (FRNK). FRNK contains the FAT sequence but is
devoid of any kinase activity (Schaller et al., 1993).
Overexpression of FRNK in CEFs reduces the tyrosine
phosphorylation state of FAK and the ability of these
cells to spread on fibronectin by competing with FAK for
sites in focal adhesions (Richardson and Parsons, 1996).
6. Focal adhesion kinase substrates Because of the
complex associations between kinases and structural
proteins, unveiling biologically relevant in vivo sub-
strates is an arduous task. For example, paxillin, tensin,
and p130
CAS tyrosine phosphorylation closely correlate
with that of FAK upon cell adhesion. Additionally, FAK
phosphorylates recombinant paxillin in immunoprecipi-
tation kinase assays, whereas FRNK overexpression re-
duces the tyrosine phosphorylation of paxillin and ten-
sin (Bellis et al., 1995; Burridge et al., 1992; Harte et al.,
1996; Richardson and Parsons, 1996); all this suggests
that these proteins may be FAK substrates. On the other
hand, Src is capable of interacting with paxillin (fig. 3A)
(Salgia et al., 1995; Weng et al., 1993), and integrin-
stimulated phosphorylation of p130
CAS likely is directed
by c-Src (Bockholt and Burridge, 1995; Hamasaki et al.,
1996; Vuori et al., 1996); further, phosphorylation of
paxillin and tensin is not altered significantly in FAK
2/2 fibroblasts (Ilic et al., 1995). Thus the precise cause
of tyrosine phosphorylation events in focal contacts re-
mains obscure.
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blast lines derived from FAK 2/2 mice downplays the
importance of FAK in the assembly of focal adhesions
during cell adhesion. FAK-deficient fibroblasts retain
the ability to spread on a fibronectin substratum and
have normal levels of tyrosine phosphorylation on pax-
illin and tensin (Ilic et al., 1995). The cells, however, are
morphologically dissimilar from wild-type controls in
that they are more rounded, exhibit abundant ventral
focal adhesions, and have numerous peripheral stress
fibers and microspikes. Further, these cells show de-
creased mobility on fibronectin (Ilic et al., 1995), which
indicates a possible defect in filopodia formation/exten-
sion and focal adhesion turnover. Relevant to this con-
cept is the knowledge that FAK tyrosine phosphoryla-
tion is increased during neurite outgrowth of
differentiating neuroblastoma cells, a process that in-
volves growth cone filopodia extension (Leventhal and
Feldman, 1996).
Findings in a variety of other cell types support the
view that FAK functions in cell migration. CHO cells
overexpressing FAK exhibit enhanced migration on fi-
bronectin, an effect dually mediated both by phosphor-
ylation at Tyr397 and p130
CAS binding to the first pro-
line-rich region of FAK, but independent of kinase
activity (Cary et al., 1996, 1998). Tyrosine phosphoryla-
tion of FAK is increased in migrating human umbilical
vein endothelial cells (HUVECs) (Romer et al., 1994),
and both FAK localization to focal adhesion sites and cell
migration in a wound healing assay are disrupted by
microinjection of a FRNK-like protein (Gilmore and Ro-
mer, 1996). Furthermore, FAK is highly localized to the
migrating edge of human keratinocytes (Gates et al.,
1994), and the migration rate of human melanoma cell
lines correlates with the level of FAK expression
(Akasaka et al., 1995).
FAK is enriched particularly in the brain (Andre and
Becker, 1993; Grant et al., 1995; Hanks et al., 1992)
where alternatively spliced forms also are expressed
(Andre and Becker, 1993; Burgaya and Girault, 1996).
In primary developing rat neurons, FAK is localized to
the growth cones of extending neurites and to the
perikarya (Burgaya et al., 1995). The FAK-Fyn interac-
tion is likely to play a physiological role in the brain as
FAK tyrosine phosphorylation is partially reduced in
Fyn 2/2 mice, which show impaired hippocampal devel-
opment, spatial learning, and long-term potentiation de-
fects (Grant et al., 1992, 1995). Activation of neuronal
cannabinoid receptors leading to inhibition of adenylyl
cyclase regulates the tyrosine phosphorylation of a FAK
isoform, termed FAK
1, that contains a three amino acid
insert within the FAT sequence (Burgaya and Girault,
1996; Derkinderen et al., 1996). These studies implicate
FAK in neuronal development and synaptic plasticity.
Evidence that FAK tyrosine phosphorylation may be
delicately balanced inside the cell can be drawn from
studies of adhesion-dependent cell survival. As will be
discussed in Section X., cell anchorage to ECM proteins
suppresses apoptosis in epithelial and endothelial cells
(Frisch et al., 1996b). A variety of studies implicate FAK
in protecting cells against apoptosis. For example, atten-
uation of high-level FAK expression in tumor cell lines
causes cell rounding and apoptosis (Xu et al., 1996) and
FAK is cleaved by caspases during Fas- and Apo-2L-
induced apoptosis of Jurkat cells (Wen et al., 1997).
Opposing effects on cell morphology are caused by ty-
rosine phosphorylation instigated by activation of inte-
grins and by v-Src transformation. Despite the phos-
phorylation of a common set of proteins, v-Src-
transformed cells exhibit reduced focal adhesions
coinciding with a loss of cell-substrate adherence
(Krueger et al., 1983); therefore, hyperphosphorylation
of FAK may have a deleterious effect on the cell.
8. Focal adhesion kinase summary Upon integrin-me-
diated cell adhesion FAK is rapidly tyrosine phosphory-
lated at Tyr397 leading to recruitment of Src and further
phosphorylation events. This sets the stage for recruit-
ment of additional SH2-domain proteins such as GRB2,
whereas other moieties such as the adapter protein
p130
CAS may be associated constitutively with FAK.
Thus FAK is a key component in the assembly of focal
contact structures that can influence the organization of
the cytoskelton and of associated signal transduction
complexes. Although the overall relationship between
integrin-mediated adhesion and FAK activation is quite
clear, the underlying mechanisms are not. Thus, the
question remains whether the FAK amino-terminal do-
main directly binds integrins, thus activating FAK, or
whether FAK recruitment and activation involves other
focal contact proteins. Cells are likely to highly regulate
FAK tyrosine phosphorylation, and abnormally high lev-
els of FAK tyrosine phosphorylation, such as those found
in v-Src-transformed cells, may alter the normal func-
tion FAK. Likewise, tyrosine phosphatases are likely to
be important in the regulation of FAK, but the identity
and role of the relevant enzymes have yet to be defined.
There is a preponderance of evidence that FAK plays
a critical role in cell migration and motility. Although
FAK activation originally was thought to promote the
establishment of focal contacts, newer insights suggest
that it may regulate the disassembly of focal adhesions
instead to permit cell movement. FAK also may have an
important part to play in the regulation of apoptosis in
certain cell types, as well as in aspects of neuronal
development. The role of FAK in integrin signaling to
the MAPK pathway remains controversial and will be
discussed in detail in Section V. Thus, FAK has been
implicated as a key structural component and upstream
signal transducer in focal contacts; however, many as-
pects of its function await more precise definition.
C. Focal Adhesion Kinase Family Members
Recently, the identification of proline-rich tyrosine ki-
nase 2 (PYK2), also known as cell adhesion kinase b
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and calcium-dependent tyrosine kinase (CADTK), has es-
tablished the existence of FAK family members (Avraham
et al., 1995; Lev et al., 1995; Sasaki et al., 1995; Yu et al.,
1996). PYK2 shows 60% identity to FAK in the kinase
domain, with approximately 40% identity in the N- and
C-terminal regions (Avraham et al., 1995; Sasaki et al.,
1995). An autophosphorylation site (Tyr402) and the abil-
ity to associate with c-Src, p130
CAS, GRB2, and paxillin are
retained in PYK2, suggesting that PYK2 and FAK may act
through similar downstream mechanisms (Astier et al.,
1997; Dikic et al., 1996; Lev et al., 1995; Li and Earp, 1997).
However, PYK2 shows a more limited tissue distribution
than FAK (Avraham et al., 1995; Sasaki et al., 1995) and is
regulated differently, becoming tyrosine phosphorylated in
response to agents that increase intracellular calcium un-
der conditions that do not influence FAK (Lev et al., 1995;
Siciliano et al., 1996; Tokiwa et al., 1996; Yu et al., 1996).
Further, recent studies have suggested that FAK and
PYK2 have opposing functions in terms of cell survival
(Xiong and Parsons, 1997). Thus the biology of FAK and
PYK2 may be quite distinct even though the two proteins
are structurally closely related. In certain cell types inte-
grin signaling may impinge on the PYK2 activation. For
example, PYK2 is tyrosine phosphorylated upon integrin-
mediated adhesion of human B cells and megakaryocytic
cells (Astier et al., 1997; Li et al., 1996), and when overex-
pressed in CEFs, is localized to focal adhesions in a fraction
of the cells (Schaller and Terukatsu, 1997). However,
PYK2 seems to show no response to ECM-mediated signals
in other cell types (Sasaki et al., 1995). Downstream sig-
naling from PYK2 can lead to the activation of both the
Jun N-terminal kinase (JNK) and ERK MAPK pathways
(Dikic et al., 1996; Tokiwa et al., 1996). It is presently
unclear whether PYK2 is capable of partially compensat-
ing for FAK in integrin signaling pathways. In particular,
this may be relevant when studying adhesion-mediated
signaling in fibroblasts derived from FAK 2/2 mice.
D. Src Family Members
1. Activation of Src family members downstream of b1
integrins Because of their ability to bind FAK and aug-
ment FAK signaling, the role of Src family kinases in
integrin-mediated signaling events warrants further
discussion. c-Src and its other family members (e.g., Yes,
Fyn, Fgr, and Hck) share common structural features;
an N-terminal myristylation and membrane localization
signal, one SH2 and one SH3 domain, the catalytic do-
main, and a short C-terminal region containing a con-
served critical tyrosine residue (see fig. 4), as described
in a recent comprehensive review (Brown and Cooper,
1996). c-Src can be activated by many extracellular stim-
uli, including the ECM through integrins, growth factors
acting via receptor tyrosine kinases (e.g., PDGF and
EGF), G-protein coupled receptor agonists (e.g., throm-
bin and LPA), signals involved in T- and B-cell activa-
tion, and ultraviolet irradiation (Erpel and Courtneidge,
1995; Parsons and Parsons, 1997). c-Src acts as a molec-
ular switch whereby activation, either by dephosphory-
lation of Tyr527 in the C-terminus or possibly through
competition for the SH2 domain, results in a conforma-
tional change that breaks an intramolecular interaction
between the SH2 domain and P-Tyr527 and in turn
exposes the kinase domain (Matsuda et al., 1990). Src
autophosphorylation at Tyr416 within the kinase do-
main is necessary for full activity but is overridden by
phosphorylation at Tyr527 (Stover et al., 1994). The SH3
domain is also important in maintaining the inactive
closed conformation of Src. This model recently was sup-
ported with structural evidence from a recombinant in-
active fragment of human c-Src showing interaction of
the SH2 domain with the phosphorylated Tyr527 resi-
due and association of the SH3 domain with the linker
region between the SH2 and kinase domains (Xu et al.,
1997).
The CSK is the major kinase responsible for phosphor-
ylating Tyr527. Adhesion-mediated c-Src activation is
transient and there is evidence that a proportion of
cellular CSK also relocates to adhesion plaques upon Src
activation (Bergman et al., 1995; Howell and Cooper,
1994). The CSK SH2 domain is capable of binding both
phosphorylated FAK and paxillin, and this interaction
may serve to anchor CSK to focal adhesions (Sabe et al.,
1994; Schaller and Parsons, 1995). CSK overexpression
in HeLa cells alters cell shape and decreases cell adhe-
sion; therefore, CSK may be important in inactivating
Src at focal adhesion sites as well as in the turnover of
focal adhesions (Bergman et al., 1995). The phosphatase
responsible for activating Src through dephosphoryla-
tion at Tyr527 in vivo is still unknown. Putative candi-
dates are the receptor PTPa (Zheng et al., 1992), the
ezrin-like PTP (Moller et al., 1994), and the SH2 domain
containing PTP, SHPTP2/Syp (Feng et al., 1993; Peng
and Cartwright, 1995). At present there is no evidence of
localization of these PTPs to focal adhesions.
Upon fibroblast adhesion to fibronectin, c-Src becomes
dephosphorylated at Tyr527, activated, and redistrib-
utes from a perinuclear localization to focal adhesions
(Kaplan et al., 1992, 1994, 1995). Mutational analyses
implicate the myristylation sequence and the SH3 do-
main, but not catalytic activity, as Src FAT require-
ments (Kaplan et al., 1994). Furthermore, this process
may involve the GTP-binding protein Rho, because v-Src
can be relocalized to focal adhesions upon microinjection
of activated RhoA into quiescent Swiss 3T3 cells (Fin-
cham et al., 1996).
As mentioned above, Src plays a vital role in the
formation of a scaffolding complex of signaling molecules
at a focal adhesions. As for FAK, the intricacies of the
interactions in vivo are still hazy at present. Both the
SH2 and SH3 domains of Src are capable of interacting
with p130
CAS (Nakamoto et al., 1996). These interac-
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enhance activation by stabilization of the open confor-
mation once Src is located at focal adhesions. The ty-
rosine phosphorylation status of p130
CAS evidently is
linked to interactions with Src family kinases, because
p130
CAS tyrosine phosphorylation levels are decreased
in all three Src-family 2/2 cell types, most notably in
Src 2/2 fibroblasts (Bockholt and Burridge, 1995; Schla-
epfer et al., 1997; Vuori et al., 1996). Furthermore,
p130
CAS tyrosine phosphorylation levels are increased
in CSK-deficient cells (Vuori et al., 1996). p130
CAS local-
ization to focal adhesions and subsequent tyrosine phos-
phorylation expands the potential signals emanating
from focal adhesions via binding of the adapter proteins
Crk and NCK (Hamasaki et al., 1996; Schlaepfer et al.,
1997; Vuori et al., 1996). A similar scenario is true of
paxillin; Src is also capable of binding, through its SH2
and/or SH3 domain, and then phosphorylating paxillin
(Schaller and Parsons, 1995; Weng et al., 1993). This
tethering may be important for localizing Src to focal
adhesions, but more likely is required to increase the
repertoire of SH2 domain binding sites. In this regard,
phosphorylated paxillin, like p130
CAS, is capable of bind-
ing Crk at least in vitro (Schaller and Parsons, 1995).
The importance of Src in this complex, in functions such
as cell migration and motility, is evident from Src 2/2
fibroblasts that show delayed spreading on fibronectin
compared with cells re-expressing c-Src (Kaplan et al.,
1995). This effect requires the SH2 and SH3 domains of
c-Src but, as with focal adhesion localization, is indepen-
dent of kinase activity (Kaplan et al., 1995). However,
other studies in fibroblast that are negative for Src fam-
ily members have not seen pronounced changes in cell
spreading (Bockholt and Burridge, 1995). Thus, whereas
Src seems to be implicated in cytoskeletal function, its
quantitative importance still is undefined.
In summary, it is becoming apparent that FAK, Src,
p130
CAS, and paxillin form a distinct quaternary signal-
ing unit in adhering cells which is initiated by autophos-
phorylation of FAK (Schlaepfer and Hunter, 1997). This
unit regulates cell spreading and mobility upon integrin
engagement through the recruitment of additional sig-
naling and adapter proteins. It is unclear why c-Src and
v-Src seem to play paradoxically opposing roles in the
focal adhesion; c-Src enhancing cell spreading, v-Src
causing morphological transformation and reduced at-
tachment. One possibility is that v-Src activity is refrac-
tory to inactivation by CSK and, hence, shows higher
and more prolonged kinase activity within focal adhe-
sions, thus disrupting the delicate balance involved in
focal adhesion assembly.
2. Activation of Src family members downstream of b2
integrins The studies mentioned thus far in this section
mainly concern signaling through b1 integrins. Interest-
ingly, signaling through other b subunits shows discrete
differences in the subset of proteins tyrosine phosphor-
ylated compared with those proteins phosphorylated
upon b1 engagement (Berton et al., 1994; Graham et al.,
1994). Differential expression of alternative Src kinases
may account for at least some of these observations. A
pertinent example here is polymorphonuclear leuko-
cytes (PMNs), in which b2-integrins are the dominant
functional adhesion receptors important for attachment
and migration into sites of inflammation, and in which
the major expressed Src family kinases are Fgr, Hck,
and Lyn (Tsygankov and Bolen, 1993). In PMNs, TNF
activation of Fgr depends on the engagement of b2 inte-
grins (Berton et al., 1994). Enhancement of Fgr activity
may result in the tyrosine phosphorylation of other pro-
teins, such as paxillin and the guanine nucleotide ex-
change factor, Vav, which also displays enhanced ty-
rosine phosphorylation levels in a b2-dependent manner
in PMNs (Graham et al., 1994; Zheng et al., 1996a).
These responses are specific to b2 because PMNs de-
rived from patients with leukocyte adhesion deficiency,
which lack b2 expression, do not activate Fgr or phos-
phorylate paxillin in response to TNF (Berton et al.,
1994; Graham et al., 1994). Other studies implicate a
role for Fgr and Hck in the spreading and respiratory
bursts of PMNs adhering to ECM components (Lowell et
al., 1996). Interestingly, b2 antibody-mediated cluster-
ing does not activate FAK, despite FAK expression in
neutrophils (Fuortes et al., 1994). Thus, several of the
Src family kinases apparently perform physiological
functions in integrin adhesion-dependent events in nu-
merous cell types, and some degree of subunit specificity
exists in the connections between integrins and cyto-
plasmic tyrosine kinases.
E. Other Tyrosine Kinases Activated by Integrins
1. C-Abl A more recently identified noncytoplasmic
tyrosine kinase that is regulated by integrins is encoded
by the c-Abl protooncogene. The kinase domain of c-Abl
is flanked by N-terminal SH2 and SH3 domains,
whereas the F-actin and DNA binding domains are at
the extreme C-terminus of the protein (fig. 4) (Wang,
1993). Both the cytoplasmic and nuclear pools of c-Abl
become activated upon adhesion of fibroblasts to fi-
bronectin and a pool of the enzyme transiently localizes
to focal adhesions (Lewis et al., 1996). It is unclear at
present where c-Abl activation is sequentially on the
integrin signaling pathway. A constitutively active form
of c-Abl, the Bcr-Abl found in human patients with
chronic myelogenous leukemia, causes enhanced phos-
phorylation of paxillin in myeloid cells (Salgia et al.,
1995). Thus, c-Abl may participate in integrin-mediated
events by phosphorylating focal adhesion proteins. Bcr-
Abl also induces anchorage-independent, but growth
factor-dependent, proliferation in fibroblasts, placing
Abl downstream of integrins but upstream of the point of
convergence with growth factor signaling pathways
(Renshaw et al., 1995). In addition, c-Abl, through inter-
actions with the C-terminal F-actin and DNA binding
domains, may function in integrin-dependent regulation
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gression.
2. Spleen tyrosine kinase In hematopoietic cell types
such as monocytes, neutrophils, and platelets, tyrosine
phosphorylation and activation of the 76 kDa SYK ap-
parently are a common link in the integrin signaling
chain. SYK is a member of a family, also containing
ZAP-70, which is characterized by the presence of two
tandem N-terminal SH2 domains and a C-terminal ki-
nase domain (fig. 4) (Law et al., 1994). The SH2 domains
of SYK are capable of binding phosphotyrosine residues
in B- and T-cell receptors, leading to phosphorylation of
SYK and activation of SYK during T- and B-cell stimu-
lation by antigens (Couture et al., 1994; Qian and Weiss,
1997).
During inflammation, migration of monocytes into tis-
sues requires adhesion to vascular endothelial cells and
ECM components. As in other cell types, engagement of
b1 integrins in monocytes by ECM proteins, or with
anti-b1 antibodies, results in the enhanced tyrosine
phosphorylation of several proteins, the most predomi-
nant of which is SYK (Lin et al., 1994, 1995). These
events in monocytes are independent of cytoskeletal in-
tegrity and correlate closely with NFkB activation and
the induction of immediate early genes, such as cyto-
kines, that mediate the inflammatory response (Juliano
and Haskill, 1993; Lin et al., 1995). FAK is undetectable
in human monocytes, although it is present in monocytic
cell lines, such as THP1, and is tyrosine phosphorylated
upon adhesion to fibronectin (Lin et al., 1994, 1995).
More recently, SYK has been shown to be activated on
TNFa-o rM n
21-induced spreading of human neutro-
phils on a fibrinogen-coated surface (Yan et al., 1997).
Thus, integrin-mediated SYK activation is a common
theme in leukocytic cell adhesion and transmigration
into a site of inflammation.
Agonist activation of platelets, by thrombin or suben-
dothelial collagen for example, triggers a cascade of
events resulting in alterations in cell shape and cell
aggregation. A pivotal stage in this response is the
change in conformation of the aIIbb3 integrin so that it
will bind to fibrinogen (Siess, 1989). Activation of plate-
lets involves several waves of tyrosine phosphorylation;
the early wave is aIIbb3-independent and results in Src
activation, the second phase is provoked by aIIbb3 en-
gagement, and the late stage depends on aggregation.
Collagen stimulation of platelets results in SYK activa-
tion within seconds, and a requirement for SYK activity
in platelet aggregation has been demonstrated through
the use of the SYK-selective inhibitor, piceatanol (Keely
and Parise, 1996). SYK activation can be mimicked by
the use of stimulatory antibodies against a2b1 (Keely
and Parise, 1996) and partially inhibited by use of a2b1
function-blocking antibodies. a2b1-independent path-
ways leading to activation of SYK also add to the com-
plexity of the response. Platelets react to thrombin stim-
ulation acting via G-protein-coupled receptors by rapidly
activating SYK (Taniguchi et al., 1993). This effect can
be simulated by cross-linking b3 integrins and partially
blocked by b3 function-blocking antibodies (Clark et al.,
1994). The response also partially depends on the pres-
ence of an intact cytoskeleton but is wholly independent
of platelet aggregation (Clark et al., 1994). Recent stud-
ies in an aIIbb3-expressing CHO cell line show that SYK
activation through aIIbb3 may be mediated through Src
activity (Gao et al., 1997). Hence, it is evident that SYK
activity is regulated at different points in the pathway
leading to platelet activation and also by different inte-
grins. It is noteworthy that SYK activation differs from
FAK activation in the platelet response, in that it occurs
earlier and does not require platelet aggregation (Lipfert
et al., 1992).
F. Summary
Activation of tyrosine kinases is a key proximal event
for integrin-mediated signal transduction. In many cells
FAK and Src are the kinases most directly responsive to
integrin-dependent cell adhesion, whereas in hemato-
poietic cells SYK seems to have a special role. Despite
extensive study, the precise mechanism by which inte-
grins activate FAK or other tyrosine kinases remains
obscure; for example, it is still uncertain whether FAK
directly interacts in vivo with integrin cytoplasmic do-
mains. The adhesion-triggered activation of cytoplasmic
tyrosine kinases, the subsequent phosphorylation of sev-
eral structural and adapter proteins, and the establish-
ment of multiple SH2 domain-mediated interactions
clearly play a vital role in the organization and function
of focal adhesions. The formation of focal contacts in-
volves a complex and seemingly redundant set of mole-
cules, because “knockout” or inhibition of any one of
several key components still permits assembly of the
essential structure, at least by morphological criteria.
However, it is clear that FAK and Src are important in
regulating focal adhesion assembly and disassembly.
FAK activation seems to be involved particularly in the
promotion of cell motility, with several lines of evidence
supporting this view. The potential role of FAK in link-
ing integrins to downstream signaling events remains
controversial, as will be described further in Section V.
of this review. Perhaps the best defined role for FAK in
downstream signaling is as an antiapoptotic factor in
epithelial cells; this role is discussed in more detail in
Section X. The functional roles of other integrin-acti-
vated tyrosine kinases, including c-Abl and SYK, are
even less well defined. In summary, during the past few
years there have been numerous studies concerning in-
tegrin-responsive tyrosine kinases. Despite this intense
interest, major gaps remain in our understanding of the
biological role of integrin-mediated tyrosine phosphory-
lation.
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Activation of the Mitogen-Activated Protein
Kinase Cascade
Activation of the MAPK cascade is a common event in
the responses to many diverse extracellular stimuli
(Cobb et al., 1994b; Gotoh and Nishida, 1995; Guan,
1994). These stimuli vary widely in both their chemical
nature (e.g., peptide growth factors, phorbol esters, oka-
daic acid) and in their biological activities [e.g., nerve
growth factor (NGF) induces neuronal outgrowth in
PC12 cells, whereas EGF induces cell division]. Several
groups now have firmly established that integrin-medi-
ated cell adhesion, in the absence of soluble factors, can
lead directly to the activation of the MAPK cascade
(Chen et al., 1994a; Clark and Hynes, 1996; Miyamoto et
al., 1996; Morino et al., 1995; Papkoff et al., 1994; Ren-
shaw et al., 1996b; Schlaepfer et al., 1994; Takahashi
and Berk, 1996; Wary et al., 1996; Zhu and Assoian,
1995). Thus, the insoluble proteins of the ECM join the
many factors that can activate this cascade. Since the
discovery of the MAPKs, an enormous literature has
accrued which describes in detail both the mechanism(s)
through which soluble factors activate MAPK and the
consequences of this activation. Currently, the activa-
tion of MAPK by cell adhesion is being similarly dis-
sected. In this section, we will review the biochemical
characteristics, possible mechanisms, and significance
of integrin-mediated MAPK activation.
A. Experimental Approaches and Cell Types
The general experimental paradigm used to demon-
strate direct integrin signaling involves detaching ad-
herent cells from tissue culture plates and replating
them onto surfaces coated with integrin ligand, typically
a purified ECM protein such as fibronectin, vitronectin,
or laminin. The supposition that MAPK activation is
caused specifically by adhesion mediated by integrins,
rather than by heterologous cell surface receptors or
through nonspecific binding, has been confirmed using
three experimental approaches. First, surfaces coated
with polylysine support firm, nonspecific attachment of
cells, but this attachment does not significantly activate
MAPK (Chen et al., 1994a; Mainiero et al., 1997; Miy-
amoto et al., 1995b; Morino et al., 1995; Schlaepfer et al.,
1994; Wary et al., 1996; Zhu and Assoian, 1995). Second,
several groups have reported activation of MAPK when
cells are plated on surfaces or incubated with beads
coated with antibodies specific for various integrins but
not with antibodies against other cell surfaces proteins,
such as CD44 or MHC class I (Chen et al., 1996b; Lin et
al., 1997a; Mainiero et al., 1997; Miyamoto et al., 1995b;
Morino et al., 1995; Wary et al., 1996). Third, immobi-
lized recombinant fragments of fibronectin and fibronec-
tin-derived RGD peptides have been used to mediate cell
attachment and subsequent MAPK activation (Chen et
al., 1994a; Lin et al., 1997a), and soluble RGD peptides
have been used to compete integrin-mediated adhesion
to fibronectin and block MAPK activation (Zhu and As-
soian, 1995).
Using this paradigm, integrin-mediated MAPK acti-
vation has been demonstrated in a wide variety of cell
types. The predominant cell type in these studies is the
fibroblast, with the source species typically being rodent
(NIH or Swiss 3T3, REF52), human (WI38, HDF), and
occasionally avian (CEF, primary quail embryo fibro-
blasts). Other cell types that exhibit integrin-mediated
MAPK activation include human epithelial cells (293,
HeLa), keratinocytes, and endothelial cells (human um-
bilical vein endothelial cells). All cell lines listed thus far
are derived from solid tissues and are grown as adherent
cultures. However, monocytic cells (THP-1) and plate-
lets are nonadherent cells that exhibit integrin-medi-
ated MAPK activation (Clemetson, 1995; Wahl et al.,
1996). The activation of MAPK in response to cell adhe-
sion is not an occurrence restricted to mammalian cells,
or even to metazoans. The unicellular parasite Entam-
oeba histolytica, which expresses an integrin-like colla-
gen receptor, shows activation of a MAPK homolog upon
attachment to collagen (Perez et al., 1996). This suggests
that integrin-mediated MAPK activation is likely to be
an important biochemical event in many cell types.
B. Time Course of Integrin-Mediated Mitogen-Activated
Protein Kinase Activation and Its Consequences
In NIH3T3 cells, MAPK activity peaks 10 to 15 min
after plating on fibronectin, whereas lower, but signifi-
cant, activity persists 40 to 60 min after plating (Chen et
al., 1994a; Clark and Hynes, 1996; Lin et al., 1997a;
Renshaw et al., 1996b; Zhu and Assoian, 1995). Similar
time courses are seen in other rodent (Swiss 3T3,
REF52) fibroblast lines (Chen et al., 1994a) as well as in
human dermal (Miyamoto et al., 1995b; Morino et al.,
1995) and lung (Chen et al., 1994a) fibroblasts. Swiss
3T3 and REF52 cells also show activation of MAPK 10
min after adhesion to laminin-coated surfaces (Chen et
al., 1994a). In primary human keratinocytes plated on
laminin, peak MAPK activation occurs 30 min after plat-
ing (Mainiero et al., 1997), slightly slower than in fibro-
blasts on fibronectin. Conversely, HUVECs plated on
fibronectin show peak levels of MAPK activity within 10
min of plating (Takahashi and Berk, 1996), slightly
faster than fibroblasts on the same matrix protein. From
its peak, MAPK activity undergoes a gradual decline
(Chen et al., 1994a, 1996b; Clark and Hynes, 1996; Lin et
al., 1997a; Renshaw et al., 1996a) or a delayed, but
relatively rapid decrease (Mainiero et al., 1997; Miy-
amoto et al., 1996; Morino et al., 1995; Zhu and Assoian,
1995). As a result, integrin-mediated MAPK activity
may persist at 60 to 100% of maximum levels for periods
ranging from 15 min to2ho rmore. Thus the time
course of integrin-mediated MAPK activation is likely to
vary based on the type of cell, integrin, and matrix
involved.
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stark contrast to that seen in response to many soluble
mitogens such as peptide growth factors (e.g., PDGF),
which typically elicit a sharp peak of activity within 2 to
5 min (Gotoh and Nishida, 1995; Zhu and Assoian,
1995). It is clear that integrin-mediated MAPK activa-
tion alone is insufficient to promote induction of DNA
synthesis (Mainiero et al., 1997; Zhu and Assoian, 1995).
This is despite the fact that integrin-mediated adhesion,
like growth factor stimulation, results in nuclear trans-
location of MAPK (Chen et al., 1994a; Davis, 1995; Zhu
and Assoian, 1995) and activation of MAPK-responsive
transcription factors (Davis, 1995; Hipskind et al., 1994;
Janknecht et al., 1993; Mainiero et al., 1997; Wary et al.,
1996). It has been suggested that the duration of MAPK
activity can affect the nature of the cellular response
(Marshall, 1995); in PC12 cells, for example, transient or
prolonged MAPK activity induces cell division or differ-
entiation, respectively. How the duration of integrin-
mediated MAPK activity may affect downstream biolog-
ical events is not yet understood.
The failure of cells to enter S phase in response to
integrin-mediated MAPK activation may be caused by
the level of activity induced by adhesion. In most cases,
the average induction of MAPK activity by adhesion is
three- to four-fold (Chen et al., 1994a; Clark and Hynes,
1996; Lin et al., 1997a; Morino et al., 1995; Renshaw et
al., 1996b; Zhu and Assoian, 1995), although some
groups have reported more robust responses (from six-
to ten-fold) in fibroblasts stimulated with ligand- or an-
tibody-coated beads (Miyamoto et al., 1995b), in
HUVECs transiently transfected with a MAPK expres-
sion plasmid (Wary et al., 1996), and in primary kera-
tinocytes (Mainiero et al., 1997). Nonetheless, the aver-
age level of integrin-induced MAPK activity is
significantly less than the 20- to 50-fold activation in-
duced in adherent cells by classical mitogens such as
PDGF (Kyriakis et al., 1993; Reuter et al., 1995; Zhu and
Assoian, 1995), EGF (Chen et al., 1996b; Zheng et al.,
1994a) and phorbol esters (Marquardt et al., 1994; Ren-
shaw et al., 1996b; Ueda et al., 1996). It is likely that a
certain threshold of MAPK activity must be reached or
exceeded to deliver a cell into S phase, whereas a sub-
threshold level of activity, regardless of duration, will
lend itself to an altogether different biochemical
event(s). The possible nature of this event in the case of
integrin-mediated MAPK activation will be discussed in
detail below. It should be noted that the robust activa-
tion of MAPK by polypeptide growth factors occurs in
adherent cells, whereas responses to growth factors are
markedly attenuated in cells in suspension. Thus, as
discussed in detail in Section IX., both soluble growth
factors and integrin-mediated cell anchorage seem to be
required for efficient mitogenic signaling and cell cycle
traverse.
C. Mechanisms for Integrin-Mediated Mitogen-
Activated Protein Kinase Activation
The previous section introduced significant differ-
ences that exist between the profiles of growth factor-
mediated and adhesion-mediated MAPK activation. Dif-
ferences between the two pathways also exist at the
molecular level. Unlike growth factor receptors, inte-
grins have no intrinsic enzymatic activity, and thus a
difference in mechanisms is somewhat expected. In this
section, we will first briefly review the canonical path-
way leading from growth factor receptors to MAPK;
then, we will discuss what is known so far of the mech-
anism of integrin-mediated MAPK activation.
1. Mechanism of growth factor activation of mitogen-
activated protein kinase Upon treatment of cells with
peptide mitogens (e.g., PDGF, EGF), the respective re-
ceptor tyrosine kinase (RTK) homodimerizes and under-
goes autophosphorylation on various tyrosine residues.
These modifications create binding sites for proteins
containing SH2 domains (Pawson and Gish, 1992). Some
of these proteins are enzymes, such as kinases (Src,
p85
PI-3K, CSK), phosphatases (SHP), GTPase activators
(p120Ras
GAP), and regulators of phospholipid turnover
[phospholipase C (PLC) g], whereas others are adapter
proteins (Shc, Nck, GRB2) that serve to relocate specific
target proteins to sites of tyrosine phosphorylation
(Schlessinger, 1994). One of these target proteins, SOS,
is a Ras guanine nucleotide exchange factor (GNEF) and
is recruited to activated RTKs through its interaction
with GRB2. Once at the membrane, SOS promotes con-
version of Ras to an activated, GTP-bound form (Down-
ward, 1996). Activated Ras binds the amino-terminal
domain of Raf-1 (Van Aelst et al., 1993; Vojtek et al.,
1993) forming a stable complex (Finney and Herrera,
1995; Hallberg et al., 1994) and thereby localizing Raf to
the plasma membrane. Subsequent to this localization,
Raf is activated (Leevers et al., 1994; Stokoe et al., 1994)
by a mechanism that remains unclear (Cutler and Mor-
rison, 1997), but is likely to involve phosphorylation of
tyrosine (Fabian et al., 1993; Marais et al., 1995) or
serine (Morrison et al., 1993) residues, and may include
interactions with 14–3-3 proteins (Fantl et al., 1994; Fu
et al., 1994; Irie et al., 1994; Michaud et al., 1995) or
phospholipid (Ghosh et al., 1996; Mott et al., 1996). Ad-
ditional complexity comes from observations that vari-
ous isoforms of protein kinase C (PKC) can directly
phosphorylate and activate Raf in a Ras-independent
manner (Cai et al., 1997; Carroll and May, 1994; Kolch et
al., 1993; Ueda et al., 1996). Once activated, Raf phos-
phorylates and activates MAPK/ERK kinase (MEK), the
dual-specificity (threonine/tyrosine) kinase directly re-
sponsible for activation of MAPK (Graves et al., 1995).
2. Mechanism of integrin-mediated activation of mito-
gen-activated protein kinase Tracing the pathway of in-
tegrin-mediated MAPK activation backward from
MAPK offered no surprises, initially. To date, the only
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by MEK (Ahn et al., 1992), and auspiciously, MEK is
activated by integrin-mediated adhesion with kinetics
similar to those of MAPK activation (Chen et al., 1996b).
Moreover, activation of MEK by adhesion is required for
the activation of MAPK, as pharmacological inhibition of
MEK activation ablates integrin-mediated MAPK acti-
vation in fibroblasts (Chen et al., 1996b) as well as
human monocytes (McGilvray et al., 1997). It is safe to
assume that, as no other mechanisms for activation of
MAPK besides phosphorylation by MEK have been dis-
covered, that integrin-mediated MAPK activation will
behave no differently in this regard.
The ability to phosphorylate and activate MEK has
been ascribed to several proteins including c-Mos (Pham
et al., 1995), Xenopus Ras-dependent ERK kinase stim-
ulator (REKs) (Kuroda et al., 1995), a 40 to 50 kDa
protein from NIH3T3 cells (Reuter et al., 1995), and the
upstream regulators of the SAPK/JNK pathway, the
MEK kinases (Gardner et al., 1994; Lange-Carter et al.,
1993). However, activation of MEK is carried out prin-
cipally by the Raf family of protein kinases (Daum et al.,
1994; Marshall, 1996; Morrison, 1995). In NIH3T3 cells,
Raf-1 is activated by adhesion to fibronectin (Chen et al.,
1996b), and the time course of activation parallels those
for MEK and MAPK, with an activity that peaks at 10
min after plating and then declines slowly over the next
50 min. To date, there is little information on the re-
sponse of other Raf family members or of the other
potential MEK activators to integrin-mediated cell ad-
hesion. However, Raf-1 is the most abundant member of
the Raf family in NIH3T3 cells (Reuter et al., 1995) (Lin,
Howe, and Juliano, unpublished observations). Further-
more, pharmacological destabilization of Raf-1 by
geldanamycin (Schulte et al., 1995; Stancato et al., 1997)
inhibits integrin-mediated MEK activation (Howe and
Juliano, unpublished observations). Therefore, in the
absence of data to the contrary, it is reasonable to as-
sume that, in fibroblasts, integrin-mediated activation
of MEK is likely to occur through activation of Raf-1.
a. EVIDENCE FOR RAS- AND FOCAL ADHESION KINASE-
DEPENDENT MECHANISMS. Raf activation is a complex
matter, and the mechanism of how it occurs after cell
adhesion is still unclear. One highly tenable mechanism
by which integrins may activate Raf (and therefore
MAPK) closely parallels growth factor stimulation. It
involves Ras activation using the same signaling inter-
mediates used by RTKs, with FAK acting as a surrogate,
integrin-associated, tyrosine kinase domain (Schlaepfer
et al., 1994). In this mechanism (fig. 6A), engagement of
integrins by fibronectin induces FAK autophosphoryla-
tion, which in turn leads to FAK association with and
tyrosine phosphorylation by Src, as discussed in Section
IV. Src-mediated phosphorylation of FAK promotes the
direct binding of the GRB2 adapter protein to Tyr925 of
FAK (Schlaepfer et al., 1994, 1996) and also may pro-
mote the formation of a complex containing FAK and a
GRB2/Shc complex, which is independent of phosphory-
lation at Tyr925 (Schlaepfer and Hunter, 1997). Both
situations would result in the recruitment of SOS to the
juxtamembrane complex (Miyamoto et al., 1995b; Schla-
epfer et al., 1994) which subsequently would activate
Ras (see fig. 6A). In this mechanism, integrin-mediated
MAPK activation depends on Ras (for activation of Raf)
and FAK (for activation of Ras). In agreement with these
notions, several groups have demonstrated an integrin-
mediated activation of Ras (as measured by GTP load-
ing), either by cell adhesion to fibronectin in fibroblasts
(Clark and Hynes, 1996; King et al., 1997) or by anti-
body-mediated engagement of integrins on T cells (Ka-
pron-Bras et al., 1993) and neutrophils (Zheng et al.,
1996a). Also, studies using beads coated with integrin
ligands or anti-integrin antibodies have demonstrated
colocalization of Ras, as well as GRB2 and SOS, with
integrins (Miyamoto et al., 1995b). Finally, expression of
dominant negative Ras (Ras
N17) or Shc (Shc
F317) can
block integrin-mediated MAPK activation in several sys-
tems (Clark and Hynes, 1996; King et al., 1997; Mainiero
et al., 1997; Schlaepfer and Hunter, 1997). A role for
FAK in integrin-mediated MAPK activation also is sup-
ported by experiments in which overexpression of wild-
type FAK in transformed human epithelial cells en-
hances integrin-mediated MAPK activation four-fold,
whereas expression of FAK
F397, to which Src cannot
bind, reduces FN-stimulated MAPK activity (Schlaepfer
and Hunter, 1997). Furthermore, fibroblasts isolated
from Src 2/2 mice still show adhesion-induced MAPK
activation, but it is ten-fold lower than in Src 2/2 cells
made to re-express c-Src through retroviral infection
(Schlaepfer et al., 1997). However, no comparison has
been made between the level of MAPK activity in these
Src “re-expressers” and normal murine fibroblasts (e.g.,
NIH3T3), which have a 5-fold lower level of Src expres-
sion. These data, in addition to the substantial body of
data describing the interaction of FAK with GRB2
(Schlaepfer et al., 1997; Schlaepfer et al., 1994; Schla-
epfer and Hunter, 1997; Schlaepfer and Hunter, 1996),
support the notion that FAK can contribute to integrin-
mediated MAPK activation.
An interesting situation arises in the case of p130
CAS
and integrin-mediated MAPK activation. It seems feasi-
ble, a priori, that p130
CAS might contribute to activation
of MAPK by adhesion: it binds the adapter proteins CRK
and NCK, which bind the GNEFs SOS and C3G (Mat-
suda and Kurata, 1996; Vuori et al., 1996), it can directly
interact with FAK (Harte et al., 1996; Polte and Hanks,
1997; Polte and Hanks, 1995, 1997), and it localizes to
focal adhesions (Harte et al., 1996; Petch et al., 1995;
Polte and Hanks, 1997). However, both wild-type FAK
and the Y397F point mutant are able to bind to p130
CAS,
but the latter is incapable of mediating integrin-medi-
ated MAPK activation (Schlaepfer and Hunter, 1997).
This suggests that p130
CAS, despite its a priori charac-
teristics, is not involved in linking integrins and/or FAK
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mediated signal transduction through other effectors,
such as p65
PAK (Galisteo et al., 1996) and PKN (Quil-
liam et al., 1996). Alternatively, p130
CAS may only be
involved when Src can bind to the Y397 site on FAK and
tyrosine phosphorylate sites on p130
CAS.
Thus, in some circumstances, there is solid (although
not overwhelming) evidence that both FAK and Ras are
directly in the signaling pathway leading from integrin-
mediated cell adhesion to MAPK activation.
b. EVIDENCE FOR RAS-INDEPENDENT MECHANISMS.I n
contrast to the discussion above, there is substantial
evidence to suggest that other, Ras- and/or FAK-inde-
pendent mechanisms for integrin-mediated MAPK acti-
vation exist. First, our laboratory did not detect a sig-
nificant increase in Ras GTP-loading after NIH3T3 cell
adhesion to fibronectin (Chen et al., 1996b). Further-
more, transfection of pZIP-Ras
N17, although able to sig-
nificantly inhibit activation of MEK by constitutively
active SOS, did not affect activation of MEK by adhesion
to fibronectin (Chen et al., 1996b). Finally, high-level
expression of an N-terminal portion of Raf (amino acids
23 to 284), which contains the Ras binding site (Brtva et
al., 1995) and completely blocks the activation of the
MAPK cascade by oncogenic Ras (Ras
V12), presumably
by precluding Ras-Raf interaction, also failed to inhibit
integrin-mediated activation of the MAPK pathway
(Chen et al., 1996b). The reasons for the discrepancy
between these results, which suggest that integrin-me-
diated MAPK activation is Ras-independent, and the
FIG. 6. Possible mechanisms for integrin-mediated activation of the MAPK pathway. Currently, the best characterized mechanisms involve
activation through FAK- and Ras-dependent pathways (A), although substantial evidence suggests that other distinct mechanisms exist. Integrin-
mediated adhesion regulates several activities that can contribute to MAPK activation, especially through activation of Raf. Among these activities
are phospholipases C and D (B), protein kinase C (B), the integrin-linked kinase (ILK) (C), and Src-family tyrosine kinases (C). Activation of Raf
coincides with its localization to the plasma membrane and cytoskeleton, raising the possibility that integrin-mediated adhesion may directly recruit
Raf to the membrane or may regulate a membrane-associated Raf activator (X in D). Other regulators of various components of the MAPK pathway
have been described (D), but their regulation by adhesion has not yet been determined. See text for details.
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are unknown. It has been suggested that the difference
may lay in the level of Ras
N17 expression, as one group
mentions a similar lack of effect of pZIP-Ras
N17 on inte-
grin-mediated MAPK activation, but demonstrates inhi-
bition with a vector in which expression is driven from
the powerful cytomegalovirus promoter (Schlaepfer and
Hunter, 1997). This would not account for the differ-
ences seen in adhesion-mediated Ras GTP loading or for
the effect seen with the Raf N-terminus, which was
expressed under the cytomegalovirus promoter, how-
ever. The existence of Ras-independent mechanisms of
integrin-mediated Raf activation has been supported by
recent observations using mutant forms of Raf defective
in the Ras binding site; nonetheless, these Raf mutants
can be activated by integrin-mediated adhesion (Howe
and Juliano, unpublished). One possible explanation
that might allow for all of these observations is that
integrin-mediated MAPK activation may require some
degree of Ras function, but not direct stoichiometric
Ras-Raf interaction. A candidate Ras effector in this
regard may be PI-3K (Rodriguez-Viciana et al., 1996),
which may contribute to Raf activation through activa-
tion of PKC isoforms (Akimoto et al., 1996; Liscovitch
and Cantley, 1995; Toker et al., 1994) and which has
been implicated recently in integrin-mediated MAPK
activation (King et al., 1997; Mainiero et al., 1997).
c. EVIDENCE FOR FOCAL ADHESION KINASE-INDEPENDENT
MECHANISMS. Similarly, reports have suggested that in-
tegrin-mediated MAPK activation can occur indepen-
dently of FAK function. The first report demonstrates
that whereas FAK tyrosine phosphorylation requires
integrin b subunits, the recruitment and activation (by
tyrosine phosphorylation) of the Shc adapter protein
apparently is specified by the transmembrane and ex-
tracellular juxtamembrane regions of a subunits in a
mechanism involving interaction with caveolin (Wary et
al., 1996) (fig. 6A). Furthermore, antibody-mediated li-
gation of the a6b1 integrin can induce tyrosine phos-
phorylation of FAK, but not Shc, whereas ligation of an
a1 mutant that lacks a cytoplasmic tail can activate Shc,
but not FAK. FAK-independent recruitment and activa-
tion of Shc also can occur through direct interaction of
Shc with the atypical cytoplasmic domain of the b4
integrin subunit, which becomes tyrosine phosphory-
lated after adhesion to laminin (Mainiero et al., 1995,
1997). In a second report, which deals specifically with
the matter at hand, several observations indicate that
activation of FAK and MAPK by integrins are separable
phenomena (Lin et al., 1997a). First, a b1 subunit mu-
tant with a deletion that overlaps the putative FAK
binding domain can support integrin-mediated MAPK
activation but not FAK tyrosine phosphorylation. Sec-
ond, experiments involving cell adhesion to recombinant
fibronectin fragments show that MAPK is activated at a
time when there is no detectable tyrosine phosphoryla-
tion of FAK, and in time course experiments, activation
of MAPK precedes the low level of FAK tyrosine phos-
phorylation induced by attachment to the fragments.
Third, expression of FRNK (see Section IV.), although
able to block integrin-mediated tyrosine phosphoryla-
tion of FAK completely, has no effect on integrin-medi-
ated MAPK activation. Taken together, these data
strongly suggest that integrin-mediated MAPK activa-
tion can occur through a FAK-independent mechanism.
d. THE NATURE OF RAS-INDEPENDENT MECHANISMS OF
MITOGEN-ACTIVATED PROTEIN KINASE ACTIVATION BY INTE-
GRINS. At this point the mechanism(s) underlying Ras-
and FAK-independent activation of MAPK by integrins
remain largely undefined. Indeed, several mechanisms
are theoretically possible (fig. 6B, C). For instance, any
one of several lipid mediators may play a role (fig. 6B).
Thus integrin-mediated cell adhesion activates PKC
(Vuori and Ruoslahti, 1993). Upon activation, several
isoforms of PKC are capable of directly phosphorylating
and activating Raf in the absence of functional Ras (Arai
and Escobedo, 1996; Cacace et al., 1996; Cai et al., 1997;
Carroll and May, 1994; Kolch et al., 1993; Sozeri et al.,
1992; Ueda et al., 1996; Zou et al., 1996). Ras-indepen-
dent activation of PKC by cell adhesion could occur
through mechanisms that generate lipid co-activators
for PKC. For example, PI-4,5-kinase-mediated synthesis
of PI(4,5)P2 and its hydrolysis to diacylglycerol (DAG)
and inositol triphosphate (IP3) by PLC are known to
occur in response to integrin-mediated cell adhesion
(Chong et al., 1994; Cybulsky et al., 1993; Kanner et al.,
1993; Ren et al., 1996; Somogyi et al., 1994); and adhe-
sion-mediated increases in PI-3K lipid products that are
potentially able to activate certain PKCs have been re-
ported recently (Khwaja et al., 1996). In addition, inte-
grin-mediated cell adhesion has been shown to activate
phospholipase A2 (PLA2), leading to production of ara-
chidonic acid products and activation of PKC (Auer and
Jacobson, 1995). Several isoforms of PKC, from both
conventional (a, b, g) and novel (d, e, h, u) subclasses, are
regulated by DAG (Newton, 1997). Also, three novel
PKCs (d, e, h), as well as the atypical isoform PKCl, can
be regulated by phospholipids generated through the
activity of PI-3K, namely PI(3,4)P2 and PI(3,4,5)P3 (Aki-
moto et al., 1996; Toker et al., 1994). Like PI4,5K, PI-3K
also is activated after integrin-mediated cell adhesion,
and this can occur through several mechanisms (see
below) (Chen and Guan, 1994a,b; Guinebault et al.,
1995; Zhang et al., 1993). Another lipid-based mecha-
nism for Ras-independent activation of Raf by cell adhe-
sion may involve integrin-mediated activation of phos-
pholipase D (PLD) (Serrander et al., 1996) and
production of phosphatidic acid, which can contribute to
Raf activation through direct interaction with Raf
(Ghosh et al., 1996) or through conversion to DAG and
activation of PKCs (Singer et al., 1997).
Integrin-mediated activation of Raf also may involve
tyrosine phosphorylation (fig. 6C). Although the extent
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ological activation of Raf is currently unclear (Morrison,
1995), there is substantial evidence that Raf can be
activated by direct tyrosine phosphorylation by Src fam-
ily members (e.g., Src, Fyn, and Lck) (Cleghon and Mor-
rison, 1994; Cutler and Morrison, 1997; Fabian et al.,
1993; Marais et al., 1995; Popik and Pitha, 1996; Thomp-
son et al., 1991). Significantly, Raf activation by tyrosine
phosphorylation does not require Ras (Dent et al., 1995;
Fabian et al., 1993; Marais et al., 1995; Stokoe and
McCormick, 1997), although Ras can augment the pro-
cess, most likely by recruiting Raf to the membrane
(Dent et al., 1995; Jelinek et al., 1994; Leevers et al.,
1994; Marais et al., 1995; Stokoe et al., 1994). Further-
more, Src is activated after adhesion to fibronectin and
localizes to focal adhesions (Fincham et al., 1996; Kaplan
et al., 1994, 1995) (see Section IV.). Thus, integrin-me-
diated activation of Src also may contribute to Ras-
independent Raf activation.
Another plausible candidate for Ras-independent ac-
tivation of Raf and MAPK is the recently described ILK
(Hannigan and Dedhar, 1997; Hannigan et al., 1996)
(see Section III.). ILK binds to the cytoplasmic tails of b1
and b3 integrins, and overexpression of ILK can promote
anchorage-independent growth. Of importance is the re-
cent observation that ILK can associate with Raf and
can induce MAPK activity in a FAK- and Ras-indepen-
dent manner (Dedhar, 1997), perhaps by recruiting Raf
to the membrane (via interaction with b integrin sub-
units) in a manner analogous to Ras (fig. 6C).
It has been known for some time that activated Raf
exists as part of an membrane-associated, NP40-insolu-
ble complex that apparently is associated with the cy-
toskeleton (Carraway and Carraway, 1995; Stokoe et al.,
1994; Wartmann and Davis, 1994). Also, constitutive
localization of Raf to the membrane via addition of an
isoprenylation sequence results in a constitutively high
level of Raf activity, presumably through constant jux-
taposition of Raf with an unidentified, membrane-asso-
ciated activator. Thus, if integrin-mediated adhesion
caused recruitment of Raf to juxtamembrane and/or cy-
toskeletal complexes, this might position Raf for effi-
cient activation independent of Ras-mediated events.
The identity of the proteins involved in this putative
integrin-dependent Raf recruitment and activation are
currently unknown (fig. 6D). In view of the above, it
seems possible that any one of several adhesion-trig-
gered mechanisms could help to recruit Raf to the jux-
tamembrane region and permit its activation. Thus inte-
grin-mediated regulation of cytoskeletal or membrane-
associated activities may directly contribute to Raf
activation and stimulation of the MAPK cascade.
3. The role of focal contact hierarchies and cytoskeletal
organization in integrin-mediated mitogen-activated
protein kinase activation As might be expected, there is
an intricate relationship between integrin-mediated fo-
cal contact assembly and integrin-triggered signal
transduction. Recent studies (Miyamoto et al., 1995a,b)
have illustrated a hierarchical order in the assembly of
cytoskeletal and signaling complexes that depends both
on receptor occupancy and on lateral aggregation of in-
tegrins in the membrane. Thus, clustering of integrins
with antibodies was sufficient to recruit the focal contact
proteins FAK and tensin to the cytoplasmic face of the
integrin cluster; in the absence of tyrosine kinase inhib-
itors, FAK was activated and numerous signaling trans-
ducing proteins were recruited. Further, integrin clus-
tering by antibodies was sufficient to activate both
MAPK and JNK, but these processes were blocked when
tyrosine kinase inhibitors were used. However, integrin
clustering, without occupancy of the integrin’s ligand
binding site, did not support additional recruitment of
focal contact proteins such as vinculin, a-actinin, and
talin. By contrast, these three proteins were recruited
when both ligand binding and integrin clustering took
place, even in the presence of tyrosine kinase inhibitors.
As discussed in more detail below, the use of cytochala-
sin D disrupted the recruitment of most signaling com-
ponents. Thus, development of a mature focal contact
assembly and its associated signaling complexes re-
quires integrin aggregation, integrin occupancy, ty-
rosine kinase activity, and actin cytoskeletal integrity in
a coordinated and hierarchical manner.
It has been suggested that activation of MAPK is
mediated by the overall change in cytoskeletal organi-
zation that parallels cell spreading rather than by ad-
hesion alone. In support of this, MAPK can be activated
in adherent cells under fluid shear stress, which causes
changes in cell shape (Berk et al., 1995; Ishida et al.,
1996; Takahashi and Berk, 1996). Also, integrin-medi-
ated MAPK activation is blocked by treatment with cy-
tochalasin D which poisons actin microfilament assem-
bly (Chen et al., 1994a; Miyamoto et al., 1995b; Morino et
al., 1995; Takahashi and Berk, 1996; Zhu and Assoian,
1995). However, others have reported significant adhe-
sion-mediated activation of MAPK in the absence of (or
at least before) significant cell spreading (Chen et al.,
1994a; Lin et al., 1997a). Furthermore, studies using
antibody- or ligand-coated beads (Miyamoto et al.,
1995a,b; Wary et al., 1996) have demonstrated that
these reagents can elicit integrin-mediated MAPK acti-
vation, even though it is highly unlikely that beads can
promote cytoskeletal reorganization as efficiently as a
solid, planar surface (i.e., a fibronectin-coated dish). The
weight of the evidence thus far suggests that some de-
gree of focal adhesion assembly and actin filament re-
cruitment is vital for integrin-mediated MAPK activa-
tion; however, long-range organization of the
cytoskeleton such as occurs in well-spread cells is not
essential.
As we will discuss in detail (see Section VI.) the Rho
family of small GTPases plays an important role in
regulation of the cytoskeleton. Rho appears to be essen-
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adhesion. Inactivation of Rho by serum starvation of
Swiss 3T3 cells (Hotchin and Hall, 1995) or inhibition of
Rho function in NIH3T3 cells by a dominant negative
mutant (Renshaw et al., 1996b) prevents MAPK activa-
tion in response to integrin-mediated cell adhesion.
However, cells in which Rho has been inactivated also
fail to form proper focal adhesions and stress fibers after
cell adhesion. Thus, rather than a direct effect on sig-
naling pathways, the effects of manipulating Rho may
reflect that normal focal adhesions, and perhaps some
degree of stress fiber organization, are the minimal
structural requirements needed for integrin-mediated
MAPK activation to occur. This view is consistent with
the aforementioned effects of cytochalasin D as well as
the concept of hierarchical assembly of adhesion/signal-
ing structures. However, Rho has many functions (see
below), and inhibition of Rho activity may have an im-
pact on the cell in several ways, any of which may
disrupt MAPK activation.
D. Integrin-Mediated Activation of the Jun N-Terminal
Kinase/Stress-Activated Protein Kinase Pathway
Although the picture is presently incomplete, it seems
that integrin-mediated cell adhesion can regulate the
SAPK or JNK pathway, a kinase cascade which closely
resembles the MAPK pathway (Kyriakis et al., 1995;
Waskiewicz and Cooper, 1995). Surprisingly, JNK activ-
ity has been reported to be both stimulated (Mainiero et
al., 1997; Miyamoto et al., 1995a,b; Wary et al., 1996)
and suppressed (Cardone et al., 1997; Frisch et al.,
1996a) by integrin-mediated adhesion, but the reason
for this contradiction is not clear. Integrin-mediated ac-
tivation of JNK may contribute to adhesion-regulated
gene expression through phosphorylation and activation
of c-Jun (Minden et al., 1995). Further, integrin-medi-
ated suppression of JNK activity may prevent apoptosis;
this topic is discussed at length in Section X.
E. Functions of Integrin-Mediated Mitogen-Activated
Protein Kinase Activation
The biological role of integrin-mediated MAPK activa-
tion is not known. Adhesion to the ECM is required for
several cellular functions. Although integrin-mediated
MAPK activation is durable (lasting tens of minutes to
hours), its duration is shorter than the time span during
which adhesion mediates its effects on cell growth and
differentiation. Thus, if integrin-mediated MAPK acti-
vation is important for regulating anchorage-dependent
events, it must establish some type of “permanent
record” to allow adhesion-dependent signaling events to
occur properly. This may be through alteration of the
cellular architecture, regulation of gene expression, or a
complex commixture of both. Alternatively, integrin-me-
diated MAPK activation may serve a more immediate
function in regulating new contacts with the ECM, such
as promotion of cell spreading or cell motility. Insight
into the function of integrin-mediated MAPK activation
is likely to come from investigation of the known effec-
tors of MAPK and their regulation by adhesion. There is
no lack of candidates, because MAPK has diverse tar-
gets. However, as discussed earlier, the kinetics of ad-
hesion-mediated MAPK activity differs substantially
from the kinetics of mitogen-stimulated MAPK activity.
Thus, the subset of potential targets that are affected, as
well as the degree to which those targets are affected,
may very well differ between adhesion-mediated and
mitogenic MAPK activities. An overview of integrin sig-
naling to the MAPK cascade is given in fig. 7.
1. Transcriptional regulation One of the hallmark
functions for MAPK is the regulation of various tran-
scription factors, including c-Myc, ATF-2, Elk-1, SAP-1,
and AP-1 (Davis, 1995; Karin, 1995; Treisman, 1996). As
mentioned previously, MAPK translocates to the nu-
cleus after integrin-mediated adhesion (Chen et al.,
1994a; Zhu and Assoian, 1995). Integrin-mediated adhe-
sion can activate transcription from the c-fos serum re-
sponse element (SRE) (Mainiero et al., 1997; Wary et al.,
1996), a MAPK-responsive promoter element that is reg-
ulated, in part, by Elk-1 and SAP-1 (Davis, 1995; Den-
hardt, 1996; Karin, 1995). Furthermore, it has been
known for several years that adhesion to fibronectin
rapidly induces the expression of both c-fos and c-jun
(Dike and Farmer, 1988). Whereas any promoter that
contains an SRE may potentially be affected by integrin-
mediated MAPK activation, it is particularly interesting
to note that the vinculin promoter contains an SRE
(Moiseyeva et al., 1993) and that expression of vinculin,
as well as actin, a-actinin, the b1 integrin subunit, and
fibronectin, is induced with immediate-early kinetics
(Ryseck et al., 1989). To date, however, physiological
transcriptional targets for integrin-mediated MAPK ac-
tivity have not been identified. Nonetheless, it is of con-
siderable importance that the role of the MAPK pathway
in integrin-induced gene expression be investigated.
2. Cytoplasmic targets In addition to transcription
factors, potential targets for adhesion-activated MAPK
also exist in the cytoplasm. One such target is pp90
RSK
(a.k.a. MAPKAPK-1) (Denhardt, 1996; Papkoff et al.,
1994); MAPK can phosphorylate and activate pp90
RSK,
which can then move into the nucleus (Chen et al.,
1992a) and contribute to the regulation of transcription
by AP-1 and cAMP-responsive element binding protein
(CREB) (Denhardt, 1996). Another candidate for inte-
grin-mediated MAPK activation is not a single enzyme,
but a cytoarchitectural system, the microtubule net-
work. MAPK is associated physically with and has en-
zymatic activity toward microtubule components
(Reszka et al., 1995) (MAPK once stood for microtubule-
associated protein-2 kinase). Two recent reports have
implicated microtubules and microtubule-associated
MAPK activity in the regulation of integrin-mediated
signaling events and the formation of focal adhesions
and stress fibers (Bershadsky et al., 1996; Reszka et al.,
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tegrin-mediated MAPK activation is PLA2 (Clark and
Hynes, 1996). PLA2 is responsible for liberating arachi-
donic acid (AA) from glycerolphospholipids such as
PI(4,5)P2 (Divecha and Irvine, 1995), an activity impor-
tant for optimal integrin-mediated cell-substrate in-
teractions in some cell types (e.g., HeLa) (Auer and
Jacobson, 1995; Chun and Jacobson, 1993) but appar-
ently not in others (e.g., NIH3T3) (Clark and Hynes,
1996).
3. Cell adhesion and motility Two recent reports pro-
vide a highly satisfying function for integrin-mediated
MAPK activation by suggesting that MAPK activated by
integrins may “feedback” and contribute to the regula-
tion of cell adhesion and motility. The first demon-
strated that constitutively active mutants of MAPK
pathway components, namely Ras and Raf, can suppress
the activation of integrins (Hughes et al., 1997). Also,
activation of Raf inhibits fibronectin matrix assembly
and induces cell rounding. Suppression of integrin acti-
vation correlates with activation of MAPK, but is not
caused by direct phosphorylation of the integrin and is
independent of protein and mRNA synthesis. Inactiva-
tion of integrins by MAPK may represent a negative
feedback loop for the regulation of integrin function
which may contribute to the dynamic modulation of
ligand binding affinity. Moreover, the efficacy of this
loop in a given cell type may be a determinant of the
duration of integrin-mediated MAPK activation in that
cell type. The second report demonstrated that expres-
sion of a constitutively active MEK mutant stimulates
cell migration on collagen and leads to phosphorylation
and activation of myosin light chain kinase (MLCK),
leading to increased phosphorylation of the myosin light
chain (MLC) (Klemke et al., 1997). Inhibition of MAPK
activity suppresses both cell migration and phosphory-
lation of MLCK and MLC, but not cell adhesion or in
situ cell spreading, suggesting that integrin-mediated
FIG. 7. Hypothetical model for collaboration between integrin-mediated signaling events. The function of integrin-mediated mitogen-activated
protein kinase (MAPK) activation is not fully understood but possibilities include activation of transcription factors, PLA2, and myosin light chain
kinase (MLCK). Rho family GTPases (Cdc42, Rac, Rho) have many effectors, some of which mediate their effects on actin cytoskeletal organization.
Among those known for Rho in this regard are PI4–5K, a lipid kinase important for PIP2 synthesis, and Rho kinase (RhoK). Synthesis of PIP2 by
PI4–5K could provide a substrate for MAPK-activated PLA2. Also, RhoK can directly phosphorylate the myosin light chain (MLC) and can inhibit
MLCP. These events may synergize with activation of MLCK by MAPK to increase MLC phosphorylation, which can lead to contractility, focal
adhesion formation, and other morphological effects. See text for details.
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in this system. In vitro experiments showed that MAPK
can phosphorylate and activate MLCK directly. Maxi-
mal phosphorylation and activation of MLCK by MAPK
in vitro required prolonged incubation (approximately
40 min). Hypothetically, a similar requirement in vivo
(should it exist) may be met by the extended duration of
MAPK activity after cell adhesion. Whereas the evi-
dence linking MAPK and MLCK is compelling, it is clear
that other mechanisms may contribute to regulation of
MLC phosphorylation and subsequent control of actino-
myosin dynamics. Most notable are the phosphorylation
of MLC and inactivation of MLC phosphatase by Rho-
kinase (Amano et al., 1996b; Burridge and Chrza-
nowska-Wodnicka, 1996; Kimura et al., 1996), which
may govern cell contractility and subsequent signal
transduction and cytoskeletal organization (Burridge
and Chrzanowska-Wodnicka, 1996; Chrzanowska-Wod-
nicka and Burridge, 1996; Tapon and Hall, 1997) (see
fig. 7 and Section VI.). The relative contributions of
MAPK and other regulators of MLCK function still must
be determined. Nonetheless, these recent observations
have placed MAPK in a central locus for the regulation
of cell adhesion, contractility, and locomotion.
F. Summary
The current picture of direct integrin-mediated acti-
vation of the MAPK cascade is marked by several con-
troversial aspects. First, as discussed above, there are at
least three models of the mechanism of activation, each
supported by considerable data. One popular model has
integrin signaling recapitulating the peptide growth fac-
tor signaling pathway with FAK, rather than the growth
factor receptor, serving as the tyrosine kinase. This
model posits key roles for FAK and Ras, with signal
generation involving activation of FAK via the integrin b
subunit cytoplasmic domain. A second model suggests
that integrin-mediated focal contact assembly can per-
mit recruitment and activation of Raf, and subsequently
of MAPK, without the involvement of Ras or FAK. Fi-
nally, a third model emphasizes interactions of integrin
a subunit transmembrane and external domains with
caveolin and Shc in a Ras-dependent but FAK-indepen-
dent signaling pathway. Because each of these models
enjoys considerable experimental support, perhaps this
suggests that integrins can signal to MAPK via several
distinct mechanisms, and the dominant mechanism in
any particular situation will depend on the cell type and
the experimental conditions used.
Perhaps more important than the mechanistic details
of the direct integrin-MAPK signaling pathway is con-
sideration of the biological significance of these events.
To a substantial degree integrin ligation triggers a set of
downstream events (activation of Raf, MEK, MAPK, and
transcription factors) similar to that triggered by pep-
tide mitogens. However, integrin ligation itself does not
result in mitogenesis. (Note: The key role of integrins in
collaborating with soluble growth factors to permit effi-
cient mitogenic signaling will be considered separately
in Section IX.) Further, in a physiological context most
cells live with their integrins continually engaged with
the surrounding ECM; thus, major global changes in
MAPK activity within the cell are unlikely. However,
cells do make and break adhesions with the ECM during
cell migration and tissue remodeling; thus local changes
in MAPK activity within the cytoplasm are quite likely.
This hints at the possibility that the key biological role
for integrin-triggered MAPK activation may be local
regulation of contractility and of movement of cellular
processes. However, it also remains possible that a low
level of MAPK activity, because of breaking and re-
forming of integrin-mediated adhesions, may play a per-
missive role in cell growth.
It is also important to realize that integrin signaling
may impinge on effectors other than MAPK. For exam-
ple, integrin-mediated activation of Raf may have down-
stream effects that are independent of MAPK. Raf is
implicated in the transcriptional activation of NF-kB
(Finco and Baldwin, 1993; Janosch et al., 1996; Li and
Sedivy, 1993), the regulation of apoptosis (Troppmair
and Rapp, 1997) through interactions with the antiapop-
totic proteins BCL-2 (Wang et al., 1994, 1996b) and
BAG-1 (a BCL-2 interacting protein) (Wang et al.,
1996b), and phosphorylation of the pro-apoptotic protein
Bcl-XL/Bcl-2-associated death promotor (BAD) (Wang et
al., 1996a). Raf also can phosphorylate the p53 tumor
suppressor protein (Jamal and Ziff, 1995) and cdc25, a
dual specificity phosphatase that activates cyclin-depen-
dent kinases (Galaktionov et al., 1995). Thus, it is im-
portant to remember that the activation of MAPK path-
way components is only one of many signaling events
triggered by integrin-mediated adhesion (see fig. 7).
VI. Integrins and Rho Family Guanosine
5*-Triphosphatases
A. Introduction
An important consideration in the field of integrin-
mediated signaling is what structure is actually eliciting
the signals. As discussed in Section V. above, the forma-
tion of signaling complexes is coordinated closely with
the assembly of focal contact/cytoskeletal structures.
Further, it is well documented that focal adhesions and
other integrin-associated structures “mature” with in-
creasing time after adhesion (Burridge et al., 1988;
Craig and Johnson, 1996; Gilmore and Burridge, 1996a;
Jockush et al., 1995). Some integrin-mediated signals
simply may promote focal adhesion assembly thus set-
ting the stage for other events, some may require early
or intermediate stages of maturation of adhesion com-
plexes, whereas others may be generated only by a fully
formed, mature focal adhesion complex and its associ-
ated linkages to the actin cytoskeleton.
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forms of Cdc42, Rac, and Rho, are involved intimately in
the regulation of the actin cytoskeleton. Several excel-
lent recent reviews describe practically every aspect of
the Rho family (Denhardt, 1996; Lim et al., 1996; Naru-
miya, 1996; Ridley, 1996; Symons, 1996; Tapon and
Hall, 1997), and an exhaustive analysis will not be at-
tempted here, but an introduction is in order. Rho family
GTPases couple extracellular signals to the formation
and/or organization of higher-order actin structures.
Specifically, Rho, Rac, and Cdc42 mediate the formation
of stress fibers, lamellipodia, and filopodia, respectively
(Nobes and Hall, 1995a; Ridley and Hall, 1992; Ridley et
al., 1992). Distinct extracellular signals activate individ-
ual members of the Rho family through specific recep-
tors, either RTKs or G-protein-coupled receptors. In this
way, LPA, bombesin, and bradykinin stimulate the ac-
tivity of Rho, Rac, and Cdc42, respectively, to induce
formation of the respective actin structures mentioned
above. Cdc42 activity can lead to Rac activation, and Rac
activity can lead to Rho activation, suggesting a GTPase
cascade (Chant and Stowers, 1995). In support of this,
LPA induces stress fibers within 2 to 5 min, whereas
induction of stress fibers by bombesin and bradykinin
(as well as PDGF, EGF, and insulin) occurs during a
longer time course of 20 to 30 min (Nobes and Hall,
1995b). However, the regulation of this cascade is not
without its intricacies, as the formation of filopodia by
Cdc42 correlates with the dissolution of stress fibers
(Kozma et al., 1995), and inhibition of Rho can enhance
Cdc42 activity (Nobes and Hall, 1995a). An overview of
Rho family GTPases in relation to integrin signaling and
the cytoskeleton is provided in fig. 7.
B. Regulation of Activity
The pathways between the various receptors and Rho
family proteins have not been fully charted, and several
candidate intermediaries have been suggested including
PI-3K, PKC, and a tyrphostin-sensitive tyrosine kinase
(Chrzanowska-Wodnicka and Burridge, 1994; Nobes et
al., 1995). However, because Rho family proteins are
active when bound to GTP and inactive when bound to
guanosine 59-diphosphate (GDP), the pathways that reg-
ulate their function will involve proteins which control
the state of the bound nucleotide, namely GAPs and
GNEFs (Denhardt, 1996; Lamarche and Hall, 1994; Lim
et al., 1996). GAPs enhance the hydrolysis of GTP and
thus promote inactivation of Ras-related proteins,
whereas GNEFs promote the release of GDP, allowing
GTP to bind and activate the proteins. GAPs specific
for Rho family members include Ral-BP1 (a.k.a.
Cdc42GAP), breakpoint cluster region (BCR) and active,
breakpoint cluster region-related (ABR), p190Rho
GAP,
chimaerins (a, b, and n) (Herrera and Shivers, 1994;
Kozma et al., 1996) and an atypical myosin (myr5) (Re-
inhard et al., 1995). Rho family GNEFs include diffuse
B-cell lymphoma (DBL), Ost (from osteosarcoma), Lbc,
Vav, Tiam1, the faciogenital dysplasia gene product
(FGD1) (Zheng et al., 1996b), and small G-protein GTP
dissociation stimulator (smgGDS). Ost acts as an effec-
tor for Rac and stimulates nucleotide exchange and ac-
tivation of Cdc42 and Rho (Horii et al., 1994), and there-
fore may play a role in mediating a GTPase cascade.
Significantly, many Rho family GNEFs contain a PH
domain, which can bind to bg subunits of heterotrimeric
G-proteins, suggesting a possible direct link between
G-protein-coupled receptors and Rho family proteins.
PH domains can also bind PI(4,5)P2, which may serve to
localize Rho GNEFs to the plasma membrane (Lemmon
et al., 1996; Michiels et al., 1997). Another class of GTP-
ase regulators is represented by Rho guanine nucleotide
dissociation inhibitor (GDI), which inhibits GDP disso-
ciation (and in some instances GTP hydrolysis), seques-
ters GDP-bound GTPases in the cytoplasm, prevents the
interaction of Rho GTPases with GAPs, and also may be
involved in membrane relocation of Rho proteins (Den-
hardt, 1996).
Although serum components clearly can activate Rho
and its relatives, the question of whether cell adhesion
also can stimulate their activation remains unanswered.
As mentioned previously, formation of focal adhesions
and stress fibers is a Rho-dependent process; in Swiss
3T3 cells, this process requires both attachment to the
ECM and serum components (Hotchin and Hall, 1995;
Burridge and Chrzanowska-Wodnicka, 1996). However,
some cell types can form stress fibers and focal adhe-
sions under serum-free conditions and can maintain
these structures after the removal of serum (Chrza-
nowska-Wodnicka and Burridge, 1996); it is not clear
whether this is because of persistence of Rho activity
after serum withdrawal or persistence of cytoskeletal
structures after Rho inactivation. This suggests that in
these cells, either Rho (and stress fiber/focal adhesion
formation) is not required continually for the mainte-
nance of cell adhesion, or Rho is not fully inactivated by
serum withdrawal. If signaling events do depend on the
formation of mature focal adhesions, and focal adhesion
formation depends on Rho, an elementary step in inte-
grin-mediated signaling must be the activation of Rho;
this also implies regulation of Rho GNEFs and Rho
GAPs. Thus, an important avenue of future experimen-
tation should be whether (and how) Rho GNEFs and
GAPs are regulated by cell adhesion. In support of this,
there is certainly emerging evidence that suggests that
Rho proteins are mediators of integrin signaling (Barry
et al., 1997; Nakahara et al., 1998; Schwartz et al., 1996).
C. Proteins that Interact with Rho Family Guanosine
59-Triphosphatases
The list of proteins with which Rho family members
interact is growing rapidly (table 2) (Ridley, 1996; Tapon
and Hall, 1997). With the knowledge that Rho GTPases
instigate complex and sometimes diverse cellular events
(see below), the notion that these proteins may have
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teins mediate cytoskeletal organization, whereas others
are likely to mediate noncytoskeletal effects, and still
others are currently without discernible function. The
assignment of effectors to downstream events is still in
the early stages, and although substantial progress has
been made, it is complicated by several regulatory intri-
cacies. For instance, several effectors are shared by more
than one GTPase: the serine/threonine kinase p65
PAK is
activated by both Cdc42 and Rac, and both Rac and Rho
associate with PI4–5K lipid kinase activity (see table 2).
Further complexity is added by communication between
effectors. A prime example of this is the direct regulation
by Cdc42 and Rac of both PI-3K and its effector p70
S6K.
D. Rho Guanosine 59-Triphosphatases, Cell Cycle
Progression, and Transcriptional Regulation
In addition to their functions in reorganization of the
actin cytoskeleton (see below), Rho, Rac, and Cdc42 are
required for the serum-induced progression of fibro-
blasts into S phase (Olson et al., 1995; Yamamoto et al.,
1993), although recent evidence casts doubt on the role
of Cdc42 in this regard (Molnar et al., 1997). Further-
more, Rac is required for induction of cell division by the
oncogenic tyrosine kinase v-Abl (Renshaw et al., 1996a)
and both Rac and Rho are required for efficient trans-
formation by oncogenic Ras (Khosravi-Far et al., 1995;
Qiu et al., 1995a,b) and can synergize with a weakly
transforming allele of Raf to promote efficient transfor-
mation (Khosravi-Far et al., 1995). Further affirmation
for the role of Rho family proteins in cell cycle progres-
sion comes from the observation that several Rho family
GNEFs, namely DBL, Vav, and Lbc have the potential to
oncogenically transform fibroblasts (Hunter, 1997;
Khosravi-Far et al., 1994; Zheng et al., 1995).
One mechanism through which Rho family proteins
could regulate cell cycle progression is by activation of
transcription factors. All three Rho family GTPases can
activate NF-kB, and Cdc42 and Rho are required for
activation of this factor by TNFa (Perona et al., 1997).
Another target for Rho family transcriptional regulation
is serum-response factor (SRF). SRF, alone or in a com-
plex with ternary complex factor (TCF) proteins (e.g.,
Elk-1, SAP-1), regulates transcription from promoters
containing an SRE (Treisman, 1995). Activated forms of
Cdc42, Rac, and Rho can all induce SRF-dependent ex-
pression from the SRE, and Rho is required for activa-
tion of the SRE by several stimuli (e.g., LPA, PDGF,
phorbol ester) (Hill et al., 1995). Recently it has been
demonstrated that activated Rho-kinase (see below) can
stimulate transcriptional activity from the c-fos SRE
(Chihara et al., 1997). The ability of Rac to regulate SRF
activity is separable from its cytoskeletal functions
TABLE 2
Proteins that interact with Rho-family guanosine 59-triphosphatases
GTPase(s) Effector Functions/comments References
Cdc42 p120
ACK Tyrosine kinase; phosphorylates NADPH-p47
phox (Aspenstrom et al., 1996)
WASP Wiskott-Aldrich Syndrome protein; binds Nck; may be involved in
regulation of hematopoietic cell cytoskeleton
(Aspenstrom et al., 1996; Quilliam et
al., 1996; Symons et al., 1996)
Rac POR-1 Partner of Rac; contains leucine-zipper; may mediate membrane
ruffling
(Van Aelst et al., 1996)
p67
phox Component of phagocytic NADPH oxidase complex (Diekmann et al., 1994)
Cdc42 and Rac MLK-3 Mixed lineage kinase; may mediate Cdc42- and Rac-dependent
activation of JNK/SAPK or p38/RK pathways
(Teramoto et al., 1996a)
MEKK1 May mediate Cdc42- and Rac-dependent activation of JNK/SAPK
pathway
(Fanger et al., 1997)
p65
PAK Serine/threonine kinase homologous to yeast Ste20p; implicated in
activation of p38/RK pathway and in regulation of actin
organization
(Manser et al., 1994; Sells et al., 1997;
Zhang et al., 1995a)
p70
S6K Ribosomal protein kinase; activated by mitogens and cell adhesion (Chou and Blenis, 1996; Malik and
Parsons, 1996)
PI-3K Important lipid kinase (generates 39-phosphatidylinositols);
involved in antiapoptotic signaling (through Akt/PKB); required
for activation of p70
S6K by some stimuli; implicated in PDGF-
mediated activation of Rac
(Franke et al., 1997; Nobes et al.,
1995; Tolias et al., 1995; Zheng et
al., 1994b)
Rho PKN Also called PRK1 or 2; related to PKC; may regulate Rho-mediated
gene expression
(Amano et al., 1996b; Watanabe et al.,
1996b)
Rhotekin,
Rhophilin
Function/activities unknown; Rho-binding domains have homology
to that in PKN
(Reid et al., 1996)
Rho kinase Also called ROKa; contains coiled-coil, leucine zipper, PH, and
cysteine-rich domains; member of kinase family that includes
myotonic dystrophy kinase and p160
ROCK/ROKb (which also
binds Rho); involved in assembly of stress fibers/focal adhesions
and in Rho-dependent regulation of MLC phosphorylation
(Ishizaki et al., 1996; Kimura et al.,
1996; Leung et al., 1995; Matsui et
al., 1996)
MLCP Myosin light chain phosphatase; associates with Rho through
myosin binding subunit; activity is inhibited by Rho kinase-
mediated phosphorylation
(Kimura et al., 1996)
Rho and Rac Citron Contains coiled-coil, leucine zipper, PH, and cysteine-rich domains (Madaule et al., 1995)
PI4P-5K Principal mediator of PI(4,5)P2 synthesis; binds GDP/GTP-bound
forms of Rac/Rho, but activated only by GTP-bound; different
isoforms may mediate Rac- and Rho-associated activity
(Chong et al., 1994; Loijens et al.,
1996; Ren et al., 1996; Tolias et al.,
1995)
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that Rho also can regulate transcription in the absence
of actin effects (Thornburn et al., 1997). Expression of a
constitutively active form of PI-3K (a putative effector
for Cdc42 and Rac) can induce the formation of Rac- and
Rho-dependent actin structures (i.e., lamellipodia and
stress fibers), but cannot stimulate Rac- and Rho-medi-
ated transcriptional activation (Reif et al., 1996), empha-
sizing the separation of these functions. The activation
of SRF transcriptional activity raises the interesting
possibility that Cdc42/Rac/Rho-stimulated SRF may
combine with TCF proteins phosphorylated by integrin-
mediated MAPK activity to induce transcription of
genes containing SREs, such as c-fos or vinculin (see
Section V.). The induction of c-fos expression is particu-
larly interesting in light of the fact that Cdc42 and Rac
can also activate JNK (Coso et al., 1995; Minden et al.,
1995), which phosphorylates and activates c-Jun. Jun
dimerizes with c-Fos to form the AP-1 complex, which is
implicated in the response to integrin-mediated cell ad-
hesion in several systems (Dike and Farmer, 1988; Fan
et al., 1995; Tremble et al., 1994) (see fig. 6).
Activation of the JNK pathway by Cdc42 and Rac
originally was thought to be mediated by p65
PAK be-
cause of its interaction with the two GTPases and its
homology to Ste20p, the upstream activator of a yeast
JNK/SAPK homolog (Waskiewicz and Cooper, 1995).
However, it seems clear that p21-activated kinase (PAK)
is not involved in Cdc42- and Rac-mediated JNK activa-
tion (Teramoto et al., 1996a,b; Westwick et al., 1997;
Zhang et al., 1995a), although it may mediate the acti-
vation of the related p38/RK pathway (Zhang et al.,
1995a). Instead, the serine/threonine kinase MLK3, a
mixed-lineage kinase that can interact with Cdc42 and
Rac and whose overexpression can activate the JNK
pathway, seems to be involved in mediating this effect
(Teramoto et al., 1996a). Finally, direct interaction be-
tween Cdc42 or Rac and MEKK1, a known upstream
activator of the JNK pathway, has been described re-
cently (Fanger et al., 1997) and provides another highly
plausible mechanism for JNK activation by Rho family
GTPases.
E. Rho Guanosine 59-Triphosphatases and the
Cytoskeleton
All three Rho family GTPases have profound effects
on cell morphology and microfilament organization
(Tapon and Hall, 1997), but the mechanisms by which
they exert their effects are not fully understood. All
three proteins cycle on and off the plasma membrane
(Adamson et al., 1992; Bokoch et al., 1994; Takeichi,
1995), although the role that this plays in the regulation
of their function is unclear. Of the known effectors (see
above), the best candidate for directly mediating Cdc42-
induced actin effects is Wiskott-Aldrich Syndrome pro-
tein (WASP). Overexpression of WASP in Jurkat cells
induces the formation of large cytoplasmic clusters of
polymerized actin which colocalized with WASP (Sy-
mons et al., 1996). However, WASP expression is re-
stricted to hematopoietic cells, and therefore cannot ex-
plain the induction of filopodia by Cdc42 in fibroblasts,
although the existence of WASP isoforms in other cells
types is a possibility. The Rac-interacting protein POR-1
clearly is involved in Rac-mediated lamellipodia forma-
tion (truncated POR-1 interferes with Rac-induced
membrane ruffling) (Van Aelst et al., 1996), although it
has no known catalytic activity and only a leucine-zipper
region to suggest a possible function. Finally, the serine/
threonine kinase p65
PAK has been implicated recently as
a possible effector for both Cdc42 and Rac in rearrange-
ment of the actin cytoskeleton (Sells et al., 1997), al-
though this is controversial (Westwick et al., 1997).
1. Lipid metabolism PI4P-5K, a kinase regulated by
Rac and Rho, is the major enzyme responsible for gen-
erating PI(4,5)P2, a lipid of critical importance in nu-
merous cellular functions. It has been known for several
years that the synthesis of this lipid is induced by inte-
grin-mediated cell adhesion (McNamee et al., 1993). By
their activation of PI4P-5K, Rac and Rho provide a mol-
ecule that can impinge on a wide variety of biochemical
pathways. PI(4,5)P2 is a substrate for phospholipases A,
C, and D, which generate AA, DAG plus IP3, and phos-
phatidic acid (PA), respectively. Integrin-mediated ad-
hesion induces PLA2 activity and a concomitant increase
in AA which precedes cell spreading (Auer and Jacobson,
1995; Chun and Jacobson, 1992; Cybulsky et al., 1993).
It is tempting to speculate that this activity may be
attributable to integrin-mediated MAPK activation, but
this has not been tested formally. AA release and sub-
sequent generation of leukotrienes may be both neces-
sary and sufficient to activate Rho (through an unknown
mechanism) and induce stress fiber formation in a Rho-
dependent manner (Peppelenbosch et al., 1995), thus
possibly linking stress fiber assembly to the initial cell
adhesion event in a positive feedback manner.
Several isoforms of PLC can be found in association
with the cytoskeleton (Banno et al., 1996; Plopper and
Ingber, 1993), and PLC activity is stimulated by inte-
grin-mediated cell adhesion (Cybulsky et al., 1993; Kan-
ner et al., 1993; McNamee et al., 1993). Furthermore,
PLC is required for integrin-mediated hydrolysis of
PI(4,5)P2 to IP3 (and, presumably, DAG) (Somogyi et al.,
1994). DAG and IP3 are best known for their ability to
activate PKC and mobilize intracellular calcium stores,
respectively. PKC activity is stimulated by integrin-me-
diated adhesion (Vuori and Ruoslahti, 1993) and has
numerous targets, including Raf-1 (see Section V.). Fur-
thermore, integrin-mediated increases in intracellular
calcium occur in many cell types through several distinct
integrin-ECM interactions (Schwartz, 1993b; Sjasstad
and Nelson, 1997). Mobilization of intracellular calcium
by adhesion has the potential to elicit numerous effects,
but some of the most relevant are modulation of integrin
activity, regulation of protease (e.g., calpain) activity,
230 APLIN ET AL.activation of CADTK/PYK2/CAKb (see Section IV.), and
activation of calmodulin (Gimond and Aumailley, 1992).
PLD can be activated by cell adhesion (Serrander et
al., 1996) as well as a host of soluble factors that pro-
mote Rho activation (Hess et al., 1997; Malcolm et al.,
1996; Martin et al., 1996; Schmidt et al., 1996). PLD-
mediated production of PA can enhance PI4P-5K activ-
ity (English, 1996), suggesting an amplification loop
that results in increased PI(4,5)P2 synthesis. PA also
can regulate stress fiber formation through a Rho-de-
pendent mechanism (Cross et al., 1996), and may con-
tribute to activation of Raf through direct binding
(Ghosh et al., 1996). Significantly, PA can be converted
into DAG, and thus activation of PLD can partially
recapitulate PLC-mediated signaling events (Singer et
al., 1997).
Although it is clear that PI(4,5)P2 is extremely impor-
tant as a phospholipase substrate, it also is well estab-
lished that the intact molecule has important functions
of its own. PI(4,5)P2 can bind to several proteins in-
volved in regulating the actin cytoskeleton and associ-
ated structures, including gelsolin, profilin, vinculin,
a-actinin, and the ERM proteins (Craig and Johnson,
1996; Hirao et al., 1996; Jockush et al., 1995; Kandzari et
al., 1996; Mitchison and Cramer, 1996). PI(4,5)P2 bind-
ing to gelsolin or profilin promotes their dissociation
from actin, allowing nucleation and polymerization of
actin filaments. PI(4,5)P2 also disrupts the head-tail
intramolecular interaction of vinculin and thereby
makes available the binding sites for actin and talin
(Gilmore and Burridge, 1995, 1996b). The interaction of
a-actinin with actin also is enhanced by PI(4,5)P2 (Burr-
idge and Chrzanowska-Wodnicka, 1996; Fukami et al.,
1992; Jockush et al., 1995). Recently, ERM proteins have
been implicated as essential cofactors in Rac- and Rho-
induced actin reorganization (Mackay et al., 1997), and
their regulation by phospholipid may provide a crucial
link in this regard.
Recently, some exciting findings have emerged con-
cerning a role for Cdc42, Rac, and PI-3K in cell motility
and tumor cell invasiveness. Thus, in mammary carci-
noma cells, activation of Cdc42 or Rac disrupts normal
epithelial polarization and promotes integrin-dependent
motility and invasiveness; these events depend on PI-3K
(Keely et al., 1997). In a similar vein, an a6b4-mediated
activation of PI-3K has been shown to increase carci-
noma cell invasiveness (Shaw et al., 1997). Although
these two studies agree on the overall importance of
Rho-family GTPases and PI-3K in motility and invasive-
ness, they disagree as to the placement of Rac and PI-3K
in the signal transduction pathway, with the first study
suggesting that the GTPases are upstream of PI-3K and
the second study suggesting the converse.
Thus, through the activation of lipid kinases and gen-
eration of PI(4,5)P2 and other lipid products, Rac and
Rho connect into a vast array of biochemical pathways
that regulate the actin cytoskeleton and control several
signal transduction pathways (Downward, 1998).
Whereas integrin-mediated cell adhesion has been re-
ported to affect several of the enzymes involved in
PI(4,5)P2 formation and breakdown, the importance of
these events in the overall processes of integrin-medi-
ated signaling and integrin influences on cell function
has yet to be fully determined.
2. Rho, mitogen-activated protein kinase, and contrac-
tility In addition to the effects on transcription and on
actin filaments mentioned earlier, another intriguing
collaboration between signals from the Rho family pro-
teins and integrin-activated MAPK might occur in the
regulation of cell contractility (fig. 7). As mentioned
above, Rho uses Rho-K as an effector to regulate MLC
phosphorylation. Specifically, Rho-K phosphorylates
and deactivates the myosin binding subunit of myosin
light chain phosphatase (MLCP) (Kimura et al., 1996).
Furthermore, Rho-K is able to directly phosphorylate
myosin at the same site targeted by MLCK (Amano et
al., 1996a). Also, as stated earlier, MAPK activated by
integrins can phosphorylate and activate MLCK (Kl-
emke et al., 1997). The result of each of these events is
the net increase in MLC phosphorylation, which acti-
vates myosin and stimulates contractility (Burridge and
Chrzanowska-Wodnicka, 1996). Although highly plausi-
ble, synergy between Rho and integrin-mediated MAPK
activation in this regard has not yet been demonstrated.
It has been proposed that contractility is the driving
force behind the Rho-mediated formation of stress fibers
and focal adhesions (Burridge and Chrzanowska-Wod-
nicka, 1996; Chrzanowska-Wodnicka and Burridge,
1996). Several other events mediated by Rho family
proteins (discussed above) also may function in this re-
gard. Increased intracellular PI(4,5)P2 induced by Rac
and Rho can stimulate actin polymerization and attach-
ment of filaments to the membrane in primordial focal-
adhesion-like structures. MLC phosphorylation is in-
creased through inhibition of MLCP by Rho-K, and
possibly by activation of MLCK by MAPK and/or cal-
modulin. This can stimulate cellular contractility and
promote formation of stress fibers and focal adhesions.
F. Summary
There is clearly an intimate as well as intricate rela-
tionship between members of the Rho GTPase family
and integrins. Rho family members seem to have two
basic but separable functions, the first being signaling to
nuclear transcription factors, and the second being con-
trol of cytoskeletal assembly. Integrins cooperate with
Rho proteins in the organization and regulation of the
actinomyosin containing cytoskeleton, because in the
absence of integrin-mediated anchorage appropriate
vectorial assembly of structures such as actin stress
fibers cannot occur. As discussed above, Rho family pro-
teins can influence cytoskeletal organization by several
different means, including activation of kinases that
regulate myosin function, and by the generation of lip-
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focal contact proteins. Conversely, Rho-dependent cy-
toskeletal structures may be essential “scaffolds” for
integrin signaling, bringing together molecules that are
involved both in direct integrin signaling and in inte-
grin-mitogen collaboration (see Section IX.). Integrin-
mediated signaling, for example through the MAPK
pathway, then potentially could collaborate with direct
Rho-family signaling via the JNK pathway or other
pathways to provide a coordinated activation of key
transcription factors involved in cell cycle progression.
One aspect of our current understanding that is still
obscure is whether integrin-mediated adhesion can in-
fluence directly the GAPs and GNEFs that regulate
Cdc42, Rac, and Rho, although recent work suggests the
existence of a link between integrins and Cdc42
(Schwartz, 1997).
VII. Other Aspects of Integrin Signaling
A. Signaling by Specific Integrins
The integrin signaling processes described in Sections
IV. and V. above, that is, FAK activation and activation
of the MAPK cascade, can be initiated by several differ-
ent integrins. However, a good deal of the biology of
integrins seems to imply specific actions of different
integrin subunits Thus, it seems likely that individual
integrins participate in specific signaling events that
thus far are delineated very poorly. Along these lines, it
is interesting to speculate that several recently discov-
ered proteins that bind selectively to the cytoplasmic
tails of individual integrin subunits (described in Sec-
tion III.) may play an important role in the specificity of
integrin-mediated events within cells. Several integrin-
specific actions on the cell cycle and on apoptosis are
discussed in Section X. Here we will simply tabulate
several examples of what are apparently specific biolog-
ical actions of individual members of the integrin family
that cannot be substituted by other members of the
family (table 3).
B. Cross-Talk Between Integrins
In this review we have emphasized integrin signaling
to downstream processes presumably involved in growth
control. However, there is another aspect of integrin
signaling that should be mentioned briefly. Several ob-
servations indicate that integrins signal to each other;
this usually takes the form of one integrin regulating the
ability of another integrin family member to support cell
adhesion, motility, or phagocytosis. There are also a few
instances of this sort of “cross-talk” between integrins
and non-integrin adhesion receptors. Some examples of
adhesion receptor cross-talk are given in table 4. In most
cases the mechanistic basis of receptor cross-talk is un-
known. However, as we proceed with the elucidation of
integrin signaling pathways, described in Sections IV.
through VI. above, several likely possibilities come to
mind, and the issue of adhesion receptor interactions
becomes less mysterious. First, recent observations
(Hughes et al., 1997) have shown that elements of the
MAPK cascade can modulate the ligand binding affinity
of integrins. Because integrins can also activate the
MAPK cascade (Section V.), this is one obvious way in
which one integrin might cross-talk with another. Sec-
ond, many integrin-mediated activities, such as cell ad-
hesion or cell motility, require engagement with the
cytoskeleton. Because of the interplay between inte-
grins, Rho family GTPases, and the cytoskeleton (Sec-
tion VI.), this suggests another way in which signals
generated by one integrin can affect functions mediated
by another. Third, it is now clear that several integrins
can share interactions with transmembrane or cytoplas-
mic binding proteins (Section III.), thus hinting at yet
another mechanism for cross-talk. With respect to cross-
talk between integrins and other adhesion receptors,
several interesting examples have emerged recently (ta-
ble 4); the mechanisms are far from clear, but the bio-
logical significance may be substantial.
C. Mechanochemical Aspects of Adhesion Signaling
One interesting hypothesis concerning signaling by
cell adhesion receptors is a mechanochemical one; the
integrins or other receptors essentially would play the
role of a physical link between the ECM and the cy-
toskelton, whereas the organization and mechanical ten-
sion of the cytoskeleton consequently would influence
events in the cytoplasm and nucleus that are involved in
cell division or cell differentiation. This “tensegrity” con-
cept has been developed elegantly by D. Ingber and his
colleagues (Ingber, 1993, 1997). In this model, overall
cell shape and the bulk mechanical properties of cells
would be as important or more important than discrete
biochemical reactions. Although somewhat unsatisfying
TABLE 3
Specific actions of individual integrins
Specific integrin Biological effect Reference
b1c (alternatively spliced b subunit) Growth inhibition (Fornaro et al., 1995)
b6 Growth promotion (Dixit et al., 1996)
avb3 Control of apoptosis in endothelial cells (Brooks et al., 1994)
a6b4 Growth control in epithelial cells (Mainiero et al., 1997)
a5b1 Control of apoptosis (Zhang et al., 1995c)
a2b1 Growth control in smooth muscle cells (Koyama et al., 1996a)
a6b1 Differentiation of skeletal muscle cells (Sastry et al., 1996)
av integrins Increase cell calcium (Schwartz and Denninghoff, 1994)
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amount of support for the idea that cell shape is a key
regulator of cell growth and differentiation. For exam-
ple, by use of powerful engineering techniques similar to
those used in microchip manufacturing, very precise
microdomains of adhesive material were placed on sur-
faces. When endothelial cells attached to those surfaces
there was an excellent correlation between cell shape
and the cell’s ability to enter S phase (Chen et al., 1997).
Another example of the importance of cell shape in con-
trolling biological processes concerns studies with breast
epithelial cells conducted by M. Bissell and colleagues.
Here a substantial amount of evidence suggests that
appropriate patterns of gene expression and cell differ-
entiation only occur when the cells have both the correct
biochemical signals and the correct cell shape (Boudreau
et al., 1996; Roskelley et al., 1995). Although at first
glance these observations seem at variance with main-
stream concepts of biochemically based signaling path-
ways, this may not be so. As illustrated in this review,
the more we learn about signaling pathways the clearer
it becomes that the three-dimensional architecture of
signaling complexes is a key aspect of efficient signaling.
Thus, in the long run, a more detailed analysis of cell
signaling may well resolve any conflicts between
“tensegrity” models and more conventional biochemical
concepts of signaling.
D. Relationships Between Integrin Signaling Pathways
One of the major unresolved issues regarding path-
ways of integrin signaling concerns the relationships
between FAK and MAPK. Under most circumstances
there are close parallels in the circumstances and kinet-
ics of FAK activation and MAPK activation. Further,
overexpression of FAK has been reported to increase
MAPK activation (Schlaepfer and Hunter, 1997). How-
ever, the preponderance of evidence suggests that FAK
is not required for integrin-mediated MAPK activation
(Frisch et al., 1996a; Lin et al., 1997a; Wary et al., 1996).
Despite the numerous studies on FAK, the precise bio-
logical role of this kinase remains open to question.
Many investigators emphasize a key role for FAK in
regulating the formation or dissolution of focal adhesion
structures and thus in controlling cell motility. Another
alternative is that FAK plays a vital role in adhesion
regulation of apoptosis (Frisch et al., 1996a); however,
other mechanisms may be equally or more important in
this phenomenon (Cardone et al., 1997) (Section X.).
Likewise, although many investigations have been
concerned with activation of the MAPK pathway by in-
tegrin-mediated adhesion, our biological insights into
this process remain limited. One important possibility is
that integrin signaling to MAPK helps regulate cytoskel-
etal assembly through PLA2 and arachidonate metabo-
lites (Auer and Jacobson, 1995; Clark and Hynes, 1996)
and contractility of actinomyosin through MLCK (Kl-
emke et al., 1997). However, one should not discount the
possibility that durable activation of MAPK via cell ad-
hesion contributes to cell cycle traverse or cell differen-
tiation mediated primarily by soluble growth or differ-
entiation factors. We will return to this theme in Section
IX.
In addition to events involving kinases, integrins
have been reported to elicit a variety of other signaling
events in cells, particularly ones involving mono- and
divalent cations. Through regulation of ionic transients,
integrin-mediated cell adhesion can affect the intracel-
lular environment which has the potential to affect myr-
iad signaling pathways. Integrin-mediated increases in
intracellular calcium play an important role in the reg-
ulation of cell adhesion and can also regulate contractil-
ity through calmodulin-dependent regulation of MLCK.
Furthermore, calcium transients may contribute to the
regulation of PKC activity and may negatively regulate
FAK-mediated signaling through calpain-mediated pro-
teolysis (Cooray et al., 1996; Schwartz, 1993a; Sjasstad
and Nelson, 1997). Integrin-mediated adhesion also el-
evates intracellular pH (pHi), largely through activation
of the Na
1/H
1 antiporter (Ingber et al., 1990; Schwartz
et al., 1989, 1991a,b). Regulation of pHi through anti-
porter activity plays an important, but not well under-
stood, role in many aspects of cell growth and division
(Bianchini and Pouyssegur, 1994; L’ Allemain et al.,
1984a,b; Pouyssegur et al., 1985; Vairo et al., 1992). One
particularly relevant observation is that inhibition of
antiporter function (pharmacologically or by genetic de-
ficiency) inhibits Rho-mediated formation of stress fi-
bers (Vexler et al., 1996). MAPK is thought to play
a major role in regulation of antiporter function
(Bianchini et al., 1997), raising the possibility that inte-
grin-mediated cell adhesion may activate the Na
1/H
1
TABLE 4
Cross-talk between integrins or with other adhesion receptors
Adhesion receptors involved Biological effect Reference
a5b1/avb3 a5b1 affects motility mediated by avb3 (Bauer et al., 1992)
avb3/a5b1 avb3 affects phagocytosis mediated by a5b1 (Blystone et al., 1995)
aMb2/FcIII aMb2 and the FcIII receptor cooperate in the respiratory burst (Zhou and Brown, 1994)
avb5/uPAR A protease receptor modulates avb5-mediated motility (Yebra et al., 1996)
L-selectin/b2 L-Selectin activates b2 integrins (Hwang et al., 1996)
PECAM-1/b2 and b1 The Ig-family receptor PECAM-1 activates b2 and b1 integrins (Newman, 1997)
N-cadherin/b1 and b3 Integrins activate N-cadherin (Monier-Gavelle and Duband, 1997)
aIIb/b3/other b1 integrins Trans-inhibition of one integrin by another (Diaz-Gonzalez et al., 1996)
SIGNAL TRANSDUCTION AND SIGNAL MODULATION BY CELL ADHESION RECEPTORS 233antiporter through a mechanism involving MAPK acti-
vation.
A confounding degree of cross-talk exists between var-
ious integrin-associated signaling events. One manifes-
tation of this is the convergence of two or more regula-
tors on a single effector. Several of the signaling events
discussed previously can be regulated by multiple adhe-
sion-related proteins. A good example is the regulation
of PI-3K activity in response to adhesion. PI-3K is im-
plicated as an effector for a host of regulators including
Cdc42 and Rac, FAK, and Abl (see Sections IV. and V.),
yet the relative contributions of each of these proteins in
the adhesion-mediated regulation of PI-3K activity is
not fully understood. Finally, the possible regulation of
MLCK by integrin-mediated MAPK activation and of
MLCP by Rho-kinase illustrates that signaling pro-
cesses can use separate pathways to achieve the same
result, in this case the phosphorylation of the MLC.
Another characteristic of the intricacy of integrin signal-
ing is that a given regulator and effector often can be
connected through multiple pathways. The multiple po-
tential mechanisms of integrin-mediated MAPK activa-
tion exemplify this. Another example is provided by the
integrin regulation of intracellular calcium, which can
be achieved through IP3-mediated release of intracellu-
lar stores or activation of plasma membrane ion chan-
nels (Sjasstad and Nelson, 1997).
In summary, integrin-mediated cell adhesion regu-
lates numerous biochemical activities that may impinge
on an even greater number of cellular pathways and
events. These activities may appear tortuously interwo-
ven and at least a bit redundant. Clearly not all activi-
ties will occur in all cells under all adhesive conditions.
Indeed, it is most likely a combination of (at least) the
species of integrin and the type of matrix that will de-
termine the panel of responses for any given cell type.
Furthermore, despite the recent flurry of activity, the
field of integrin signaling is still in its infancy. The
consequences of integrin-mediated signals, their actual
contributions to cell function, have been speculated upon
more often than investigated. A simplistic, but func-
tional hypothesis is that signals generated by the inter-
action of a cell with a physiologically relevant matrix
will be permissive for or causal to that cell’s function,
whereas interaction of a cell with an inappropriate ma-
trix will generate signals that suppress cell function or
growth, or perhaps lead to apoptosis. Permissiveness for
cell function can include regulation of cell morphology
and/or motility, induction of specific acute responses
(e.g., in immune or inflammatory cells), or communica-
tion of the state of proper attachment to other biochem-
ical pathways to allow appropriate response to other
extracellular signals such as differentiation and growth
factors. This last aspect is of particular importance and
will be discussed in detail in Section IX.
VIII. Signaling by Cadherins, Selectins, and
Immunoglobulin-Cell Adhesion Molecules
In this section we will deal with signaling mediated by
non-integrin cell adhesion receptors, particularly the
cadherins, selectins, and Ig-CAMs. Considerable infor-
mation is available concerning cadherin signaling,
whereas less is known about signaling mediated by the
other families of adhesion receptors. As we shall see,
there are both similarities and differences in signal
transduction pathways mediated by integrins and by
non-integrin adhesion receptors.
A. Cadherin Signaling
1. Cadherins, catenins, adenomatous polyposis coli,
and the Wnt pathway Current understanding of a major
aspect of signal transduction involving cadherins comes
through a felicitous congruence of research from several
different fields. As described above, investigators inter-
ested in cadherin-mediated adhesion initially described
the catenins as a family of peripheral membrane pro-
teins involved in cadherin function and in the structure
of cell-cell adherence junctions. At approximately the
same time, developmental biologists were delineating
the Wingless signaling pathway in Drosophila that is
vital for establishing segment polarity in fly embryos
and adults. Genetic evidence implicated the Armadillo
protein as a key player in Wingless signaling; it turns
out that Armadillo is the fly homolog of mammalian
b-catenin and has approximately 70% amino acid iden-
tity to the mammalian protein. Wingless is a secreted
glycoprotein that is a member of the Wnt family of
growth factors that control developmental patterning in
both vertebrates and insects. Thus, Armadillo/b-catenin
is not only a structural protein of cell adhesion junctions,
but also a key player in a vital developmental signal
transduction cascade. To make matters even more inter-
esting, tumor biologists identified a tumor suppressor
gene called adenomatous polyposis coli (APC) whose loss
or inactivation is responsible for a familial predisposi-
tion to colon cancer. The protein product of APC can bind
to b-catenin and regulate its stability, abundance, and
ability to participate in signaling events. At this point
the reader can appreciate that cadherins, catenins, APC,
and Wnt proteins are all implicated in a complex signal-
ing and growth control network. The past several years
have seen a coalescence of our understanding of this
network, as we now will discuss.
2. Components of the Wnt-cadherin signaling pathway
a. WNT PROTEINS. Wnt genes express a family of gly-
coproteins of approximately 350 to 380 amino acids in
length that play key roles in embryonic development in
flies, frogs, and mammals (Nusse and Varmus, 1992;
Torres et al., 1996). Wnt proteins have signal sequences
and thus seem destined for secretion; however, little
soluble Wnt is recovered from cells expressing these
proteins because they seem to bind to ECM components,
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paracrine fashion. In mammals, Wnt genes originally
were identified as proto-oncogenes and seem to play this
role in mammary carcinogenesis. In addition, members
of the Wnt family are expressed in a highly localized and
regulated manner during mammalian development, and
have been implicated in cell fate determination (Nusse
and Varmus, 1992). The biological actions of Wnts are
complex; for example, members of the Wnt-1 subgroup
promote formation of the dorsoanterior axis in Xenopus,
whereas members of the Wnt-5A subgroup antagonize
this process (Torres et al., 1996).
b. FRIZZLED, DISHEVELED, AND GLYCOGEN SYNTHASE KI-
NASE 3. Downstream elements of the Wnt signaling
pathway have been delineated largely through genetic
screens in Drosophila. The receptor for Wingless, a Dro-
sophila Wnt protein, is encoded by the frizzled gene
(Bhanot et al., 1996). This suggests that known verte-
brate frizzled homologs may code for other Wnt recep-
tors. The frizzled protein of 694 amino acids has an
N-terminal cysteine-rich extracellular domain that is
important in Wingless binding, seven putative trans-
membrane segments, and a cytoplasmic C-terminal re-
gion. Although frizzled seems to be a seven-spanner, its
homology to well known G-protein-coupled receptors is
low. Little is known currently about the nature of the
signal immediately generated by frizzled proteins. The
disheveled gene, which codes for a protein of unknown
function, seems to be most immediately downstream of
frizzled. The next component of the pathway, zeste
white3/shaggy, has a mammalian homolog in the form
of glycogen synthase kinase 3 (GSK3). Wingless signal-
ing leads to inactivation of zeste white3/GSK3 kinase
activity, and as we shall see subsequently, to the accu-
mulation of cytoplasmic pools of Armadillo/b-catenin.
c. ARMADILLO/b-CATENIN. Both Armadillo and b-cate-
nin (781 amino acids) contain 13 consecutive partially
conserved 42 amino acid “armadillo” repeats flanked by
N-terminal and C-terminal domains (Cowin and Burke,
1996). Interactions of b-catenin with classic cadherins
occur through the armadillo repeats as does binding of
APC; indeed cadherin and APC compete for binding at
overlapping sites (Hulsken et al., 1994). The N-terminal
domain of b-catenin binds to a-catenin in the context of
adherence junctions (Cowin and Burke, 1996). In addi-
tion, the N-most 7 armadillo repeats of cytosolic b-cate-
nin also can bind to transcription factors termed LEF-
1/TCF (Behrens et al., 1996; van de Wetering et al.,
1997), and the LEF-1/b-catenin complex can migrate
from the cytoplasm to the nucleus. Once there, the DNA
binding domain of LEF-1 interacts with specific se-
quences, whereas the C-terminal domain of b-catenin
seems to be involved in transcriptional activation (van
de Wetering et al., 1997).
d. ADENOMATOUS POLYPOSIS COLI. The APC gene orig-
inally was identified as a key tumor suppressor gene in
colorectal carcinogenesis. Individuals with inherited
mutations in APC develop numerous colon polyps and
are predisposed to the development of colon cancer. Hu-
man APC is a very large protein (2843 amino acids) with
several distinct domains. APC interacts with b-catenin,
g-catenin, GSK3, tubulin, as well as several other pro-
teins (Huber et al., 1996; Morin et al., 1997; Su et al.,
1993); of most interest here is the ability of APC to bind
b-catenin and regulate its activity. The N-terminal re-
gion of APC plays a role in oligomerization; this is fol-
lowed by seven armadillo repeats, three 15 amino acid
repeats, seven 20 amino acid repeats, and a basic region
(Morin et al., 1997; Vleminckx et al., 1997). The 15
amino acid and 20 amino acid repeats are the critical
sites for binding of catenins; many of the APC mutations
observed in colon cancer result in truncations affecting
the 15 amino acid or 20 amino acid repeats, thus pre-
venting APC association with b-catenin.
3. A model for the Wnt-cadherin signaling pathway
Here we present a consensus model of the Wnt-Cadherin
signal transduction cascade (see fig. 8) (Gumbiner, 1996;
Huber et al., 1996; Peifer, 1996). The key feature of this
model is the existence of discrete but interchangeable
pools of b-catenin/Armadillo which can function both in
cell adhesion and in regulation of transcription. One pool
exists at the adherence junction where b-catenin can
interact with cadherins and, via a-catenin, with the
actin cytoskeleton. Another pool of b-catenin exists in
the cytoplasm. Molecules from this pool can bind to
LEF-1/TCF and the resulting binary complex can mi-
grate into the nucleus forming a ternary complex with
DNA (and thus a third pool of b-catenin) that selectively
regulates transcription of LEF-1 responsive genes. In
the consensus model, the size of the cytoplasmic pool of
b-catenin determines the extent of binary complex for-
mation and the degree of transcriptional activation. A
fourth pool of b-catenin associates with APC, which tar-
gets the b-catenin for degradation by an as yet undeter-
mined mechanism. The Wnt/Wingless signaling path-
way regulates the size of the cytoplasmic pool of
b-catenin. Thus binding of Wingless to Frizzled (or
Wnt-1 to a vertebrate frizzled homolog) sends a signal to
Disheveled which in turn negatively regulates the ki-
nase ZW3 (or its vertebrate homolog GSK3). Active ZW3/
GSK3 kinase binds the APC/b-catenin complex, phos-
phorylates APC, and enhances its association with
b-catenin (Rubinfeld et al., 1996). Wingless/Wnt signals
inhibit ZW3/GSK3 thus permitting dissociation of the
APC/b-catenin complex and increasing cytoplasmic
pools of free b-catenin. The cadherins of the adherence
junction compete for b-catenin binding and thus can also
influence the pool of free cytoplasmic b-catenin.
Although the general features of this model are widely
accepted, several points of controversy remain. One is-
sue concerns the role of cadherins in the Wnt signaling
pathway. There is significant evidence that b-catenin
plays independent roles in adherence junctions and in
signaling (Sanson et al., 1996). For example, mutational
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madillo for these two functions (Orsulic and Peifer,
1996). However, there is also considerable evidence that
cadherins can influence the Wnt signaling pathway by
competing for free b-catenin (Fagotto et al., 1996; Heas-
man et al., 1994). This controversy seems a matter of
emphasis and most investigators would probably agree
that the adherence junction pool of b-catenin is not
involved directly in signaling, but that recruitment to
this pool from the free cytoplasmic pool can negatively
modulate the Wnt pathway. Another issue concerns the
precise functional relationship between APC and b-cate-
nin. In mammalian cells wild-type APC seems to in-
crease b-catenin turnover/degradation, whereas mu-
tants of APC associated with tumorigenesis fail to do
this (Peifer, 1996; Rubinfeld et al., 1996). Recent studies
in melanoma cells (Rubinfeld et al., 1997) and in colon
carcinoma cells (Morin et al., 1997) have suggested
strongly that b-catenin is the key downstream effector of
the tumor suppressive effects of APC. However, in Xe-
nopus axis formation, APC seems to have a signaling
role that is at least partially independent of its role in
regulating b-catenin turnover, because overexpression
of APC does not alter b-catenin levels perceptibly (Vlem-
inckx et al., 1997).
4. Other aspects of cadherin signaling In addition to
modulating the Wnt pathway, cadherins have been im-
plicated in other signal transduction events. Cadherin-
mediated cell-cell association itself can trigger intracel-
lular tyrosine phosphorylation events (Kinch et al.,
1997); the proteins which are tyrosine phosphorylated
are quite distinct from those that are phosphorylated in
response to integrin-mediated adhesion to the extracel-
lular matrix. Cadherins have been reported to associate
with other types of receptors and signaling molecules in
the context of the adherence junction. For example,
b-catenin seems to mediate an association between the
EGF-receptor and cadherins (Hoschuetzky et al., 1994),
whereas the cytoplasmic kinase FER is associated with
p120cas, another structural component of the adherence
junction (Kim and Wong, 1995). Shc, an adapter protein
implicated in Ras pathway signal transduction, recently
has been reported to bind to the cytoplasmic domain of
cadherins via the Shc SH2 domain (Xu et al., 1997). A
early report that cadherin/catenin complexes interact
with RPTPm, an Ig-CAM family receptor tyrosine phos-
phatase (Brady-Kalnay et al., 1995), has been chal-
lenged recently (Zondag et al., 1996). However, it seems
likely that members of other adhesion receptor families
will “talk” to cadherins; for example, an integrin-cad-
FIG. 8. The cadherin-Wnt signaling pathway. The drawing illustrates the concept that both cadherins and the Wnt/Wingless signaling pathway
contribute to the control of cell growth and differentiation by regulating the pool of intracellular b-catenin/Armadillo. Four interchangeable pools of
b-catenin/Armadillo are shown: (1) at the cadherin-containing adherence junction; (2) free in the cytoplasm; (3) associated with the Lef-1/TCF DNA
binding protein in the nucleus; (4) associated with APC and targeted for degradation. Signaling through the Wnt/Wngless pathway regulates
APC-b-catenin association via the GSK3/ZW3 kinase.
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cently (Monier-Gavelle and Duband, 1997). Along these
lines, an exciting recent study indicates a direct link
between integrin signaling and regulation of the cad-
herin/b-catenin pathway. Thus, transfection of epithe-
lial cells with ILK (see Section III.A.3.a. above) results
in an epithelial to mesenchymal conversion, with a dis-
ruption of cadherin-based adherence junctions and the
production of a more motile fibroblastic phenotype (No-
vak et al., 1998). This seems to result from ILK phos-
phorylation and inhibition of ZW3/GSK3, leading to ac-
cumulation of b-catenin and activation of mesenchymal
genes responsive to the b-catenin/LEF-1 complex. These
results offer important new insights into the complex
relationships between cadherin-mediated cell-cell inter-
actions and integrin-mediated cell-matrix interactions.
B. Signaling by Immunoglobulin-Cell Adhesion
Molecules
1. Neural immunoglobulin-cell adhesion molecules
NCAM and L1 are neural Ig-CAM family members that
play an important role in neurite outgrowth (Tessier-
Lavigne and Goodman, 1996). Several years ago it was
established that a signal transduction process involving
tyrosine kinases, AA metabolites, and calcium fluxes
was responsible for NCAM/L1-mediated growth cone ac-
tivation and neurite extension (Baldwin et al., 1996).
During the past few years two distinct models have been
proposed to explain this phenomenon. One model pred-
icates a key role for an fibroblast growth factor (FGF)
receptor, suggesting that NCAM (or L1) can interact
directly with FGF receptor via a peptide sequence con-
served between the two types of molecules, thus activat-
ing tyrosine kinase activity and subsequently triggering
PLCg-mediated calcium responses (Saffell et al., 1997).
This model is discussed further in Section IX. of this
review concerning adhesion receptor-growth factor re-
ceptor interactions.
An alternative model implicates Src family tyrosine
kinases in NCAM and L1 signaling; thus neurons from
fyn minus “knockout” mice display inhibition of NCAM-
mediated neurite outgrowth, whereas neurons from src
minus mice display impairment of L1-mediated out-
growth (Beggs et al., 1994; Ignelzi et al., 1994). Recently,
biochemical evidence has been developed for a direct
association between the 140 kDa isoform of NCAM and
Fyn (Beggs et al., 1997). This same group also demon-
strated that NCAM binding interactions induce tyrosine
phosphorylation of FAK, the cytoplasmic tyrosine kinase
closely involved in integrin signaling (see Section IV.).
Because activated FAK binds to Src family members,
this suggests formation of a macromolecular complex
involving NCAM140, FAK, and Fyn that may regulate
neurite extension. This represents one of the first times
that FAK activation has been observed in response to a
non-integrin-mediated adhesion process. The two mod-
els of growth cone signaling may not be mutually exclu-
sive, because there are numerous examples in the sig-
naling literature of interplay between RTKs and Src-
family kinases.
In addition to activating intracellular kinases, neural
Ig-CAMs may also be functionally regulated by phos-
phorylation. Thus, the p90
rsk kinase (a downstream el-
ement of the Ras-MAPK pathway) has been shown to
phosphorylate L1 on Ser
1152 and modulate its neurite
outgrowth activity. NgCAM, an L1-related protein, has
been reported to associate with and be phosphorylated
by a casein kinase II (Kunz et al., 1996). Finally, L1
family adhesion molecules in chick retina are tyrosine
phosphorylated by Cek5, an Eph family tyrosine kinase
which is itself a member of the Ig-CAM superfamily of
receptors (Zisch et al., 1997).
Other Ig-CAM family members also have been impli-
cated in neuronal growth cone extension and guidance.
Thus DLAR, a Drosophila Ig-CAM family receptor ty-
rosine phosphatase, has been shown to be critical for
motor axon pathfinding (Krueger et al., 1996); whether
the phosphatase activity of DLAR is essential remains
undefined. Also in flies, the frazzled gene, which codes
for an Ig-CAM related to mammalian DCC (deleted in
colorectal cancer), and which is a receptor for netrins,
has been shown to play a key role in several aspects of
axon guidance (Keino-Masu et al., 1996; Kolodziej et al.,
1996).
2. Other signaling by immunoglobulin-cell adhesion
molecules A vast literature on the role of Ig-CAMs in
signal transduction in the immune system is available.
Indeed both the T-cell receptor and the B-cell receptor
are members of the Ig-CAM family, as are several other
key receptors in lymphoid cells. Because of the special-
ized nature of this extensive literature we cannot pursue
it in the context of this article. For further information
on Ig-CAM signaling and the immune response the
reader is referred to excellent reviews on these topics
(Crabtree and Clipstone, 1994; Weiss and Littman,
1994).
There recently has been increased interest in the role
of Ig-CAM receptors in nonneural and nonimmune sys-
tem cells. PECAM-1, a homotypic Ig family receptor
found on endothelial cells, platelets, and several types of
white blood cells seems to have a particularly interest-
ing and complex biology. It is critically involved in the
formation of intercellular junctions between endothelial
cells; it is also involved in leukocyte emigration (diape-
desis) from the blood through the vascular endothelium
and into sites of inflammation (Newman, 1997). PECAM
is clearly a signal transducing receptor because anti-
body-induced dimerization of PECAM on blood cells can
result in activation of b1 and b2 integrins. Recently, a
novel mechanism was elucidated that seems to be re-
sponsible for PECAM signaling (Jackson et al., 1997).
Upon platelet aggregation the cytoplasmic domain of
PECAM becomes tyrosine phosphorylated; this creates a
binding site for SHP-2, a cytoplasmic tyrosine phospha-
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implicated previously in signaling from certain receptor
tyrosine kinases to the Ras pathway, thus suggesting a
possible mechanism for PECAM signaling. Although
these events have been described in platelets, presum-
ably similar activities can occur in other cells expressing
PECAM.
Although there has been a great deal of interest in the
ICAM family as counter-receptors for b2 integrins,
ICAMs have been shown only recently to generate sig-
nals. Thus antibody cross-linking of ICAM-1 has been
shown to trigger an oxidative burst in monocytes, ty-
rosine phosphorylation in endothelial cells, and induc-
tion of the IL-1b gene in synovial cells (Koyama et al.,
1996b).
C. Signaling by Selectins
Relatively little is known currently about signaling by
members of the selectin family of adhesion receptors;
however, this area is developing very rapidly. One very
important aspect of selectin signaling concerns the role
of selectins as cosignaling agents in leukocyte activation
by vascular endothelial cells (Zimmerman et al., 1996b).
Thus, at sites of inflammation, endothelial cells both
up-regulate surface expression of P-selectin and also
express factors [platelet-activating factor (PAF), C-X-C
and C-C family chemokines] act through G-protein-cou-
pled receptors to activate b2 integrins on leukocytes.
The activating factors such as PAF act in a juxtacrine
fashion and require P-selectin-mediated interaction for
full effect. This topic is discussed in more detail in Sec-
tion IX. below, which deals with cooperation between
adhesion receptors and other receptors.
Here we will deal with the limited information cur-
rently available on direct signaling by selectins or their
mucin-type counter receptors. Downey and colleagues
provided some of the earliest observation on selectin
signaling, showing that engagement of L-selectin con-
tributed to the oxidative burst in neutrophils (Waddell et
al., 1994), and later showing that the MAPK pathway in
these cells could be triggered through L-selectin (Wad-
dell et al., 1995). In a more detailed analysis, Brenner et
al. (1996) showed that antibody engagement of L-selec-
tin in wild-type Jurkat T-lymphoid cells led to tyrosine
phosphorylation of the selectin, association with GRB2/
SOS, GTP-loading of Ras, activation of MAPK, and a
Ras/Rac-dependent oxidative burst; however, in Jurkat
cells deficient in p56
lck, a Src family member, none of
these events occurred. Thus, L-selectin signaling re-
quires the Lck kinase as an early upstream signaling
pathway component. In contrast to integrin signaling,
L-selectin signaling to tyrosine kinases and MAPK does
not seem to require extensive cross-linking, because use
of a secondary antibody does not enhance the effects of
primary anti-L-selectin. In contrast, a pathway leading
from L-selectin to activation of b2 integrins in T cells
seems to require use of a secondary antibody to promote
cross-linking, or use of GlyCAM-1, a physiological ligand
for L-selectin that is polyvalent (Hwang et al., 1996).
The mucin-like counter receptors for selectins also seem
to be able to signal. An early study (Celi et al., 1994)
showed that adhesion of monocytes to P-selectin could
induce the expression of tissue factor mRNA in these
cells; the adhesion presumably is mediated through
PSGL-1, the P-selectin counter receptor. In a similar
vein, the binding of T cells to P-selectin has been re-
ported to trigger tyrosine phosphorylation of FAK and
other cellular proteins (Haller et al., 1997). Thus both
selectins and transmembrane counter-receptors for se-
lectins (such as PSGL-1) seem to be able to generate
various types of signaling events in leukocytes. This
area is still in an early phase of development and much
remains to be learned about the biochemistry and bio-
logical implications of signaling involving the selectin
family.
D. Collagen Binding Receptor Tyrosine Kinases
An important new development in adhesion signaling
is the identification of the “orphan” tyrosine kinases
DDR1 and DDR2 as collagen binding receptor tyrosine
kinases (Shrivastava et al., 1997; Vogel et al., 1997).
These molecules have an extracellular domain that is
related to discoidin 1, a lectin-like adhesion protein from
Dictyostelium discoideum, whereas the intracellular do-
mains have typical tyrosine kinase structures. DDR1
and DDR2 bind to native triple helical collagens,
whereas collagen-associated carbohydrates also may
play a role in binding and stimulation of tyrosine kinase
activity. Because integrins (particularly a2b1) also in-
teract with collagens, these novel kinases may well play
some sort of cosignaling role with integrins. Activation
of DDR1 and 2 proceeds relatively slowly, does not seem
to trigger MAPK, but enhances the expression of matrix
metalloproteases and thus may play a role in tumor
invasion.
E. Summary
The Wnt signaling pathway influenced by cadherins
seems to be quite distinct from integrin signaling with
its interplay of tyrosine kinases and MAPK cascade com-
ponents. However, as described above, cadherins also
may influence other signaling pathways, including ones
involving tyrosine kinases and phosphatases, and thus
may have some similarity to integrin signaling. In sig-
naling by Ig-CAMs and selectins, tyrosine phosphoryla-
tion is a key event, whereas some studies also are be-
ginning to implicate MAPK cascade components in these
pathways. Thus integrins and other cell adhesion recep-
tors may share much of the same basic signal transduc-
tion machinery. The biological raison d’e ˆtre for signaling
by adhesion receptors remains unclear but presumably
is related to the cell’s need to process positional infor-
mation, as well as information about the availability of
soluble growth and differentiation factors.
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Mitogens and Differentiation Factors
A. Introduction
It has become increasingly clear that, in addition to
generating their own brand of signals, cell adhesion
receptors can regulate the cellular response to other
extracellular stimuli, such as soluble growth factors and
differentiation-inducing agents. Perhaps the best known
incarnation of this is anchorage-dependent growth, a
phenomenon which has been studied for nearly 30 years
(Stoker et al., 1968). Recently many aspects of anchorage
control of cell growth have been ascribed to integrin-
mediated interactions with ECM proteins, thus placing
anchorage dependence in a more biochemical context. At
one level, the reason for adhesion-mediated regulation of
signal-induced events is simple; not everything a cell can
do should happen wherever and whenever a cell hap-
pens to be. Thus, the regulation of cellular events, both
reversible (e.g., synthesis/secretion of specific proteins)
and irreversible (e.g., cell division, differentiation, apo-
ptosis), is through the coordinated effects of positive and
negative signals, including ones from soluble factors, as
well as ones from the ECM and from adjacent cells. It is
this summation of signals conveying both chemical and
positional information which tells a cell when the time
and place is right to conduct a particular activity. In this
section we will deal with cooperation or collaboration
between soluble factors and cell adhesion receptors.
Once again the emphasis is on integrins, but we will deal
with other adhesion receptors as well.
B. Integrin Modulation of Growth Factor Signaling
Integrin regulation of signaling by soluble growth fac-
tors has been documented in many types of adherent
cells. These include endothelial cells (Short et al., 1998),
epithelial cells (Streuli, 1993), fibroblasts (Lin et al.,
1997b; Miyamoto et al., 1996), keratinocytes (Mainiero
et al., 1997), hepatocytes (Liu et al., 1991), chondrocytes
(Arner and Tortorella, 1995), myoblasts (Sastry et al.,
1996), astrocytes (Cazaubon et al., 1997), and neurons
(Schmidt and Kater, 1995).
There are several ways in which integrins and growth
factors may cooperate in mediating cellular events (see
fig. 9A). For example, there is compelling evidence that
ECM and soluble factors can synergize to regulate the
intracellular ionic environment. Specifically, whereas
both bFGF and adhesion to fibronectin can indepen-
dently activate the Na
1/H
1 antiporter and raise pHi in
endothelial cells, growth factor stimulation of adherent
cells is more efficient in the process (Ingber et al., 1990).
Similarly, in fibroblasts, PKC-dependent activation of
the antiporter (and elevation of pHi) by PDGF requires
cell adhesion (Schwartz and Lechene, 1992). Also,
PDGF-stimulated Ca
21 mobilization, another ion tran-
sient required for cell cycle progression in murine fibro-
blasts, does not occur in cells in suspension but readily
occurs in cells adherent to fibronectin (Tucker et al.,
1990). The mechanism underlying this regulation is
among the most intellectually satisfying in the field. In
adherent cells, PDGF stimulates tyrosine phosphoryla-
tion and activation of PLCg, which hydrolyzes PI(4,5)P2
into DAG and IP3, which in turn activate PKC and
increase Ca
21
i. In nonadherent cells, the activation of
PLCg by PDGF still occurs, but there is a dramatic
decrease in the level of its substrate, PI(4,5)P2, and
therefore no appreciable generation of DAG and IP3 can
occur (McNamee et al., 1993). Presumably, the adhesion-
dependent synthesis of PI(4,5)P2 is largely caused by the
activation of PI4–5K activity by Rac and Rho (as dis-
cussed in Section VI.).
Perhaps the most direct mechanism whereby inte-
grins can collaborate with soluble factors is the physical
interaction of integrins and associated proteins with one
or more components of a given growth factor signaling
cascade. Assembly of these “signaling scaffolds” would
localize, or rather juxtapose normally diffusible ele-
ments of the signaling cascade and thereby allow trans-
duction of the signal to occur more efficiently. Receptor-
mediated signals are generated at the membrane and
propagated through the cytoplasm to their appropriate
targets. Within focal adhesions, integrins physically
bridge the ECM to the network of cytoplasmic actin
microfilaments, a situation that seems particularly well
suited for providing an appropriate molecular scaffold
for signaling components, as discussed in Section III.
above. One of the most direct examples of physical cou-
pling of adhesion and growth factor pathways is the
insulin-stimulated association of avb3 with the IRS-1
(Vuori and Ruoslahti, 1994), and in a recent report, with
the insulin receptor itself (Schneller et al., 1997). IRS-1
is heavily tyrosine phosphorylated after insulin stimu-
lation and is required for the transduction of signals
initiated at the insulin receptor. Significantly, insulin-
stimulated DNA synthesis in avb3-expressing cells is
enhanced when the cells are plated on vitronectin (an
avb3 ligand) versus other substrates, whereas no en-
hancement is seen in cells expressing the avb5 vitronec-
tin receptor (Vuori and Ruoslahti, 1994). There are other
examples of scaffolding occurring directly at the level of
the growth factor receptor. Thus the EGF receptor di-
rectly associates with microfilaments, and its close rel-
ative, p185
neu, is found in a microfilament- and mem-
brane-associated, high-molecular weight glycoprotein
complex that contains elements of several signal trans-
duction cascades, including the Ras-MAPK pathway
(Carraway and Carraway, 1995). In epithelial cells, the
association of the EGFR with the actin cytoskeleton
appears to be regulated by cell density, being far less
stable in subconfluent versus confluent cells, and this
affects the efficiency of EGF-induced signal transduction
(Bedrin et al., 1997). Recently, it has been reported that
a highly tyrosine-phosphorylated subfraction of PDGF
receptor from stimulated cells coimmunoprecipitates
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avb3 by adhesion to vitronectin can enhance PDGF-
induced mitogenesis (Schneller et al., 1997).
In another report of integrin-mediated scaffolding,
cells incubated with microbeads coated with integrin
ligands (fibronectin or RGD peptides) form focal contact-
like structures at the cell-bead interface, and these
structures are enriched for several signaling molecules,
including Src, FAK, PLCg, PI-3K, the Na
1/H
1 anti-
porter, and the high-affinity FGF receptor flg (Plopper
FIG. 9. Collaboration between cell adhesion molecules and soluble factors. (A) Mechanisms for collaboration between integrins and soluble factors.
Integrin-mediated adhesion and signaling may down-regulate a factor that inhibits receptor signaling [e.g., a protein tyrosine phosphatase (PTPase)]
or may provide a necessary substrate (e.g., PIP2) or cofactor for a growth factor-mediated activity (e.g., PLC). Also, integrin-mediated adhesion may
establish “signaling scaffolds” that juxtapose cytoskeleton-associated coactivators (X) with growth factor-regulated activities (e.g., Ras/Raf), or which
physically interact with growth factor receptors themselves. (B) Signal transduction events stimulated by N-cadherin, L1, and NCAM leading to
neurite outgrowth. Homophilically-bound N-cadherin, L1, or NCAM (CAM) molecules are postulated to recruit the FGF receptor (FGFR) via binding
motifs to the CAM homology domain (filled triangle). FGFR recruitment causes autophosphorylation of the FGFR at Tyr766 in the cytoplasmic domain
creating a binding site for the SH2 domain of phospholipase C gamma (PLCg). Activation of PLCg triggers a cascade through the utilization of
phosphatidylinositol 4,5-bisphosphate (PIP2) to yield diacylglycerol (DAG) and inositol trisphospate (IP3), conversation of DAG to arachidonic acid (AA)
culminates in the AA-dependent influx of calcium ions through N- and L-type calcium channels. Diagram adapted from Doherty and Walsh, 1996. (C)
Collaboration between P-selectin and platelet-activating factor (PAF) in the activation of leukocytes. Upon activation of endothelial cells P-selectin and
PAF are expressed rapidly on the endothelial cell surface. P-selectin is capable of binding carbohydrate moieties such as PSGL-1 on the surface of
leukocytes, such as neutrophils. Tethering of neutrophils to the vascular vessel wall promotes binding of PAF with its receptor on the neutrophil
membrane. Resultant activation of neutrophils leads to increases in intracellular calcium, cell polarization and activation of b2 integrins by an
inside-out signaling mechanism. Diagram adapted from Zimmerman et al. (1996).
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bead-associated complexes, after isolation, retained ty-
rosine kinase and inositol lipid-metabolizing activities.
As discussed in Section V. above, other experiments,
using ligand- or anti-integrin antibody-coated beads,
have identified more than 20 signaling molecules asso-
ciated with focal contacts (Miyamoto et al., 1995b, 1996),
including several Src family kinases, the PTP-1D ty-
rosine phosphatase, PLCg, and PI-3K, as well as Rho
family GTPases Rac and Rho, several components of the
MAPK and JNK cascades, and most recently, receptors
for bFGF, PDGF, and EGF. The association of RTKs
with integrin/focal adhesion complexes is transient (last-
ing approximately 60 min after bead addition) and in-
dependent of growth factor binding, but it seems to
require both integrin aggregation and occupancy (Miy-
amoto et al., 1996). Integrin engagement apparently is
sufficient to induce ligand-independent RTK tyrosine
phosphorylation in some systems (Sundberg and Rubin,
1996), but not in others (Lin et al., 1997a; Miyamoto et
al., 1996).
Recent findings hint at several different mechanisms
whereby integrins may regulate growth factor signal
transduction. Several reports have described coopera-
tion between adhesion and growth factors in the activa-
tion of MAPK (Cybulsky and McTavish, 1997; Inoue et
al., 1996; Lin et al., 1997b; Miyamoto et al., 1996; Ren-
shaw et al., 1997). In most instances, growth factor stim-
ulation of nonadherent cells or cells attached nonspecifi-
cally to polylysine or plastic has little or no effect on
MAPK activity [but not so in some systems (Hotchin and
Hall, 1995)], and in all cases, engagement of integrins
through adhesion to ligand-coated substrata or beads
significantly enhances growth factor activation of
MAPK. The adhesion dependence of growth factor acti-
vation of MAPK is ablated in cells transformed by viral
oncogenes, including v-ras,v - src, and v-mos (Inoue et al.,
1996). Dissection of the pathway between growth factor
receptors and MAPK suggests that in nonadherent fi-
broblasts, the early stages of growth factor signaling,
including RTK autophosphorylation (Chen et al., 1996b)
and Ras GTP-loading, are intact, whereas the activation
of downstream kinases (i.e., Raf, MEK, and MAPK) is
attenuated significantly, with Raf activation being par-
ticularly affected (Lin et al., 1997b). Observations in a
recent report partially reiterate these results, but sug-
gest that attenuation of mitogenic MAPK activation in
suspended cells may occur at the level of MEK (Renshaw
et al., 1997). However, effects of adherence also have
been observed on receptor autophosphorylation in fibro-
blasts and epithelial cells (Cybulsky and McTavish,
1997; Miyamoto et al., 1996). In both cases, integrin
engagement through either adhesion to ligand-coated
plates (Cybulsky and McTavish, 1997) or incubation
with antibody- or ligand-coated beads (Miyamoto et al.,
1996) was shown to synergize with growth factors to
allow efficient tyrosine phosphorylation of the growth
factor receptor. Thus, there is convincing evidence in
several cell types that integrin-mediated cell adhesion
can increase the efficiency of growth factor signaling to
the MAPK pathway. Whether the locus of adhesion mod-
ulation of growth factor signaling is at the level of the
receptor tyrosine kinase or at a downstream step may
vary among cell types or be influenced by experimental
conditions.
C. Signal Modulation by Other Cell Adhesion
Molecules
1. Neuronal cell adhesion molecules Neuronal axon
guidance and outgrowth involve the integration of sig-
nals emanating from growth factors and guidance mol-
ecules, and from interactions of cell adhesion receptors
with ligands on surrounding cells and the ECM. As
mentioned in Section VIII., there are currently two the-
ories concerning the mechanism of signaling by neuro-
nal adhesion molecules involved in neurite outgrowth.
One version suggests direct intracytoplasmic interac-
tions between the cytoplasmic domains of adhesion re-
ceptors such as NCAM and Src-family kinases. Another
theory, now also supported by compelling data, is that in
the neuronal growth cone, homotypic cell adhesion re-
ceptors such as N-cadherin, NCAM and L1 promote
axon extension through their ability to modulate the
fibroblast growth factor receptor (FGFR) (reviewed in
Doherty and Walsh, 1996).
To study neurite outgrowth mediated by different
neuronal cell adhesion molecules, Doherty and col-
leagues extensively used a coculture system whereby rat
cerebellar neurons or PC12 pheochromocytoma cells are
plated onto a transfected 3T3 cell monolayer. Expression
of physiological levels of N-cadherin, NCAM or L1 in the
3T3 cells enhances neurite extension from cerebellar
neurons or PC12 cells relative to that exhibited by cells
plated onto untransfected 3T3 cells (Doherty et al.,
1991). In this experimental paradigm, a battery of phar-
macological agents have been used to define the down-
stream components of the pathway. The initial step de-
pends on an erbstatin-sensitive tyrosine kinase and
subsequent events activate PLCg and in turn stimulate
the liberation of DAG from PI(4,5)P2 and the production
of AA by a DAG lipase (Williams et al., 1994b,c,d). AA
production can lead to the influx of calcium via N- and
L-type channels. Hence agents that block Ca
21 influx
also inhibit the neurite outgrowth supported by neuro-
nal CAMs and conversely, agonist-induced activation of
calcium channels enhances neurite extension in the ab-
sence of intercellular neuronal CAM interactions (see
fig. 9B) (Doherty et al., 1991; Saffell et al., 1992; Wil-
liams et al., 1994b). A similar cascade of events is trig-
gered by FGF binding to its receptor, as indicated by the
finding that FGF treatment of cerebellar neurons or
soluble L1 treatment evokes the same pattern of ty-
rosine phosphorylation (Williams et al., 1994a).
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pressed widely in the developing nervous system and
activation of the receptor results in neurite outgrowth
(Green et al., 1996; Jaye et al., 1992; Wanaka et al.,
1990; Williams et al., 1994b). A conserved 20 amino acid
region of the FGFRs contains three sequences that are
individually homologous to short extracellular se-
quences in N-cadherin, L1, and NCAM and this region
in FGFRs has been termed the CAM homology domain
(CHD) (Williams et al., 1994a). Several lines of experi-
mental evidence suggest that regions of this FGFR-CHD
bind via intracellular cis-interactions with regions in
N-cadherin, NCAM, and L1 (Doherty and Walsh, 1996;
Saffell et al., 1997; Williams et al., 1994b). The same
group recently has shown that treatment with soluble
forms of L1 and NCAM leads to FGFR tyrosine phos-
phorylation (Saffell et al., 1997) and that a peptide that
inhibits FGF binding to its receptor does not perturb
N-cadherin, L1, and NCAM-induced neurite outgrowth
(Williams et al., 1994a). Thus, NCAM modulation of the
RTK apparently occurs in the absence of FGF ligand.
These effects are seemingly specific to N-cadherin,
NCAM, and L1 versus integrin-mediated outgrowth
(Williams et al., 1994a), and neurite outgrowth induced
by NGF, potassium depolarization, or cholera toxin is
unaffected in cells expressing a dominant-negative
FGFR (Saffell et al., 1997). In summary, these studies
indicate that neurite outgrowth supported by N-cad-
herin, NCAM, and L1 is mediated through the activation
of the FGFR, with the CHD of the FGFR being critical to
this response. Despite these data, no direct evidence of
N-cadherin, NCAM, or L1 binding to FGFR has been
presented to date. An additional complexity is the find-
ing that the cytoplasmic domain of NCAM is required for
its ability to act as a neuronal receptor and promote
neurite outgrowth (Saffell et al., 1995). A likely expla-
nation here is that the cytoplasmic domain is necessary
for the localization of NCAM to sites of cell-cell contact.
Thus, in the neuronal growth cone, homophilic bind-
ing of N-cadherin, L1, and NCAM may lead to their
recruitment to sites of cell-cell contact. Neuronal CAM
aggregation, directly or indirectly, leads to coclustering
of FGFR family members into a complex, resulting in
FGFR activation and initiation of a cascade that leads to
calcium influx and neurite outgrowth (fig. 9B). In this
scenario, activation of FGFR via heterophilic binding of
two neuronal CAMs, for example different cadherin fam-
ily members, is not ruled out. This model, which relies
on a similar cellular distribution of the relevant cell
adhesion molecule and FGFR, and a common down-
stream mechanism of action for all three adhesion mol-
ecules, seemingly is opposed to studies indicating diver-
gent pathways whereby L1 signals via Src and NCAM
via Fyn and FAK (Beggs et al., 1994, 1997; Ignelzi et al.,
1994).
2. Cadherin-catenin complexes In a manner analogous
to the neuronal CAM-FGFR model, cadherin-catenin
complexes have been proposed to interact with mem-
brane-bound signaling molecules. As described above,
cadherins in complex with cytoplasmic catenins mediate
cell-cell interactions in a variety of cell types. Hos-
chuetzky and colleagues have shown that in epithelial
cells, the autophosphorylated EGF receptor coimmuno-
precipitates with cadherin-catenin complexes (Hos-
chuetzky et al., 1994). Binding may be mediated through
b-catenin, as under in vitro assay conditions the central
core of b-catenin can bind directly to the EGF receptor
(Hoschuetzky et al., 1994). b-Catenin does not contain
regions with obvious homology to SH2 domains, and so
in this case, the binding is not through SH2-phosphoty-
rosine interactions. Another putative physical associa-
tion of this class of cell adhesion molecules is with the
receptor-type protein tyrosine phosphatase, PTPm; coim-
munoprecipitation and immunofluorescence studies
demonstrated an interaction in mink lung cells and rat
tissue lysates (Brady-Kalnay et al., 1995). However,
whether this is true, nonartifactual interaction recently
has been questioned, because Zondag and colleagues
failed to detect PTPm-cadherin-catenin complexes in re-
ciprocal immunoprecipation experiments in the same
cell line (Zondag et al., 1996). The physiological rele-
vance of these putative interactions, as yet, remains
unclear. Tyrosine phosphorylation is critical to the func-
tion of cadherin-catenin complexes and the integrity of
cell junctions (Behrens and Birchmeier, 1994; Behrens
et al., 1993; Birchmeier, 1995); hence, their association
with RTKs or PTPs may influence adhesion by altering
the phosphorylation state of cadherins and catenins. In
accord with this theory are the findings that b- and
g-catenins are tyrosine phosphorylated in epidermoid
carcinoma cells after EGF stimulation (Hoschuetzky et
al., 1994) or after treatment with a broad specificity
phosphatase inhibitor (Brady-Kalnay et al., 1995). The
influence of catenin binding on the respective pathways
downstream of the EGF receptor and PTPm is open to
conjecture.
3. Selectins Cellular interactions between leukocytes
and endothelial cells are critical during inflammation
because circulating blood cells adhere to and subse-
quently migrate through the endothelial layer of the
blood vessel. Initial binding of leukocytes to and rolling
along the endothelium is mediated by low-affinity inter-
actions with the selectin family of cell adhesion recep-
tors (Lasky, 1992; McEver, 1994). Studies in this field
have provided a model of collaboration whereby a cell
adhesion receptor, P-selectin, and signaling molecule,
PAF, act in combination on the endothelial cell surface
to elicit a signaling pathway in an attached leukocyte.
Endothelial stimulation by agents, such as thrombin or
histamine, results in both the translocation of P-selectin
to the plasma membrane and cell surface expression of
PAF. P-selectin relocalization enables leukocytes to ad-
here loosely and then roll along the endothelial cell
surface through binding of ligands, e.g., PSGL-1. This
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an elevation of intracellular calcium levels, functional
activation of b2 integrins, cell polarization, and priming
for enhanced degranulation (Ben-Baruch et al., 1995;
Lorant et al., 1991, 1993). However, none of these acti-
vation steps are direct responses to P-selectin binding
alone (Lorant et al., 1993). Enhanced granular secretion
from neutrophils bound to activated endothelial cell
monolayers or CHO cells expressing transfected P-selec-
tin on their surface is inhibited by an adhesion-blocking
anti-P-selectin antibody or by competitive agonists for
the PAF receptor (Lorant et al., 1993). Similarly, immo-
bilized P-selectin moderately enhances b2 integrin func-
tion only when bound neutrophils are costimulated with
PAF (Lorant et al., 1993). These data indicate that P-
selectin and PAF act together to bind and activate neu-
trophils. P-selectin acts to capture neutrophils on the
endothelial cell surface enabling activation of neutro-
phils by the juxtracrine signaling molecule, PAF (see fig.
9C). The resultant increase in b2 integrin affinity teth-
ers the leukocytes to the surface of an inflamed vessel
and is essential for transmigration to extravascular
sites. This model depicts endothelial cell-mediated acti-
vation of leukocytes occurring in a localized fashion,
thereby targeting the response and reducing widespread
reaction. These concepts were discussed in more detail
in a recent review (Zimmerman et al., 1996a).
D. Summary
The ability to influence the downstream signaling of
receptors that are activated by soluble growth and dif-
ferentiation factors may be one of the most vital biolog-
ical functions of cell adhesion receptors. This is a rela-
tively new and rapidly growing area of investigation and
much remains to be learned; however, several alterna-
tive models for collaboration between adhesion receptors
and other receptors have emerged already, as discussed
in detail above. Perhaps the simplest situation is where
interaction with an adhesion receptor directly activates
a growth factor receptor without the need for that recep-
tor’s soluble ligand. This seems to be true when NCAM
interacts with FGFR during neurite outgrowth, or when
b1 integrins directly activate PDGFb receptor. A second
model entails the ligand-mediated activation of growth
factor receptors that have been recruited to integrin-
dependent adhesion sites. The increased concentration
of receptor tyrosine kinases (and possibly direct interac-
tions with integrins) increases the efficiency of receptor
activation; this type of event has been reported for EGF
receptor, PDGF receptor, and insulin receptor. A third
model suggests that integrin-dependent adhesion struc-
tures act as molecular “scaffolds” for the downstream
components of signaling cascades, thus allowing more
efficient propagation of the signal. This type of event has
been reported in fibroblasts for activation of the MAPK
cascade. Finally, cell adhesion receptors may simply
bring two cells into juxtaposition, thus allowing efficient
transmission of paracrine signals, as has been described
in leukocyte-endothelial cell interactions.
X. Cell Adhesion Receptors and the Control of
Cell Cycle and Programmed Cell Death
A. Cell Adhesion and Cell Cycle Control
1. Overview of the cell cycle machinery The importance
of adhesion in the control of cell growth and division has
been known for many years. One of the key differences
observed between transformed cells and their normal
counterparts is that transformed cells can respond to
soluble growth factors and proceed through the cell cycle
while in suspension, whereas nontransformed cells re-
quire adherence to a substratum to respond (Clarke et
al., 1970). In recent years some of the molecular and
biochemical events underlying anchorage dependence of
cell growth and division have begun to come to light.
Before discussing the details of recent findings, however,
it is worthwhile to briefly review some of the basic fea-
tures of the cell cycle.
The molecular machinery that dictates movement of a
cell through the phases of the cell cycle comprises a
series of cyclins and CDKs. Levels of expression of var-
ious cyclin proteins change during different phases of
the cycle, typically with gradual increases followed by
precipitous drops as the cell passes the phase where a
particular cyclin-CDK complex is needed. By contrast,
the expression levels of the kinases do not vary so dra-
matically throughout the cycle. To a first approximation,
cyclin A/B-CDC2 complexes are required for entry into
M phase, cyclin A-CDK2 complexes for transit of S
phase, whereas cyclin D-CDK4/CDK6 complexes are as-
sociated with G1, and cyclin E-CDK2 with the G1/S
transition (Sherr, 1993, 1996) (see fig. 10).
The G1 phase of the cell cycle is regulated by external
factors such as peptide mitogens, whereas later events
in the cycle are more autonomous and reflect the inexo-
rable turning of the cell cycle machine. Several years
ago, Pardee (1989) defined a point late in G1 termed “R”
the “restriction point” (equivalent to “START” in yeast)
that is the demarcation between mitogen-dependent and
mitogen-independent cell cycle progression. Recently, it
has become clear that anchorage dependence of cell
growth also is confined to G1, and that once cells pass a
point essentially identical with R, they no longer require
adhesion to a substratum to complete the cycle (Bohmer
et al., 1996). Thus, mitogens and anchorage need to play
coordinate roles in transit through a key point of the cell
cycle. Movement through the R point is associated with
activation of cyclin D-CDK4,6 complexes and (possibly to
a lesser degree) with activation of cyclin E-CDK2 com-
plexes (Assoian, 1997; Sherr, 1994). A key function for
these cyclin-CDK complexes is to phosphorylate Rb pro-
tein and its family member p107. These so-called “pocket
proteins,” in their hypophosphorylated forms, tightly
bind members of the E2F transcription factor family;
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complexes, E2F is released and then can transcription-
ally activate genes that are required for further progress
through the cell cycle (fig. 10).
The kinase activity of cyclin-CDK complexes is regu-
lated by the interplay of several factors. First, CDKs
require association with their cognate cyclin to be active.
In addition, an upstream CDK-activating kinase phos-
phorylates both CDK2 and CDK4, and this event is also
required for activation. Cyclin-CDK complexes are neg-
atively regulated by the of binding cyclin-dependent ki-
nase inhibitor proteins (CDIs), with the ratio of CDI to
CDK in a complex regulating its level of activity. There
are two families of CDIs: the cip/kip group (p21
cip1/waf1,
p27
kip1, p57
kip2) that are essentially universal negative
regulators of cyclin-CDK complexes, and the INK4
group (p15, p16, p18, p19) that specifically act on cyclin
D-CDK4,6 complexes (Sherr, 1994). Thus, there is intri-
cate regulation of the G1 cyclin-CDK complexes, afford-
ing both mitogens and cell anchorage many opportuni-
ties to affect progression through this phase of the cell
cycle.
2. Links between signaling pathways and the cell cycle
Initiation of the G1 phase of the cell cycle is under the
control of external signals such as polypeptide growth
factors. However, the mechanistic connections between
growth factor-triggered signaling cascades and the
events of the cell cycle are just beginning to be worked
out. The immediate-early gene c-myc seems to be a key
link between growth factor-induced signals and cell cy-
cle components. Expression of c-Myc is low in quiescent
cells and is induced shortly after exposure to growth
factors by signals projected through the Ras/MAPK cas-
cade. As discussed above, regulation of cyclin D-depen-
dent kinases is a key aspect of early events of cell cycle
traverse and seems a convergence point for mitogenic
signals (Lukas et al., 1996). Expression of cyclin D1
message and protein is increased by ectopic expression
or activation of c-Myc (Daksis et al., 1994; Russell et al.,
1995). In addition, c-Myc seems to act to cause the se-
questration of the p27 CDI in an inactive form, thus
potentiating the activation of G1 CDKs (Vlach et al.,
1996). There is also direct evidence that MAPKs can
increase expression of cyclin D1. Promoter activity for
cyclin D1 is stimulated by overexpression of MAPK and
inhibited by a dominant negative form of this kinase
(Albanese et al., 1995). Cells transfected by SV40 small
t-antigen display increased cyclin D1 promoter activity
via a mechanism that involves t-antigen inhibition of
phosphatases that regulate MAPK and JNK pathways
(Watanabe et al., 1996a). Finally, recent work has shown
that cyclin D1 expression in fibroblasts is positively reg-
ulated by p42/p44 MAPK and negatively regulated by
the related p38 kinase pathway (Lavoie et al., 1996). By
this means early signaling events in the MAPK pathway
and related pathways can have an impact on the G1 cell
cycle transition.
3. Cell cycle activities regulated by cell adhesion Most
of the work done thus far on anchorage regulation of the
cell cycle has been done in various fibroblast lines, al-
though there have been some studies in other cell types.
Whereas different studies disagree about some of the
details, there seems to be a general consensus emerging
on the overall mechanism. The key event of hyperphos-
phorylation of the Rb protein requires both soluble mi-
togens and cell anchorage; this is seen in both human
and rodent fibroblasts (Kang and Krauss, 1996; Schulze
et al., 1996; Zhu and Toews, 1994). The identity of the
cyclin-CDK complexes most important for regulating Rb
phosphorylation in response to adhesion is somewhat
uncertain at this point. Two groups have found that the
expression of cyclin D1 mRNA and protein is strongly
adhesion-dependent (Assoian, 1997; Resnitzky, 1997;
Zhu et al., 1996), thus placing emphasis on cyclin D1-
CDK4,6 complexes. This emphasis is supported by the
observation that ectopic expression of cyclin D1 can re-
lieve anchorage dependence of cell cycle traverse in rat
fibroblasts (Resnitzky, 1997). However, another group
found no difference in levels of cyclin D1, D3, or CDK4 or
6 proteins, and no difference in cyclin D-CDK6 kinase
activity in anchored versus suspended cells (Fang et al.,
1996). Several investigators have observed an anchor-
age dependence of the activity of cyclin E-CDK2 com-
plexes because of changes in the levels of associated
CDIs. In suspended cells, the expression of p21 is in-
creased and the turnover of p27 is decreased (Schulze et
al., 1996; Zhu et al., 1996); this may lead to an increase
in the amount of p21 and p27 associated with cyclin
E-CDK2 complexes and thus a reduction in activity
(Fang et al., 1996). In situations where there is reduced
FIG. 10. Anchorage regulation of the cell cycle. Key regulators of the
cell cycle including cyclins, cyclin-dependent kinases (CDKs), the p21 and
p27 inhibitor proteins, and the Rb protein are shown at the approximate
times of their major periods of activity. Positive (1) or negative (2)
influences of integrin-mediated cell anchorage on these cell cycle regula-
tors are shown. Adapted from Sherr (1993).
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lead to a redistribution of p21 and p27 to cyclin E-CDK2
complexes, thus furthering the inhibitory process (As-
soian, 1997). Cyclin A expression and the S phase tran-
sition are also affected by adherence in NRK and
NIH3T3 fibroblasts (Guadagno et al., 1993; Schulze et
al., 1996; Zhu et al., 1996). In NIH3T3 cells, the expres-
sion of cyclin A is regulated transcriptionally through an
E2F site in the cyclin A promoter (Schulze et al., 1996).
The effects of loss of anchorage in these cells could be
reversed by overexpression of cyclin D1, whereas over-
expression of p27 could repress cyclin A promoter activ-
ity in adherent cells. The underlying mechanisms here
presumably relate to the abundance and state of activa-
tion of cyclin D- and cyclin E-dependent kinase com-
plexes and their ability to phosphorylate Rb and p107
and thus release E2F family transcription factors. A
generally similar picture, relating cyclin A induction to
anchorage regulation of cyclin E-CDK2 complex activity,
also was observed in NRK cells (Carstens et al., 1996).
Although, the mechanisms involved in cell anchorage
regulation of cell cycle activities are still obscure, one
interesting possibility is that the anchorage regulation
of MAPK described at length above can influence acti-
vation of the cyclin D1 promoter in the same manner as
growth factor regulation of MAPK pathways.
In addition to anchorage dependence of cell growth,
many normal (untransformed) fibroblasts also display
contact inhibition of cell growth; that is, as cells reach
high density cell cycle progression ceases (this is clearly
because of cell contact, not nutrient depletion). Contact
inhibition is presumably a consequence of cell-cell adhe-
sion between fibroblasts, although the cell surface mol-
ecules responsible for this process have not been identi-
fied. In contact-inhibited rat fibroblasts, there was a
reduction in cyclin D-CDK4 kinase activity (Kato et al.,
1997). This was not caused by reduced levels of the
cyclin or kinase proteins, but rather by maintenance of
high levels of the p27 CDI; thus the picture in contact-
inhibited cells resembles that seen in some types of
fibroblasts where accumulation of CDIs blocks G1 CDK
activity in nonanchored cells (Fang et al., 1996).
One of the hallmarks of oncogene-transformed cells is
their loss of the anchorage requirement for cell cycle
progression. Recently there have been a few direct stud-
ies of the interplay between oncogenes and anchorage in
cell cycle regulation. For example, Kang and Krauss
(1996) used a mutant fibroblast cells line (ER-1–2), that
upon ras oncogene transformation, retains anchorage
dependence of cell growth, although displaying other
aspects of the transformed phenotype. In wild-type fi-
broblasts cyclin A expression was highly anchorage de-
pendent; as expected, ras transformation of these cells
abrogated anchorage dependence of cyclin A expression.
By contrast, in the ER-1–2 line both untransformed and
ras transformed cells displayed anchorage-dependent
cyclin A expression. Interestingly, ras transformation of
both wild-type and ER-1–2 fibroblasts led to anchorage-
independent activation of cyclin E-dependent kinases
and Rb hyperphosphorylation. Further, overexpression
of cyclin A in ras-transformed ER-1–2 cells, but not in
untransformed ER-1–2, supported anchorage-indepen-
dent growth, suggesting that cyclin A is the key limiting
factor in the ras-transformed cells, but that other an-
chorage-dependent factors are vital in the untrans-
formed cells. Thus in the ER-1–2 ras system there seems
to be an uncoupling between G1 CDK activation and Rb
phosphorylation, and the subsequent induction of cyclin
A, in contrast to the observations of Schulze et al. (1996)
in 3T3 cells. Interestingly, the defect in anchorage con-
trol in ER-1–2 ras cells is rescued by extracellular ATP,
presumably acting through a P2 purinergic receptor
(Yang and Krauss, 1997). The studies of Krauss and
colleagues thus have underlined the multifactorial na-
ture and complexity of anchorage regulation of the cell
cycle, especially in the context of oncogene effects.
4. Anchorage regulation of the cell cycle: a role for
specific integrins? The investigations described thus far
compared anchored and nonanchored cells, but did not
consider in detail the underlying mechanism of cell an-
chorage. Thus, an issue arises as to whether anchorage
regulation of the cell cycle is an integrin-mediated phe-
nomenon, or whether any form of cell attachment to a
substratum would do (for example, tethering cells to a
positively charged polymer or via an adsorbed antibody
to a cell surface protein not known to be involved in
cell-ECM adhesion). Several recent publications suggest
that, at least in some circumstances, anchorage control
of cell cycle activities is a specific integrin-mediated
process. For example, vascular smooth muscle cells can
attach to both polymerized type I collagen fibrils and to
denatured “monomer” collagen; however, cells on poly-
merized collagen arrest in G1, whereas cells on mono-
mer collagen can proliferate (Koyama et al., 1996a). The
biochemical basis for cell cycle arrest on polymerized
collagen seems to be an inhibition of cyclin E-CDK2
kinase activity because of increased levels of the p21 and
p27 CDIs and is thus similar to the effect of loss of
anchorage. Cells attach to both polymerized and mono-
mer collagen using the a2b1 integrin; however, on poly-
merized collagen fewer focal contacts are formed and the
cells are less spread. This suggests that integrin-medi-
ated focal contact formation supports cell cycle traverse
and that disruption or reduction of focal contacts pro-
motes arrest. This notion is supported by the observa-
tion that an anti-a2 integrin antibody Fab fragment
inhibited cell cycle traverse of cells attaching on mono-
mer collagen. It should be noted that the cells remain
“anchored” under all these circumstances but that the
extent of the integrin-mediated connections between an
ECM protein (collagen) and the cytoskeleton is different
in the two cases.
In another situation, in vascular endothelial cells, en-
gagement of the integrin avb3, but not other integrins,
SIGNAL TRANSDUCTION AND SIGNAL MODULATION BY CELL ADHESION RECEPTORS 245led to effects on both apoptotic pathways (see below) and
on components involved in the cell cycle, particularly
p21
cip1 (Stromblad et al., 1996). In a study that indi-
rectly connects integrin-specific events to cell cycle con-
trol, Radeva et al. (1997) showed that overexpression of
the ILK induced anchorage-independent, but not serum-
independent, growth of rat intestinal epithelial cells.
The associated biochemical events included activation of
CDK4 and cyclin E-associated kinases and phosphory-
lation of Rb protein. Because ILK binds to b1 and b3
integrin subunits and is regulated by integrin-mediated
cell adhesion, this suggests that the anchorage regula-
tion of cell cycle in this system is integrin dependent.
There are also several other studies where expression
of specific integrin subunits has had a profound impact
on cell growth control. In most of these cases investiga-
tion of changes in the cell cycle machinery was pursued
to only a limited degree, but it seems clear that such
effects will underlie the alterations in growth control. A
very interesting set of observations concerns the b1c
subunit; this alternatively spliced version of the b1 sub-
unit contains a unique 48 amino acid C-terminal se-
quence. Potentially b1c can complex with several inte-
grin a subunits. Expression of b1c in mouse fibroblasts
or CHO cells reduced expression of key cell cycle com-
ponents and inhibited DNA synthesis (Meredith et al.,
1995). The b1c subunit is expressed in normal prostate
epithelium, but not in prostate carcinoma (Fornaro et
al., 1996). These observations suggest that b1c is a neg-
ative regulator of growth in normal cells, and its loss in
tumor cells may contribute to their uncontrolled growth.
Another case of specific integrin effects on cell growth
control concerns the b6 subunit. This subunit complexes
with the av subunit to form avb6 integrins that bind the
matrix proteins fibronectin and tenascin. Expression of
b6 in a tumor line that lacks this subunit results in
enhanced proliferation; this function has been mapped
to a unique 11 amino acid region of the b6 cytoplasmic
domain that is not required for cell adhesion or focal
contact formation (Yokosaki et al., 1996). The a6b4 in-
tegrin is a receptor for laminins and usually is found in
hemidesmosomes rather than focal contacts. The ex-
tremely long cytoplasmic tail of b4 interacts with cy-
toskeletal elements of hemidesmosomes and may have
signaling functions as well. Ligation of a6b4 leads to
phosphorylation of the b4 subunit, recruitment of the
Shc adapter protein, and activation of the Ras-MAPK
pathway in keratinocytes (Mainiero et al., 1997). How-
ever, in colorectal carcinoma cells (Clarke et al., 1995)
and in bladder carcinoma (Kim et al., 1997), overexpres-
sion of the b4 subunit arrests cell growth, likely because
of increased expression of the p21 CDI (Clarke et al.,
1995). Thus the b4 subunit seems to have a unique and
complex role in regulating cell cycle events in epithelial
cells. Other recent work (Wary et al., 1996) has sug-
gested that specific a subunits may be involved in inte-
grin signaling and cell cycle control.
In summary, integrin-mediated cell anchorage is a
key regulator of cell cycle traverse. Nonanchored fibro-
blasts display impairment of cyclin D-, cyclin E-, and
cyclin A-dependent kinase activity, with the most im-
pacted kinase complex being a function of the cell type
and experimental conditions. In addition to effects
caused by the dramatic change between anchored and
nonanchored states, the expression or ligation of specific
integrins also can modulate cell cycle events.
B. Cell Adhesion and Apoptosis
1. Overview of apoptosis Cell adhesion is an important
regulator of apoptosis. The induction of a programmed
cell death pathway through abrogation of anchorage to
the substratum occurs most prominently in epithelial
and endothelial cells, and has been termed “anoikis.” In
addition, more subtle changes in engagement of specific
integrins also can affect programmed cell death path-
ways. Before discussing cell adhesion effects on cell
death, it is worthwhile to review briefly present concepts
concerning the mechanisms of apoptosis.
Programmed cell death (apoptosis) plays an important
physiological role in shaping the tissues of the develop-
ing organism and a pathophysiological role in many
diseases, including neurodegenerative disorders, as well
as in cellular responses to toxic insults such as ionizing
radiation and DNA-damaging drugs (Steller, 1995). In
contrast to death by necrosis, which involves generalized
intracellular damage, a loss of membrane integrity, and
release of cell contents, death by apoptosis involves a
very specific set of intracellular changes that culminates
in cell death without loss of plasma membrane integrity.
Some of the hallmark changes in apoptosis include in-
ternucleosomal cleavage of DNA leading to the forma-
tion of DNA “ladders” readily visualized by gel electro-
phoresis, the “blebbing” of plasma membrane and
shedding of membrane vesicles, nuclear condensation
and fragmentation, and eventual engulfment of mem-
brane-bound cellular fragments by phagocytes (Martin
et al., 1994).
The genes involved in the programmed cell death
pathway have been most clearly defined in Caenorhab-
ditis elegans where ced-3 and ced-4 were identified as
“killer” genes, whereas ced-9 antagonizes the death pro-
cess (Vaux, 1997). The ced-3 gene was shown to encode a
member of the caspase family of cysteinyl proteases,
formerly termed “ICE” proteases in mammalian sys-
tems. The ced-9 gene product finds its mammalian ho-
molog in BCL-2, a member of a family of proteins that
operate as homo- or heterodimers to either promote or
antagonize apoptosis. A mammalian homolog of the ced4
gene product has been identified only recently; this pro-
tein, termed Apaf-1, has a caspase recruitment domain
and can bind to and activate pro-caspase-3. In C. el-
egans, the apoptotic pathway is rather simple; CED-4
activates CED-3 and this process is inhibited by CED-9,
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(Golstein, 1997; Vaux, 1997).
As one would expect, regulation of apoptosis is more
complex in mammalian cells. There are at least 10
caspases in human cells. In most cases these CED-3
homolog proteins are present as proenzymes that are
cleaved and activated by other members of the caspase
family, indicating the existence of a proteolytic cascade
that ultimately leads to cell death (Porter et al., 1997).
Caspases are relatively promiscuous enzymes and thus
there are numerous caspase substrates in cells, includ-
ing key proteins such as Rb, nuclear lamins, poly(ADP-
ribose) polymerase, DNA-dependent protein kinase and
many others. It is not clear whether any one substrate is
the key to cell death; more likely there are multiple
parallel pathways contributing to the death process.
However, it is clear that activation/overexpression of a
single caspase is sufficient to trigger programmed cell
death (Porter et al., 1997).
The BCL-2 family of proteins (CED-9 homologs) plays
a key role in the regulation of apoptosis (White, 1996).
There are multiple representatives of this family in
mammals, both as individual gene products and as pro-
teins derived by alternative splicing. In this family, sup-
pressors of apoptosis include BCL-2 itself, BCL-XL, and
BCL-W, whereas BAX, BAK, and BAD promote or accel-
erate apoptosis. These molecules function as homo-and
heterodimers with the ratio of death promoters to death
suppressors presumably determining whether or not a
cell enters the apoptotic pathway. It seems clear that
BCL-2-related proteins operate upstream of caspases
and regulate their proteolytic activity (White, 1996);
however, the precise mechanism involved still is not
settled completely. Some powerful recent evidence sug-
gests that CED-4 can interact simultaneously with a
BCL-2 family member (BCL-XL) and with mammalian
caspases 1 and 8, indicating that BCL-2 regulates the
mammalian caspase cascade through CED-4, a situation
essentially parallel to that in C. elegans (Chinnaiyan et
al., 1997). However, the story may be more complicated
than that. BCL-2 and BCL-XL are membrane-bound
proteins; in particular they are located on the mitochon-
drial outer membrane. It has been proposed that BCL-2
can function as a pore or channel (Reed, 1997), perhaps
regulating the loss of mitochondrial membrane potential
known to occur in apoptic cells (Golstein, 1997). BCL-2
and BCL-XL can prevent the release of cytochrome C
from mitochondria, whereas release of cytochrome C
into the cytoplasm can activate the caspase cascade
(Kluck et al., 1997; Vander Heiden et al., 1997; Yang et
al., 1997). Thus BCL-2 may regulate apoptosis by con-
trolling the mitochondrial membrane permeability bar-
rier and the consequent release of cytochrome C and
other proapoptotic factors (Li et al., 1997b).
A cell’s decision whether or not to enter the apoptotic
pathway will depend on signaling processes that moni-
tor extracellular and intracellular events. The clearest
example of intracellular regulation concerns the p53
tumor suppressor gene, sometimes called the “guardian
of the genome” because it is up-regulated in response to
DNA damage and, in turn, can slow cell cycle progres-
sion and/or promote apoptosis (Ko and Prives, 1996). An
important mechanism whereby p53 promotes apoptosis
is through transcriptional activation of the bax gene,
thus changing the BAX/BCL-2 ratio to favor cell death
(White, 1996). The clearest example of extracellular reg-
ulation involves “death factors” such as TNF and Fas-
ligand (Nagata, 1997). These trimeric proteins bind to
their cognate cell surface receptors, thus triggering for-
mation of multimeric receptor complexes. The receptors
contain so-called “death domains” that tend to self-ag-
gregate; in addition, the receptor death domains bind to
similar domains in cytoplasmic adapter proteins (FADD/
MORT1 for Fas, TRADD for TNF-R). The adapter pro-
teins can bind to downstream effectors; among these are
caspase 8 which can interact with FADD/MORT1 (bound
to Fas, or via TRADD to TNF-R); the caspase and FADD/
MORT both possess a “death effector domain” that sus-
tains protein-protein interaction and self-activation of
the caspase. Thus cognate ligand binding to Fas or to
TNF-R can directly trigger a caspase cascade leading to
cell death.
Other extracellular factors provide survival rather
than death signals. It has become clear that several
peptides initially identified as “growth factors” are prob-
ably better described as survival factors; this would in-
clude the cytokines IL-2, 3, 4, 7, as well as granulocyte-
macrophage colony–stimulating factor, NGF, and
insulin-like growth factor-1 (Gajewski and Thompson,
1996). Recently, evidence has emerged that Raf-1, a key
kinase in the signaling cascade activated by growth fac-
tors, may exert a powerful influence on apoptosis. Thus
BCL-2 can recruit Raf-1 to the mitochondrial mem-
brane; once there, activated Raf can (directly or indi-
rectly) phosphorylate and inactivate BAD, relieving its
inhibition of BCL-2 and providing an antiapoptotic effect
(Wang et al., 1996b). Thus, some of the linkages between
growth regulatory signaling pathways and the control of
apoptosis are beginning to emerge. As we will see below,
signals from the ECM also play an important role in
regulating apoptosis.
2. Anchorage regulation of apoptosis A key set of early
observations showed that when untransformed epithe-
lial (Frisch and Francis, 1994) or endothelial (Meredith
et al., 1993; Re et al., 1994) cells are deprived of anchor-
age to an ECM substratum, the cells die by an apoptotic
mechanism. By contrast, fibroblasts respond to loss of
anchorage by G1 arrest. A new term “anoikis” was used
to describe programmed cell death initiated by loss of
anchorage (Frisch and Francis, 1994). In epithelial cells
overexpression of BCL-2 countered anoikis, as did trans-
formation with oncogenic forms of ras or src (Frisch and
Francis, 1994). The role of anoikis in normal physiolog-
ical function is unclear at this point; one possibility is
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cells that lose contact with their normal supporting ex-
tracellular matrix would die rather than survive to in-
vade or metastasize elsewhere.
The mechanistic basis of anoikis is the subject of very
active investigation. Because anchorage to ECM is me-
diated largely by integrins, one would presume that
integrins provide the initial signals governing anoikis;
however, this has not been studied in detail. It seems
clear that the FAK tyrosine kinase plays an important
role in antagonizing this process. Expression of an acti-
vated, membrane-anchored form of FAK rescued epithe-
lial cells from anoikis; also, the cells became anchorage
independent for growth and tumorigenic in nude mice
(Frisch et al., 1996a). Cell transformation seemed to
result primarily from resistance to apoptosis rather than
activation of cell growth pathways, because the acti-
vated FAK-expressing cells showed no change in MAPK
activity. Further study of the anoikis pathway showed
that activation of JNKs and of ICE/LAP3 (caspase 7)
occurred in response to loss of cell anchorage (Frisch et
al., 1996a). As expected, both caspase activity and
anoikis were blocked by the protease inhibitor crmA and
by overexpression of BCL-2. Activation of the JNK path-
way also may be essential to anoikis because expression
of a dominant negative JNK-kinase blocked the process.
Surprisingly, crmA and BCL-2 blocked the activation of
JNK, suggesting that a caspase might be involved in
activation of the JNK pathway. This novel concept was
supported in a recent report which demonstrated that
loss of matrix anchorage activates a caspase that cleaves
and activates MEK kinase-1 (MEKK-1), an upstream
kinase in the JNK pathway (Cardone et al., 1997).
Cleavage of MEKK-1 occurred in cytoplasmic extracts of
suspended epithelial cells and this could be blocked by
peptide inhibitors of Asp-Glu-Val-Asp (DEVD) specific
caspases. When overexpressed in cells, the MEKK-1
cleavage product triggered apoptosis, whereas full-
length MEKK-1 sensitized cells to anoikis. These inves-
tigations also suggested the existence of a positive feed-
back loop between MEKK-1 activation and caspase
activation. In summary, the investigations of Frisch and
colleagues (Cardone et al., 1997; Frisch et al., 1996a,b)
suggested a pathway that links integrins, BCL-2 family
proteins, MEKK-1/JNK signaling kinases, and caspases
as regulators of anchorage-dependent apoptosis (see fig.
11).
There are still issues regarding this scheme that must
be resolved. The role of the JNK pathway in apoptosis
seems to be quite variable in different model systems.
For example, JNK has been implicated in apoptosis in
response to growth factor deprivation (Xia, 1995) but
has been ruled out in TNF-mediated apoptotic responses
(Liu et al., 1996). Thus it is unclear whether the path-
way described above, which is based largely on observa-
tions in MDCK cells, will be conserved elsewhere. In-
deed, recent observations (Khwaja and Downward,
1997) have questioned the role of JNK in the suppres-
sion of apoptosis by cell anchorage. Another loose end
concerns the role of FAK, which seems to play no obvious
part in the caspase/MEKK-1 connection. One interesting
possibility is that FAK lies on a different pathway of
apoptosis regulation, one that also involves PI-3K. As
described in Section IV. above, FAK can bind to PI-3K
and may be involved in its regulation. Recently, it be-
came clear that PI-3K and its downstream effector the
Akt/PKB serine-threonine kinase play a key role in reg-
ulation of apoptosis caused either by anchorage loss or
by radiation-induced DNA damage (Khwaja et al., 1997).
Thus overexpression of activated forms of Ras or PI-3K
(but not of other effectors downstream of Ras) conferred
protection against anoikis. Cell anchorage was shown to
result in elevation of 39-phosphorylated phosphoinositi-
des and stimulation of the Akt kinase; further, overex-
pression of Akt provided protection against anoikis.
These studies provide a convincing demonstration of the
role of PI-3K in regulation of programmed cell death. At
this point, however, it is still not entirely clear how cell
anchorage might regulate PI-3K activity, thus linking
the two sets of events.
Although fibroblasts ordinarily respond to loss of in-
tegrin-mediated cell anchorage by arresting in G0/G1
rather than entering an apoptotic pathway, recent stud-
ies have shown that this choice can be modulated by
oncogenes. Thus Myc/Ras- or E1A/Ras-transformed cells
display anoikis when placed in suspension or when their
FIG. 11. Anchorage regulation of apoptosis. Two major pathways of
anchorage regulation of apoptosis have been described. One involves
FAK, PI-3K, and the Akt kinase. The other apparently parallel pathway
involves Bcl-2, Caspases, and MEKK1/JNK. Positive (1) or negative (2)
regulation of each factor on the next factor in the pathway is indicated.
The two pathways may be operant to different degrees in different cell
types. Adapted from Frisch and Rouslahti (1997).
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et al., 1997). When cells were transformed with Src
rather than Ras, the cells were resistant to anoikis. In a
study with rather different outcomes, Ras-transformed
fibroblasts either were allowed to attach to a substratum
or not, and then treated with farnesyl transferase inhib-
itors (Lebowitz et al., 1997). Exposure to farnesyl trans-
ferase inhibitors provoked massive apoptosis in cells;
this was p53 independent and could be blocked by BCL-
XL. Apoptosis also was attenuated by transfection of a
farnesyl-independent form of Rho B, arguing that the
Ras and farnesyl transferase effects were mediated
through a Rho protein. Although the mechanistic foun-
dations for these effects are unclear, they illustrate that
specific signals from different oncogenes can cooperate
with anchorage signals to regulate the choice between
cell cycle arrest and apoptosis.
Anoikis involves a radical disruption of the cell’s as-
sociation with its extracellular matrix substratum. How-
ever, matrix effects on apoptosis also have been observed
when more limited perturbations of cell-matrix interac-
tion have occurred, and evidence points to the involve-
ment of specific integrins. For example, as part of a
series of studies concerning integrins in angiogenesis,
Cheresh and colleagues examined the role of the avb3
integrin in regulating apoptosis in endothelial cells
(Brooks et al., 1994; Stromblad et al., 1996). The avb3
integrin is highly expressed in angiogenic but not in
resting endothelial cells. When avb3 is blocked in an in
vivo tumor angiogenesis model using inhibitory peptides
or antibodies, proliferative endothelial cells in capillary
sprouts undergo apoptosis, leaving cells in quiescent
vessels unaffected. This very interesting observation
eventually may form the basis of a novel approach to
cancer therapy. It should be noted that, in contrast to
anoikis, the endothelial cells in these studies remain
attached to ECM via adhesion receptors other than avb3
integrin; it is the specific disruption of the linkage be-
tween avb3 and matrix that initiates the apoptotic re-
sponse.
In a somewhat similar fashion, Bissell and colleagues
studied the effects of ECM on breast epithelial cell
growth and differentiation (Boudreau et al., 1995a).
They found that engagement with complex ECM, but not
with purified collagen or fibronectin, could suppress
mammary cell apoptosis (Boudreau et al., 1995b). Apo-
ptosis also could be induced by anti-b1 integrin antibod-
ies or by expression of a metalloprotease which degrades
matrix. The apoptotic process was blocked by inhibitors
of ICE proteases, as might be expected. It should be
noted that the cells always remained attached to the
matrix in these cases, and thus the situation was unlike
the simple loss of anchorage. In further work this group
suggested that a three-dimensional ECM is important in
allowing full epithelial cell differentiation and in sup-
pressing both inappropriate secretion of growth stimu-
latory autocrine factors and consequent apoptosis (Bou-
dreau et al., 1996). Although some of the underlying
mechanisms remain obscure, these studies illustrate
that very subtle changes in the manner in which cells
engage the ECM can strongly influence the cell’s com-
mitment to growth, differentiation, or apoptosis.
Another example of a specific integrin effect in apo-
ptosis concerns a5b1, the “classic” fibronectin-binding
integrin. Two groups have shown that overexpression of
a5b1 can confer resistance to apoptosis because of mito-
gen deprivation in both colon carcinoma cells (O’ Brien et
al., 1996) and in CHO cells (Zhang et al., 1995c). The
effect was quite specific in that expression of the inte-
grin avb1, also a fibronectin receptor, failed to prevent
apoptosis; the effect of a5b1 probably was mediated
through increased expression of BCL-2 (Zhang et al.,
1995c).
In summary, it is now clear that integrin-mediated
anchorage plays a key role in the regulation of pro-
grammed cell death. Complete deprivation of anchorage
leads to anoikis in epithelial and endothelial cells via a
pathway that involves caspase-dependent cleavage and
activation of MEKK1, a regulator of the JNK pathway.
Another, possibly completely independent, pathway
seems to involve FAK, PI-3K, and the Akt kinase (fig.
11). More subtle changes in integrin engagement with
the ECM also can modulate apoptotic pathways, and
some examples of integrin subunit-specific effects on
apoptosis are beginning to emerge.
XI. Cell Adhesion Receptors and the Regulation
of Gene Expression
Several lines of investigation have converged to show
that cell-matrix and cell-cell adhesion have important
consequences in terms of the regulation of gene expres-
sion during development and in adult tissues. Many
important insights into the role of adhesion molecules in
cell differentiation and tissue development have been
provided through study of targeted mutation of cell ad-
hesion genes. What is often striking is the exquisite
specificity of some of the phenotypes observed; for exam-
ple, an a8 integrin subunit knockout results primarily in
a profound disruption of epithelial-mesenchymal inter-
actions in the kidney (Muller et al., 1997). The approach
of targeted mutations recently has been reviewed thor-
oughly (Huber et al., 1996; Hynes, 1996) and will not be
discussed further here. The general topic of adhesion
molecules regulating gene expression also has been re-
viewed extensively by us previously (Juliano and
Haskill, 1993; Rosales et al., 1995). Here we will briefly
recapitulate selected aspects of the earlier work, and
add to that a presentation of some more recent findings.
Most of the work to be discussed relates to integrins.
There is much less information available concerning
gene regulation by adhesion receptors other than inte-
grins. Early studies have been discussed in a previous
review (Rosales et al., 1995), whereas additional exam-
ples are listed in table 5.
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icant fraction of the investigations thus far on adhesion
molecules and gene expression, namely fibroblasts,
monocytic cells, and breast epithelial cells, although
some work has been done in other cell types. In fibro-
blastic cells, a particularly interesting example of gene
regulation by adhesion receptors is the control of metal-
loprotease expression by a5b1 and a4b1 integrins. At-
tachment of cells to a fibronectin fragment containing
the RGD site, which binds a5b1, or attachment to anti-
a5b1 antibodies induces the expression of collagenase
and stromelysin, although expression was not induced
by adhesion to full-length fibronectin (Werb et al., 1989).
The full-length protein also contains a sequence recog-
nized by a4b1, and this interaction generates a signal
that suppresses metalloprotease expression (Huhtala et
al., 1995). A similar situation is seen in cells plated on a
mixed matrix containing fibronectin and tenascin, which
induces metalloprotease expression, whereas fibronectin
alone does not (Tremble et al., 1994). There are many
other examples of regulation of protease expression and
function by adhesive interactions with the ECM; this
topic has been reviewed recently (Werb, 1997).
A robust example of direct integrin-regulated gene
expression occurs in monocytes (Eierman et al., 1989;
Haskill et al., 1991; Yurochko et al., 1992). This system
has allowed new insights into the relationships between
matrix proteins, integrins, protein kinases, transcrip-
tion factors, oncogenes, and gene regulation (Juliano
and Haskill, 1993). In physiological terms, monocytes
need to engage with the ECM as they migrate from the
bloodstream into sites of inflammation. Experimentally,
when peripheral blood monocytes are plated onto sub-
strata coated with ECM ligands such as fibronectin,
collagen, or laminin, there is a rapid and profound in-
duction of several immediate-early genes including tran-
scription factors such as c-fos, c-jun, IkB, as well as
cytokines such as IL-1b, IL-8, and TNFa. The blood
coagulation component, tissue factor, also is induced in
monocytic cells by integrin engagement (Fan et al., 1995;
McGilvray et al., 1997). Cross-linking of b1, but not b2,
integrins with antibodies is sufficient to trigger the in-
duction of multiple immediate-early genes, indicating a
critical role for b1 integrins in this response (Yurochko
et al., 1992). Many of the genes induced by integrin
ligation have NF-kB motifs in their upstream regulatory
regions (Juliano and Haskill, 1993). Use of electro-
phoretic mobility shift assays and NF-kB reporter con-
structs have provided direct evidence that the NF-kB
transcription factor is activated after integrin ligation
(Lin et al., 1995). It seems likely that integrin-mediated
tyrosine phosphorylation is critically involved in imme-
diate-early gene induction in monocytes (Lin et al.,
1994), and that the key integrin-responsive tyrosine ki-
nase in monocytic cells may be SYK (Lin et al., 1995).
Ligation of b1 integrins in monocytic cells also causes
activation of MAPK (McGilvray et al., 1997), and inhi-
bition of the MAPK pathway with a specific inhibitor of
MEK-1 was sufficient to block integrin-mediated activa-
tion of NF-kB and expression of tissue factor. By con-
trast, intentional overexpression of activated elements
of the Ras/MAPK cascade can block integrin-mediated
activation of NF-kB (Rosales and Juliano, 1996); how-
ever, this may be caused by Ras/MAPK effects on the
activation status of integrins (Hughes et al., 1997). In
addition to activation at the transcriptional level, inte-
grin engagement also can regulate message stability in
monocytic cells (Lofquist et al., 1995; Sirenko et al.,
1997). In summary, some of the connections between
integrin ligation and monocyte gene induction are be-
ginning to be worked out; however, the picture is com-
plex and much remains to be done.
In addition to examples of direct integrin effects on
gene expression, there are several interesting situations
where integrin engagement modulates cellular re-
sponses to growth and differentiation factors. A good
example of this is myoblast differentiation as monitored
by expression of muscle-specific genes and formation of
myotubes (Sastry et al., 1996). Thus, ectopic expression
of the a5 subunit in primary quail myoblasts can syner-
gize with bFGF and insulin to allow cell survival and
induce proliferation in serum-free conditions. By con-
TABLE 5
Regulation of gene expression by cell adhesion receptors
Receptor Involved Gene Regulated Cell Type Reference
b1 integrins IE genes (cytokines TFs) Human monocytes (Yurochko et al., 1992)
b1 integrins Tissue factor Human monocytes (Fan et al., 1995)
b1 integrins (other integrins?) Milk genes Mouse breast cells (Streuli et al., 1991)
b1 integrins Muscle-specific genes Quail myoblasts (Sastry et al., 1996)
b1 integrins Metalloproteases Synovial fibroblasts (Werb et al., 1989)
b1 integrins Cytokines Chondrocytes (Yonezawa et al., 1996)
b2 integrins E-selectin Endothelial cells (Noble et al., 1996)
avb3 Metalloproteases Melanoma (Seftor et al., 1992)
avb3 p53 Endothelial (Stromblad et al., 1996)
a5b1 IE genes Colon carcinoma cells (Varner et al., 1995)
a5b1 Bcl-2 CHO cells (Zhang et al., 1995c)
Integrins IL-2 T cells (Udagwa et al., 1996)
Matrix (integrins?) Integrins Breast epithelia (Delcommenne and Streuli, 1995)
Matrix (integrins?) Liver specific Hepatocytes (DiPersio et al., 1991; Liu et al., 1991)
CEA (an Ig-CAM) NCAM, MUC18 Melanoma (Grimm and Johnson, 1995)
E-cadherin Syndecan (a proteoglycan) Mammary tumor cells (Leppa et al., 1996)
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proliferation and a high propensity to differentiate into
myotubes, whereas myoblasts expressing a5 proliferate
to a high cell density and resist differentiation even at
confluence. Another interesting example that may be
mediated at the level of gene expression concerns the
regulation of smooth muscle cell responsiveness to the
neuropeptide substance P (Dahm and Bowers, 1996).
Thus, an integrin-dependent interaction with the matrix
protein thrombospondin results in a suppression of sub-
stance P responsiveness in these cells.
Another system in which differentiation is regulated
by both integrins and soluble factors is mammary epi-
thelia. When cultured in the presence of a reconstituted
basement membrane matrix (Matrigel) and the lacto-
genic hormone, prolactin, mouse mammary epithelial
cells form multicellular, alveoli-like structures and se-
crete milk proteins (e.g., b-casein, lactoferrin) unidirec-
tionally into the lumen of the structure (Schmidhauser
et al., 1990). In the absence of cell-cell contact (i.e., no
alveolus formation), single cells cultured with Matrigel
and prolactin also express milk proteins but fail to do so
when on collagen, despite the presence of hormone
(Streuli et al., 1991). Milk production in collagen cul-
tures can be restored by allowing cell-cell contact
(Streuli et al., 1991). Addition of anti-b1 integrin anti-
bodies to the cultures can block casein production, sug-
gesting that the signal from the matrix is transduced
through integrins. Furthermore, the contribution of the
complex basement membrane matrix could be singularly
provided by laminin (Streuli et al., 1995a). The identifi-
cation of a matrix-responsive promoter element up-
stream of the b-casein gene (Schmidhauser et al., 1992),
and the observation that interaction with the ECM reg-
ulates the DNA binding activity of the prolactin-respon-
sive transcription factor STAT-5 (Streuli et al., 1995b)
demonstrate that matrix- or integrin-mediated signals
collaborate with lactogenic hormones at the level of tran-
scription. Recently, it has become clear that matrix en-
gagement prevents the activation of a tyrosine phospha-
tase that negatively regulates the activation of STAT-5
caused by lactogenic hormones (Edwards et al., 1997).
The establishment of cell polarity by integrin-mediated
matrix interaction is not required for prolactin-depen-
dent expression of milk proteins, as rounded, single cells
actively produce b-casein (Streuli et al., 1991). However,
in the multicellular alveolar structures, unidirectional
secretion of b-casein indeed does occur, implying cellular
polarity. Although it is clear that matrix interaction is
necessary and sufficient to allow b-casein expression, it
is likely that signals from matrix interactions cooperate
with signals from cell-cell contact to establish cell polar-
ity and allow proper, unidirectional secretion (Gum-
biner, 1996).
Another interesting example of integrin-related gene
expression concerns ILK, the integrin-linked kinase de-
scribed in Section III. Very recent work (Dedhar S.,
personal communication) has suggested that ILK may
play a key role in epithelial-mesenchymal transitions, as
often occur in development. Thus, ILK phosphorylates
and inhibits GSK3b, a key element of the Wnt signal
pathway (see Section VIII.), eventually leading to in-
creased transcription of mesenchymal genes regulated
by the LEF-1/b-catenin complex. This exciting result
introduces an important new link between the integrin
and cadherin signaling pathways at the level of gene
regulation.
XII. Conclusions
The concept that adhesion receptors such as integrins
or cadherins can serve as signal transducers is only
approximately 8 years old. Before that time adhesion
molecules were regarded as being vital structural com-
ponents that contributed to the architecture of cells and
tissues, but were not thought to play a role in the dy-
namic aspects of cell regulation. Now the field of adhe-
sion receptor signaling is burgeoning, as indicated by
the numerous very recent citations in this review. Ad-
hesion receptors are known to be critically involved in
fundamental cellular processes including cell differenti-
ation, cell cycle control, and programmed cell death,
whereas cooperation or coordination between cell adhe-
sion receptors and receptors for soluble growth and dif-
ferentiation factors may be the norm rather than the
exception.
The teleological basis for this receptor-receptor collab-
oration seems quite clear. In making decisions to commit
to growth, differentiation, or death, cells need informa-
tion about the availability of nutrients and soluble
growth/differentiation factors. However, cells also need
positional information about whether they are in an
appropriate relationship to the ECM and surrounding
cells; this information is provided through cell adhesion
receptors. Perhaps the most surprising thing about this
process is the mechanism for coordinating biochemical
and positional signals. It would be conceivable a priori to
have quite distinct signaling pathways for soluble fac-
tors and for positional cues; however, what seems to
have evolved is a situation whereby adhesion receptors
contribute to or modulate the signaling cascades used by
receptors for soluble factors. Perhaps the best described
example of this is the role of integrin-mediated adhesion
in modulating signaling through the peptide growth fac-
tor-MAPK pathway, but other examples also exist, as we
have discussed in Section IX. above. The primary mech-
anism for the coordination of soluble and positional sig-
nals is also becoming clear. It involves the adhesion-
dependent formation of “scaffolds” that allow the
efficient assembly and interaction of signaling molecules
such as GTPases and kinases. Much remains to be
learned concerning the molecular details of “who talks to
whom,” but the concept of adhesion receptors and cy-
toskeletal components forming supramolecular struc-
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ing cascades seems to have broad validity.
Thus, in a few short years our concepts of the biolog-
ical role of cell adhesion receptors have changed com-
pletely, leading to the opening of an exciting and dy-
namic new field of investigation. It is hoped that studies
in this area will result not only in important cell biolog-
ical insights, but also in novel approaches to pharmaco-
logical intervention in a variety of disease processes.
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